phosphorus has been researched along with Hyperparathyroidism, Secondary in 557 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 131 (23.52) | 18.7374 |
| 1990's | 68 (12.21) | 18.2507 |
| 2000's | 198 (35.55) | 29.6817 |
| 2010's | 130 (23.34) | 24.3611 |
| 2020's | 30 (5.39) | 2.80 |
| Authors | Studies |
|---|---|
| Adamska-Tomaszewska, D; Chudek, J; Kocełak, P; Olszanecka-Glinianowicz, M; Owczarek, AJ | 1 |
| Chon, Y; Drayer, D; Goodman, WG; Lai, J; Martin, KJ; Moore, C; Nemeth, EF; Ward, DT; Xu, J | 1 |
| Cao, J; Gan, W; Wen, P; Xie, W; Xiong, M; Yang, J; Zhang, L; Zhao, S | 1 |
| Huang, J; Huang, T; Xie, X; Xu, M; Xu, W; Zhang, C; Zhang, X; Zhang, Y | 1 |
| Lin, B; Liu, Y; Peng, C; Ren, M; Shen, W; Wu, J; Zheng, D | 1 |
| He, J; Nie, R; Sun, X; Zhao, L | 1 |
| Jiang, Y; Jin, Y; Wei, M; Wu, M; Wu, X; Yu, D; Zou, L; Zuo, L | 1 |
| Dudar, I; Dudar, S; Kulish, V; Shifris, I | 1 |
| Chen, G; Liu, Y; Yang, Q; Zhou, T | 1 |
| Gong, X; Jiang, X; Li, C; Li, S; Liao, X; Lu, Y; Sun, Y; Tong, Z; Wang, YA; Xu, J; Yang, L | 1 |
| Goto, M; Horii, Y; Morimoto, N; Nishimura, G; Sato, H; Takahashi, N; Tokushima, H | 1 |
| Deng, X; Ge, X; Tian, W; Yuan, Y; Yue, R | 1 |
| Cheng, F; Gong, L; Li, S; Li, Y; Lu, J; Tang, W; Wang, Z; Xu, W | 1 |
| Chen, X; Dong, X; Guo, Z; Li, J; Li, X; Ma, L | 1 |
| An, N; Bai, Y; Chen, R; He, J; Wang, C; Xu, M | 1 |
| Gao, MZ; Hong, FY; Lin, LP; Lin, M; Liu, WH; Ruan, YP; Wu, SS; Zhang, L | 1 |
| Gong, L; Jiang, W; Li, X; Liu, X; Xu, W; Yang, Q | 1 |
| Barreto, FC; Bucharles, SGE; Riella, MC | 1 |
| Bellorin-Font, E; Martin, KJ; Vasquez-Rios, G | 1 |
| Feng, S; Lu, Y; Shen, H; Zhan, Z; Zhang, Y | 1 |
| Fujii, H; Goto, S; Ito, J; Kono, K; Nishi, S | 1 |
| Asif, N; Ijaz, A; Khadim, MT; Khan, NB; Memon, AA; Nawaz, MA; Sawal, HA | 1 |
| Duque, EJ; Elias, RM; Moysés, RMA | 1 |
| Gutiérrez, OM | 1 |
| Li, Y; Peng, L; Wei, Y; Yu, MA; Zhao, ZL | 1 |
| Nakashima, A; Ohkido, I; Okabe, M; Saito, Y; Uchiyama, T; Yokoo, T | 1 |
| Endo, Y; Fukagawa, M; Hamano, N; Kawata, T | 1 |
| Rodríguez, M; Rodríguez-Ortiz, ME | 1 |
| Akizawa, T; Asada, S; Fujii, N; Fukagawa, M; Fukuhara, S; Fukuma, S; Kato, C; Miyakoshi, C; Nomura, T; Onishi, Y; Wada, M | 1 |
| Al Salmi, I; Csomor, PA; Evenepoel, P; Fukagawa, M; Jacobson, SH; Karaboyas, A; Liang, X; Pisoni, RL; Robinson, BM; Spiegel, DM; Tabibzadeh, N; Ureña-Torres, PA; Young, EW | 1 |
| Guo, W; Han, X; Liu, WH; Wang, LY | 1 |
| de Brito Marques, F; Ferreira, JL; Freire, L; Guedes, C; Guerreiro, L; Silva, S; Soares, V | 1 |
| Cekic, B; Erturk, MS; Pamuk, BO; Sarı, IK | 1 |
| Ariceta, G; Dell, KM; Dufek, MB; Eldred, A; Greenbaum, LA; Hoppe, B; Lee, HJ; Lerner, G; Linde, P; Warady, BA; Webb, NJA | 1 |
| Du, R; Gu, L; Hu, Z; Li, X; Li, Y; Shi, Y; Tang, C; Tang, Y; Wang, H; Xi, C; Yang, L; Yuan, H | 1 |
| Elias, RM; Moysés, RMA | 1 |
| Li, Z; Ma, L; Zhao, S | 1 |
| Alexander, S; Asuncion, F; Dean, C; Dwyer, D; Grisanti, M; Han, CY; Hensley, K; Ke, HZ; Li, X; Niu, QT; Ominsky, MS; Richards, WG; Stolina, M; Tomlinson, JE; Villasenor, K; Yu, L | 1 |
| Chen, X; Liu, H; Wang, C; Yuan, F; Zhou, A | 1 |
| Hu, XJ; Li, JG; Li, Y; Shan, AQ; Xiao, ZS; Zhang, SZ; Zhang, X | 1 |
| Liu, Y; Ran, J; Xiao, X; Xiong, X; Zhong, X; Zhou, D | 1 |
| Huang, L; Ji, H; Lu, Y; Sun, X; Yang, M; Zhang, L | 1 |
| Cannavò, R; Cestone, G; Cirillo, L; Cutruzzulà, R; Dattolo, PC; Errichiello, C; Gallo, P; Gregori, M; Mehmetaj, A; Sorrentino, A | 1 |
| Chen, Q; Liu, BC; Lv, LL; Ni, HF; Ni, LH; Song, KY; Tang, RN; Wang, B; Wang, FM; Wang, LT; Wu, M | 1 |
| Chen, X; Chen, XJ; Gong, XH; Shi, BM; Wu, WJ; Zhou, Q | 1 |
| Mima, A; Nagahara, D; Tansho, K; Watase, K | 1 |
| Cossi, MS; Delgado, MF; Lira, ALBC; Macedo, BM; Paiva, MDGMN; Tinôco, JDS | 1 |
| Jovanovich, A; Kendrick, J | 1 |
| Akizawa, T; Fukagawa, M; Shigematsu, T; Shimazaki, R | 1 |
| Koiwa, F; Mizobuchi, M; Ogata, H | 1 |
| Block, GA; Chertow, GM; Deng, H; Mather, O; Serenko, M; Sullivan, JT; Tomlin, H | 1 |
| Dumrongpisutikul, N; Eiam-Ong, S; Jakchairoongruang, K; Praditpornsilpa, K; Singhan, W; Susantitaphong, P; Susomboon, T; Vadcharavivad, S | 1 |
| Akdag, Y; Ersoy, FF; Hoser, H; Kendir, C; Koc, H | 1 |
| Brunini, F; Capone, V; Cozzolino, M; Cusi, D; Kwaidri, Y; Montanari, E; Ricca, F | 1 |
| Abbachi, F; Abouchacra, S; Bernsen, R; Chaaban, A; Gebran, N; Haq, N; Hassan, M; Khan, I | 1 |
| Kilpatrick, RD; Liu, J; Newsome, BB; Nieman, K; Solid, CA; St Peter, WL; Zaun, D | 1 |
| Chen, YW; Huang, CJ; Kawai, M; Nakane, M; Wessale, JL; Wu, MT; Wu-Wong, JR | 1 |
| Arenas-Fernández, J; Cannata-Andía, JB; Fernández-Martín, JL; Martínez-Camblor, P | 1 |
| Berenguer, L; Capra, R; Castellano, M; Chiurchiu, CR; de Arteaga, J; de La Fuente, JL; Douthat, WG; Garay, G; Guzmán, MA; Massari, PU | 1 |
| Albero-Molina, MD; Álvarez-Avellán, L; del Pozo-Fernández, C; López-Menchero-Martínez, R; Sánchez-Rodríguez, L | 1 |
| Akizawa, T; Fukagawa, M; Fukuhara, S; Fukuma, S; Hasegawa, T; Kido, R; Komaba, H; Kurita, N; Onishi, Y; Yamaguchi, T | 1 |
| Amdahl, M; Chen, N; Huang, Z; Jiang, G; Khan, S; Li, X; Lin, H; Liu, L; Qian, J; Wang, M; Xing, C; Yan, Y; Yu, X; Zuo, L | 1 |
| Chang, JF; Chen, HY; Hsu, SP; Pai, MF; Peng, YS; Tsai, WC; Wu, HY; Yang, JY | 1 |
| Furth, SL; Jüppner, H; Kumar, J; Messinger, S; Portale, AA; Salusky, IB; Schwartz, GJ; Warady, BA; Wesseling-Perry, K; Wolf, M | 1 |
| Chen, J; Wang, JD | 1 |
| Bravo, J; Crespo, J; Díaz, JM; García, MR; Gentil, MÁ; Gómez Alamillo, C; Gómez, G; Gutiérrez Dalmau, A; Jiménez, VL; Jimeno, L; Morales, E; Rodríguez Benot, A; Romero, R; Sáez, MJ; Torregrosa, JV | 1 |
| Biggar, P; Graf, H; Ketteler, M; Klauser-Braun, R; Kovarik, J; Müller, HW; Seidinger, S; Veres, A | 1 |
| Cozzolino, M; Goldsmith, D; Ketteler, M; Khan, S; Martin, KJ; Sharma, A | 1 |
| Blinov, SA; Denisov, SA; Kolevatov, AP; Teplykh, NS; Zarivchatskiĭ, MF | 1 |
| Clagett-Dame, M; DeLuca, HF; Plowchalk, DR; Plum, LA; Potochoiba, M; Zella, JB | 1 |
| Aguiar-Oliveira, MH; Campos Neto, IA; Oliveira, TC; Pereira, Fde A | 1 |
| Bolasco, P; Caria, S; Cupisti, A; Sau, G | 1 |
| Farbodara, T; Haghverdi, F; Mortaji, S; Saidi, N; Soltani, P | 1 |
| Ballinger, AE; Craig, JC; Nistor, I; Palmer, SC; Strippoli, GF | 1 |
| Baiko, S; Bakkaloğlu, S; Battelino, N; Bonthuis, M; Busutti, M; Gaydarova, M; Gianoglio, B; Gomes, C; Groothoff, JW; Heaf, JG; Jager, KJ; Kuzmanovska, D; Molchanova, MS; Pankratenko, TE; Papachristou, F; Parvex, P; Podracka, L; Reusz, G; Sanahuja, MJ; Schaefer, F; Shroff, R; van Stralen, KJ; Verrina, E | 1 |
| Coe, FL; Ennis, JL; Sprague, SM; Worcester, EM | 1 |
| Fukagawa, M; Iseki, K; Komaba, H; Taniguchi, M; Tsubakihara, Y; Wada, A | 1 |
| Alesutan, I; Amann, K; Artunc, F; Bohnert, BN; Daniel, C; Häring, HU; Heyne, N; Lang, F; Voelkl, J | 1 |
| Buerkert, J; Cooper, K; Da Roza, G; Goodman, W; Gurevich, K; Reiner, M; Sprague, SM; Wetmore, JB | 1 |
| Bos, WJ; Cannata-Andia, JB; Covic, A; Dionisi, MP; Fernández-Martín, JL; Ferreira, A; Floege, J; Gorriz, JL; Ketteler, M; Locatelli, F; London, G; Martínez-Camblor, P; Rodríguez-García, M; Rodríguez-Puyol, D; Rutkowski, B; Sánchez, JE | 1 |
| Chen, HY; Chiu, YL; Hsu, SP; Pai, MF; Peng, YS; Tsai, WC; Tung, KT; Wu, HY; Yang, JY | 1 |
| Block, GA; Bradbury, BD; Collins, AJ; Do, TP; Ishani, A; Liu, J; Lowe, KA; Wetmore, JB | 1 |
| Erb, H; Hemetsberger, M; Oberbauer, R; Pronai, W | 1 |
| Acosta Martínez, Y; Borrego Utiel, FJ; Bravo Soto, JA; García Álvarez, T; González Carmelo, I; López Jiménez, V; Mazuecos Blanca, MA; Merino Pérez, MJ | 1 |
| Duarte-Gallego, V; Esteve Simo, V; Fulquet Nicolas, M; Macias-Toro, J; Martínez Calvo, G; Moreno-Guzmán, F; Pou Potau, M; Ramírez-de Arellano Serna, M; Saurina Sole, A | 1 |
| Bondor, C; Gherman-Căprioară, M; Kacso, IM; Moldovan, D; Patiu, IM; Potra, A; Racasan, S; Rusu, C | 1 |
| Bradbury, BD; Brookhart, MA; Dluzniewski, PJ; Do, TP; Kshirsagar, AV; Reams, BD; Yue, SV | 1 |
| Hong, YA; Hwang, SY; Jung, MY; Kang, BH; Kim, JY; Ko, GJ; Kwon, YJ; Lee, EA; Lee, JB; Lee, JE; Pyo, HJ | 1 |
| Li, W; Lv, MD; Peng, L; Yao, L; Yu, MA; Zhang, L; Zhang, Y; Zhuo, L | 1 |
| Chen, J; Feng, J; Luo, Y; Wang, J; Zhou, Q | 1 |
| Bover, J; Egido, J; Fernández-Giráldez, E; Martínez-Castelao, A; Praga, M; Solozábal, C; Torregrosa, JV | 1 |
| Bravo, J; Castilla, YA; Esteban, MA; Esteban, RJ; Fernández-Castillo, R; García-Valverde, M; Nozal-Fernández, G; Orellana, JM | 1 |
| Akizawa, T; Fukagawa, M; Fukuhara, S; Fukuma, S; Kurita, N; Kurokawa, K; Onishi, Y; Yokoyama, K | 1 |
| Kalantar-Zadeh, K; Kumar, J; Pahl, M; Schomberg, J; Streja, E; Tran, NT | 1 |
| Diao, Z; Liu, J; Liu, S; Liu, W; Liu, X; Qian, L | 1 |
| Alcalde-Rodrigo, M; Galicia-Basart, M; Montoro-Ronsano, JB; Pérez-Ricart, A; Segarra-Medrano, A; Suñé-Negre, JM | 1 |
| de Luis Román, DA; López-Gómez, JJ; Pérez Castrillón, JL | 1 |
| Bell, RZ; Bezzaoucha, S; Desforges, K; Lafrance, JP; Lamarche, C; Leblanc, M; Lepage, L; Ouellet, G; Ouimet, D; Pichette, V; Rauscher, S; Vallee, M | 1 |
| Diao, Z; Li, D; Liu, W; Wang, L | 1 |
| Blaser, WJ; Buck, RD; Clagett-Dame, M; DeLuca, HF; Knutson, DC; Plum, LA; Thadhani, R; Zella, JB | 1 |
| Akiba, T; Akizawa, T; Fujii, A; Fukagawa, M; Kuramoto, T; Odani, M; Shigematsu, T; Yokoyama, K | 1 |
| Hirakata, H; Iida, M; Taniguchi, M; Tokumoto, M; Tsuruya, K | 1 |
| Fukagawa, M; Komaba, H; Tanaka, M | 1 |
| Hamada, C; Hasegawa, H; Higuchi, C; Hiramatsu, M; Hosoya, T; Itami, N; Kasai, K; Kawaguchi, Y; Kawanishi, H; Kubota, M; Masakane, I; Minakuchi, J; Mitarai, T; Nakao, T; Suzuki, H; Tomo, T; Yamamoto, H | 1 |
| Cointault, O; Durand, D; Esposito, L; Gandia, P; Gennero, I; Guitard, J; Kamar, N; Lavayssière, L; Rostaing, L; Spataru, L | 1 |
| Bolin, A; Dixon, D; Koch, K; Ma, J; Nakane, M; Noonan, W; Reinhart, G | 1 |
| David, K; Kumar, N; Lindberg, J; Menoyo, J; Morris, J | 1 |
| Jayaraman, M; Kumar, HK; Modi, KD | 1 |
| Gupta, A; Kermah, D; Norris, K; Omije, D; Pan, D; Wang, J | 1 |
| Valdivieso, JM | 1 |
| Charytan, C; Corry, DB; Fishbane, S; Goodman, WG; Ling, X; Rappaport, K; Roppolo, M; Shapiro, WB; Turner, S; Vicks, SL | 1 |
| Drüeke, TB | 2 |
| Tahara, H | 1 |
| Matsuoka, S; Sato, T; Tominaga, Y; Uno, N | 1 |
| Fukagawa, M; Komaba, H | 1 |
| Abboud, HE; Albizem, MB; Block, GA; Charytan, C; Chonchol, M; de Francisco, AL; Jolly, S; Kaplan, M; Kubo, Y; Locatelli, F; Mix, TC; Roger, SD; Sarkar, S | 1 |
| Arko, C; Block, GA; Li, Q; Liu, J; Nieman, K; Persky, M; St Peter, WL | 1 |
| Kalantar-Zadeh, K; Kovesdy, CP | 1 |
| Choucair, MK; Nabbout, LA; Salti, IS | 1 |
| Apostolou, T; Balaska, K; Drakopoulos, S; Gavriil, S; Hadjiconstantinou, V; Koukoulaki, M; Pistolas, D | 1 |
| Cannata-Andía, JB; Carrillo-López, N; Román-García, P | 1 |
| Hutchison, AJ; Mohammed, I | 1 |
| Chiarelli, G; Levin, A; Lim, L; Sigrist, MK | 1 |
| Abitbol, CL; Chandar, J; Freundlich, M; Seeherunvong, W; Zilleruelo, G | 1 |
| Filson, J; Nguyen, TV | 1 |
| Bakris, GL; Bhuriya, R; Chen, SC; Li, S; McCullough, PA | 1 |
| Elashoff, RM; Gales, B; Harkins, GC; Jüppner, H; Sahney, S; Salusky, IB; Wang, HJ; Wesseling-Perry, K | 1 |
| Inaguma, D; Tatematsu, M | 1 |
| Bos, WJ; Bouman, K; Braun, J; Brink, H; Carter, D; Frazão, JM; Graf, H; Macário, F; Maduell, F; Messa, P; Pontoriero, G; Reichel, H; Saha, H; Torregrosa, V; von Albertini, B; Wilkie, M; Yaqoob, M; Zani, VJ | 1 |
| Ashman, N; Baños, A; Bencova, V; Fouque, D; Jacobson, SH; Leavey, S; Malberti, F; Os, I; Rix, M; Ryba, M; Saha, H; Ureña, P; Vervloet, M; Zani, V; Zitt, E | 1 |
| Brandenburg, V; Cozzolino, M | 1 |
| Ito, H; Kinugasa, E; Ogata, H; Shishido, K; Taguchi, S; Takahashi, J; Takahashi, K; Yamamoto, M | 1 |
| Fukagawa, M; Goto, S | 1 |
| Brazhnikova, VV; Orlova, II; Rodosskaia, NK | 1 |
| Himeno, Y; Shigeno, K; Sugimoto, T; Sumi, M; Suzuki, K; Tokumoto, A; Yano, S | 1 |
| Andress, DL; Joyce, AT; Kalantar-Zadeh, K; Marx, SE; Schumock, GT; Sterz, R | 1 |
| Blough, DK; Johnson, ES; Petrik, A; Smith, DH; Thorp, ML; Yang, X | 1 |
| Yokoyama, K | 2 |
| Curzi, MP; Evenepoel, P; González, MT; Husserl, FE; Kopyt, N; Mix, C; Sprague, SM; Sterling, LR; Wong, G | 1 |
| Hirukawa, T; Kakuta, T; Kanai, G; Saito, A; Sato, A; Sawaya, A; Tanaka, R | 1 |
| Chew, D; Kidder, AC | 1 |
| Shaheen, FA; Souqiyyeh, MZ | 1 |
| Kapetanos, GA; Kenanidis, EI; Kirkos, JM; Papavasiliou, KA; Potoupnis, ME; Sarris, IK | 1 |
| Coyne, D; Sprague, SM | 1 |
| Asaka, M; Matsumoto, Y; Oyama, Y; Saito, A; Yokoyama, H | 1 |
| Imanishi, Y; Inaba, M; Ishimura, E; Kurajoh, M; Nagayama, H; Nishizawa, Y; Okuno, S; Shoji, S; Yamada, S; Yamakawa, T | 1 |
| Martin, KJ; Qazi, RA | 1 |
| Komaba, H | 1 |
| Joki, N; Tanaka, Y | 1 |
| Koiwa, F; Maruta, Y | 1 |
| Hofman-Bang, J; Lewin, E; Martuseviciene, G; Olgaard, K; Santini, MA | 1 |
| Dehmel, B; Fouque, D; Jacobson, SH; Pétavy, F; Rix, M; Ryba, M; Ureña Torres, P; Zitt, E | 1 |
| Anattiwong, P; Arruda, JA; How, PP; Lau, AH; Mason, DL | 1 |
| Bayés, B; Bonet, J; Casals, M; Fernández-Crespo, P; López-Ayerbe, J; Romero, R | 1 |
| Pestana Vasconcelos, M; Pinho, LR; Ribeiro Santos, MJ | 1 |
| Arkouche, W; Attaf, D; Boumendjel, N; Cardozo, C; Cardozo, J; Fouque, D; Karaaslan, H; Laville, M; Lenz, A; Mpio, I; Pastural-Thaunat, M; Silou, J | 1 |
| Christensson, A; Fernström, A; Giæver, J; Granroth, B; Hylander, B; Jacobson, SH; Jensen, G; Weiss, L; Wikström, B; Wrege, U | 1 |
| Fukagawa, M; Itoh, K; Kadowaki, D; Komaba, H; Maruyama, T; Matsushita, K; Otagiri, M; Tanaka, M; Tokunaga, K; Watanabe, H | 1 |
| Arenas, L; Bover, J; Cannata Andía, J; Caravaca, F; de Francisco, AL; Fernández Giráldez, E; González Parra, E; Lorenzo, V; Martín-Malo, A; Martínez, I; Rodríguez Portillo, M; Torregrosa, JV; Torres, A | 1 |
| Morishita, R; Nakagami, H | 1 |
| Bacevicius, E; Brandi, L; Danielsen, H; Hansen, D; Kreiner, S; Lauridsen, TG; Madsen, JK; Marckmann, P; Meyer-Hofmann, H; Nielsen, JE; Rasmussen, K; Thye-Roenn, P; Tougaard, BG | 1 |
| Akizawa, T; Fukagawa, M; Fukuhara, S; Hasegawa, T; Kido, R; Kurokawa, K; Onishi, Y; Yamaguchi, T | 1 |
| Plosker, GL | 1 |
| Arletti, S; Carboni, C; Ferrari, F; Graziani, R; Graziosi, C; Lucchi, L; Malaguti, V; Stipo, L | 1 |
| Hatamura, I; Kusano, E; Mato, M; Nakazawa, E; Ogura, M; Onishi, A; Saji, F; Shiizaki, K; Watanabe, Y | 1 |
| Ferreira, HG; Pires, A; Raposo, JF; Yokota, H | 1 |
| Awni, WM; Garimella, TS; Klein, CE; Lichtenberger, O; Noertersheuser, PA; Palaparthy, R; Pradhan, RS; Williams, LA | 1 |
| Cannata-Andía, JB; Mejía, N; Miar, AB; Roman-García, P; Tavira, B | 1 |
| Martínez, AI; Milán, JA; Salgueira, M | 1 |
| Brunner-Ziegler, S; Fröschl, B; Hiebinger, C; Zsifkovits, J | 1 |
| Gadde, S; Greenberg, M; Greenberg, S; Janga, K; Pagala, M; Shneyderman, I | 1 |
| Kinugasa, E; Koiwa, F; Kumata-Maeta, C; Mizobuchi, M; Ogata, H; Shishido, K; Yamamoto, M; Yoshida, N | 1 |
| Arnaud, F; Drüeke, TB; Kirilov, GG; Kovatcheva, RD; Krivoshiev, SG; Ortuno, C; Stoinov, JI; Vlahov, JD | 1 |
| Cornago, I; Gallardo, I; García-Ledesma, P; Hernando, A; Martinez, I; Montenegro, J; Muñoz, RI; Romero, MA | 1 |
| Colloton, M; Davis, J; Henley, CM; Martin, D; Miller, G; Shatzen, E | 1 |
| Ferlito, A; Fraser, WD; Madorin, C; Owen, RP; Pellitteri, PK; Radbill, B; Rinaldo, A; Seethala, RR; Shaha, AR; Silver, CE; Suh, MY; Weinstein, B | 1 |
| Alsahow, AE; Alsaran, K; Atia, M; El-Shafey, EM; Sabry, AA | 1 |
| Cerezo Morales, S; Hervás Sánchez, JG; Polo Moyano, A; Prados Garrido, MD | 1 |
| Fukagawa, M; Kakuta, T; Koizumi, M; Komaba, H; Sawada, K; Takahashi, H; Tanaka, H | 1 |
| Levin, NW; Raimann, JG; Thijssen, S | 1 |
| Cuk, V; Ignjatovic, M; Kovacevic, B; Paunovic, I; Petrovic, Z; Scepanovic, M; Zivaljevic, V | 1 |
| Coe, F; Ennis, J; Worcester, E | 1 |
| Beato-Coo, L; Blanco-García, R; Bravo-López, JJ; Cossio-Annibar, C; Moreiras-Plaza, M; Nájera-de la Garza, W; Rodríguez-Goyanes, G | 1 |
| Fukushima, S; Hagino, S; Kanasaki, T; Matsumoto, T | 1 |
| Hashimoto, H; Hosoya, T; Ishida, M; Kimura, Y; Ohkido, I; Sekino, H; Shimada, H; Urae, J; Urashima, M; Yokoyama, K | 1 |
| Isakova, T | 1 |
| Akizawa, T; Fukagawa, M; Fukuhara, S; Fukuma, S; Hasegawa, T; Kurokawa, K; Onishi, Y; Yamaguchi, T | 1 |
| Braun, J; Dehmel, B; Frazão, JM; Mattin, C; Messa, P; Wilkie, M | 1 |
| Barros, X; Campistol, JM; Durán, CE; Paschoalin, RP; Torregrosa, JV | 1 |
| Isaksson, E; Sterner, G | 1 |
| Chen, J; Gu, Y; Hao, C; Li, H; Li, M; Ni, L; You, L; Zhang, Q | 1 |
| Barros, X; Campistol, JM; Durán, CE; Paschoalin, RP; Sánchez-Escuredo, A; Torregrosa, JV | 1 |
| Cooper, K; Goodman, W; Kubo, Y; Quarles, D; Tomlin, H | 1 |
| Bridges, I; Christiano, C; Cooper, K; Cournoyer, SH; Covic, A; Farouk, M; Kopyt, NP; Rodriguez, M; Ureña-Torres, P; Zehnder, D | 1 |
| Benessiano, J; Berjeb, N; Boutten, A; Dehoux, M; Dupré, T; Duval, X; Flamant, M; Hekimian, G; Huart, V; Iung, B; Messika-Zeitoun, D; Tubach, F; Vahanian, A | 1 |
| Fujii, H; Goto, S; Kono, K; Maeda, A; Miura, S; Nakai, K; Nishi, S; Takeda, K | 1 |
| Alghareeb, A; Alsaran, K; Bawadekji, H; Sabry, A | 1 |
| Chmielewski, C; Foerster, D | 1 |
| Fukagawa, M; Hosoya, T; Kagami, S; Kato, N; Kawaguchi, Y; Nakayama, M; Ohkido, I; Shigematsu, T; Yamamoto, H; Yokoyama, K | 1 |
| Chen, HH; Chen, YC; Yeh, JC | 1 |
| Burke, SK; Cozzolino, M; Dusso, AS; Finch, J; Liapis, H; Lu, Y; Slatopolsky, E | 1 |
| Doğan, M; Koç, O; Nart, A; Ozbakkaloğlu, M; Uslu, A; Yildirim, Y | 1 |
| Cannata Andía, JB; Fernández Martín, JL; Hervás Sánchez, J; Rodríguez García, M; Ruiz de Castañeda, J | 1 |
| Blaisdell, PW; Brenner, RM; Coburn, JW; Goodman, WG; Lindberg, JS; Liu, W; Martin, KJ; Moe, SM; Sprague, SM; Turner, SA | 1 |
| Castro, R; Ferreira, C; Herman, A; Nunes-Azevedo, J; Oliveira, M; Travassos, F | 1 |
| Fuertes, S; Fuster, D; Martin, F; Martinez-Osaba, MJ; Ortega, ML; Pons, F; Setoain, X; Torregrosa, JV; Ybarra, J | 1 |
| Adler, S; Bushinsky, DA; Liu, W; McCary, LC; Quarles, LD; Rosansky, SJ; Sherrard, DJ; Turner, SA | 1 |
| de Arteaga, J; Douthat, WG; Massari, PU; Orozco, SE | 1 |
| Goodman, WG | 1 |
| Hasegawa, T; Ideura, T; Koiwa, F; Kojima, I | 1 |
| Cannata Andía, JB; Fernández Martín, JL; González Suárez, I | 1 |
| Martínez, I; Montenegro, J; Muñoz, RI; Ocharán, J; Saracho, R | 1 |
| Amor, J; Aresté, N; Cambil, T; Gómez, O; Páez, C; Palma, A; Salgueira, M; Sánchez-Palencia, R | 1 |
| Amor, J; Palma, A | 1 |
| Alles, A; Douthat, WG; Marinovich, S; Peñalba, A; Prudkin, S; Tirado, S | 1 |
| Cannata Andía, JB; Díaz López, JB; Forascepi, R; Gago, E; Gómez Alonso, C; Megido, J; Naves Díaz, M; Rodríguez García, M | 1 |
| Altiparmak, MR; Apaydin, S; Erek, E; Sariyar, M; Serdengeçti, K; Seyahi, N; Trabulus, S | 1 |
| Chou, FF; Hsu, KL; Huang, FJ; Lee, CH; Lee, CT | 1 |
| Nolan, CR; Qunibi, WY | 1 |
| Spotswood, TC | 1 |
| Arruda, JA; Barton Pai, A; Lau, AH; Lin, S | 1 |
| BARRETT, RB; KROOK, L; USUI, K; WOLKE, RE | 1 |
| Inou, T; Ogawa, Y; Otsubo, O; Takahashi, HE; Tominaga, Y; Yajima, A | 1 |
| Fuchinoue, S; Nakamura, M; Teraoka, S | 1 |
| Aljama, P; Almaden, Y; Cantor, T; Felsenfeld, A; Gao, P; Martin-Malo, A; Rodriguez, M; Santamaria, R | 1 |
| Chow, KM; Li, PK; Szeto, CC | 1 |
| Casez, JP; Jaeger, P; Lippuner, K; Perrelet, R; Popp, A; Uskokovic, MR | 1 |
| Ebihara, I; Fukuwatari, T; Koide, H; Nakamura, T; Shibata, K; Shimada, N; Takahashi, Y; Tanaka, A | 1 |
| Washimi, Y | 1 |
| Abu-Alfa, AK; Avram, MM; Block, GA; Braun, J; Cohen, RM; Coyne, DW; Cunningham, J; de Francisco, AL; Drüeke, TB; Evenepoel, P; Fournier, A; Goodman, WG; Hercz, G; Locatelli, F; Martin, KJ; McCary, LC; Messa, P; Moe, SM; Olson, KA; Suranyi, MG; Turner, SA; Zani, VJ | 1 |
| Curhan, G | 1 |
| Bishop, CW; Coburn, JW; Elangovan, L; Germain, MJ; Lindberg, JS; Maung, HM; Sprague, SM; Williams, ME | 1 |
| Hayashi, M; Ichihara, A; Itaya, Y; Kobayashi, K; Monkawa, T; Nakamura, R; Takenaka, T; Tsuchiya, Y; Yoshizawa, M | 1 |
| Alves, GV; Crossetti, LB; Furlanetto, TW; Premaor, MO | 1 |
| Nakazawa, R | 1 |
| Hosoya, T; Imamura, N; Katoh, N; Kono, T; Kubo, H; Murai, S; Nakayama, M; Shigematsu, T; Shoji, R; Takasu, S; Yamamoto, H; Yokoyama, K; Yoshida, T | 1 |
| Block, GA; Chertow, GM; Klassen, PS; Lazarus, JM; Lowrie, EG; Ofsthun, N | 1 |
| Hörl, WH | 1 |
| Ureña Torres, P | 1 |
| González, A; Martín, F; Martínez, F; Sarró, F; Verdú, J | 1 |
| dos Reis, LM; Graciolli, FG; Jorgetti, V; Moysés, RM; Neves, KR; Pasqualucci, CA | 1 |
| Ito, H; Kinugasa, E | 1 |
| Akiba, T; Tanabe, K; Tokumoto, T; Toma, H | 1 |
| Hoshino, J; Takaichi, K; Ubara, Y | 1 |
| Fukagawa, M; Nishi, H | 1 |
| Yamashita, T | 1 |
| Tominaga, Y | 2 |
| Yumita, S | 2 |
| Akizawa, T; Sakaguchi, T | 1 |
| Tsukamoto, Y | 1 |
| Suzuki, M | 1 |
| Ando, R | 1 |
| Ikeda, Y; Takemoto, F | 1 |
| Hayakawa, H; Hirano, K; Kawamura, Y; Shigematu, T; Yamamoto, I | 1 |
| Nagano, N | 1 |
| Block, GA; Chertow, GM; Coburn, JW; Cunningham, J; Drüeke, TB; Goodman, WG; Martin, KJ; McCary, LC; Moe, SM; Olson, KA; Quarles, LD; Sherrard, DJ; Turner, SA | 1 |
| Albizem, MB; Borah, MF; Clark, RV; Coburn, JW; Culleton, B; Guo, MD; Husserl, FE; Klassen, PS; Lindberg, JS; Roger, SD; Shapiro, WB; Wong, G | 1 |
| He, YZ; Sanchez, CP | 1 |
| de Francisco, AL | 1 |
| De Leiva, A; Gich, I; Pérez, A; Rius, X; Rodríguez-Espinosa, J; Sánchez-Hernández, J; Ybarra, J | 1 |
| Kinugasa, E; Koiwa, F; Ogata, H; Shishido, K | 1 |
| Ando, R; Chida, Y; Hata, T; Inagaki, Y; Inoue, A; Ishida, Y; Naito, S; Ohtsuka, M; Tachibana, K; Takayama, M | 1 |
| Fukagawa, M; Kurihara, T; Kurosawa, T; Nishi, H; Sato, T | 1 |
| Fukagawa, M; Itoh, K; Matsushita, K; Tanaka, M | 2 |
| Sun, LY; Wang, M; Yang, L | 1 |
| Cattley, RC; Colloton, M; Henley, C; Lacey, D; Martin, D; Shatzen, E; Towler, DA | 1 |
| Brown, A; Dusso, A; Slatopolsky, E | 2 |
| Kasiliauskiene, A; Priluckiene, J; Slepavicius, A | 1 |
| Graves, KL; Hellman, RN; Karp, SL; Kraus, M; LaClair, RE; Li, Q; Moe, SM; Ofner, S | 1 |
| Holick, MF | 1 |
| Cheng, SC; Coyne, DW; Staniforth, ME | 1 |
| Charytan, C; Chonchol, M; Coburn, JW; Herman, J; Klassen, PS; Lien, YH; Liu, W; McCary, LC; Pichette, V | 1 |
| Lewin, E | 1 |
| Adler, S; Albizem, MB; Bommer, J; Cunningham, J; Goodman, WG; Guo, MD; Moe, SM; Rosansky, SJ; Sprague, SM; Urena-Torres, P; Zani, VJ | 1 |
| Andrés, E; Ballarín, J; Barceló, P; Bover, J; Ortiz-Herbener, F | 2 |
| Cunningham, J | 2 |
| Delanaye, P; Krzesinski, JM; Van Overmeire, L | 1 |
| Coladonato, JA | 1 |
| Hashimoto, N; Koike, T; Miyata, M; Mochizuki, T; Sato, N | 1 |
| Abe, M; Kobayashi, N; Miyata, S; Nagano, N; Wada, M; Wakita, S | 1 |
| Chiba, E; Sugawara, G | 1 |
| Mano, T; Onodera, Y; Yokoyama, T | 1 |
| Eriguchi, R; Satou, Y; Takei, S | 1 |
| Kumafuji, M; Momose, M; Sodeyama, T; Suzawa, T; Tokoo, M; Yamada, Y | 1 |
| Anzai, T; Ishida, H; Ishida, M; Kobayashi, T; Yachiku, S; Yao, N | 1 |
| Cunningham, J; Fukagawa, M; Ishida, M; Onoda, N; Tahara, H; Tokumoto, M; Tominaga, Y; Tsuruta, Y; Yumita, S | 1 |
| Fukagawa, M; Nakanishi, S | 1 |
| Imanishi, Y; Kobayashi, K | 1 |
| Finch, J; Liapis, H; Slatopolsky, E | 1 |
| Dong, BJ | 1 |
| Chertow, GM; Danese, MD; Doan, QV; Dylan, M; Griffiths, R; Kim, J | 1 |
| Aguilera-Tejero, E; Estepa, JC; Mayer-Valor, R; Perez, J; Rodríguez, M; Zafra, R | 1 |
| Brown, AJ; Coyne, DW; Koch, MJ | 1 |
| Abboud, H; Anger, M; Batlle, D; Coyne, D; Hippensteel, R; Kavanaugh, A; Lunde, N; Melnick, JZ; Palaparthy, RV; Pradhan, RS; Qiu, P; Smolenski, O; Williams, LA | 1 |
| Ahya, SN; Coyne, DW; Giles, K; Joist, HE; Norwood, K; Slatopolsky, E | 1 |
| Drüeke, TB; Landais, P | 1 |
| Benghanem, MG; Ramdani, B; Sif, H; Tarrass, F; Yazidi, A; Zamd, M | 1 |
| Akizawa, T; Honda, H; Sanada, D | 1 |
| Imanishi, Y; Inaba, M | 1 |
| Fukagawa, M | 1 |
| Bedrick, EJ; Hunt, WC; Johnson, HK; Meyer, KB; Rohrscheib, MR; Stidley, CA; Tentori, F; Zager, PG | 1 |
| Bell, S; Casey, L; Chonchol, M; Parker, M; Spiegel, DM | 1 |
| Craig, JC; Elder, G; Palmer, SC; Strippoli, GF; Tong, A | 1 |
| Michigami, T; Ozono, K | 1 |
| Bolasco, PG; Cadinu, F; Casu, D; Cogoni, G; Contu, B; Ferrara, R; Ganadu, M; Gazzanelli, L; Ghezzi, PM; Ghisu, T; Logias, F; Maxia, M; Passaghe, M; Pilloni, A; Pinna, M | 1 |
| Chen, CA; Chiu, JS; Huang, WH; Li, YC; Lin, YF; Yu, FC | 1 |
| Cincotta, E; Doshi, MD; El-Amm, JM; Gruber, SA; Losanoff, JE; Migdal, S; Morawski, K; Singh, A; Sternbauer, D; West, MS | 1 |
| Brown, AJ; Clagett-Dame, M; DeLuca, HF; Finch, JL; Mizobuchi, M; Plum, LA; Ritter, CS; Sicinski, RR; Slatopolsky, E | 1 |
| Antonelli, M; Basile, C; Giammaria, B; Lomonte, C; Losurdo, N; Marchio, G | 1 |
| Craver, L; Fernández, E | 1 |
| Ito, H; Kinugasa, E; Koiwa, F; Ogata, H; Shishido, K; Taguchi, S; Takahashi, K | 1 |
| Inoue, T; Kagitani, M; Katsuoka, Y; Kitagawa, Y; Nagatoya, K; Nishimoto, K; Ohashi, S; Shibahara, N; Ueda, H; Yasuda, H | 1 |
| Belozeroff, V; Kestenbaum, B | 1 |
| Abboud, H; Hamm, LL; Hippensteel, R; Melnick, JZ; Pradhan, RS; Ross, EA; Sprague, SM; Tian, J; Williams, LA | 1 |
| Kazama, JJ | 1 |
| Eriguchi, R; Kato, M; Sato, Y; Umakoshi, J | 1 |
| Osawa, Y | 1 |
| Akiba, T; Asamiya, Y; Ikebe, N; Iwasaki, T; Kimata, N; Kiuchi, K; Mineshima, M; Miwa, N; Miyabe, K; Otsubo, S; Sato, K; Sugi, O; Yabuki, Y | 1 |
| Belozeroff, V; Danese, MD; Martin, LP; Olgaard, K; Sprague, SM | 1 |
| Aguilera-Tejero, E; Guerrero, F; Lopez, I; Martin, D; Mendoza, FJ; Perez, J; Rodriguez, M | 1 |
| Bajo, MA; Codoceo, R; Del Peso, G; Díez, JJ; Gancedo, PG; Gil, F; Iglesias, P; Martinez-Ara, J; Miguel, JL; Sánchez, C; Selgas, R | 1 |
| Yano, S | 1 |
| Batuman, V; Ghosh-Narang, J; Jones, TM; Menke, A; Muntner, P; Todd, AC | 1 |
| Akizawa, T; Hatamura, I; Imazeki, I; Kusano, E; Negi, S; Saji, F; Sakaguchi, T; Shigematsu, T; Shiizaki, K | 1 |
| Hanba, Y; Negi, S; Ooura, M; Shigematsu, T | 1 |
| Bos, WJ; Bouman, K; Braun, J; Brink, H; Carter, D; Frazão, JM; Graf, H; Locatelli, F; Macário, F; Maduell, F; Messa, P; Molemans, B; Reichel, H; Saha, H; Torregrosa, V; von Albertini, B; Wilkie, M; Yaqoob, M; Zani, VJ | 1 |
| Castaldo, L; Gutierrez, O; Holmes, J; Isakova, T; Lee, H; Shah, A; Wolf, M | 1 |
| Block, GA; Bushinsky, DA; Chertow, GM; Chi, EM; Sugihara, J; Turner, SA; Zeig, S | 1 |
| Akiba, T; Akizawa, T; Iwasaki, M; Koshikawa, S; Tsukamoto, Y; Uchida, E | 1 |
| Date, T; Funakoshi, S; Hashiguchi, J; Itoh, K; Kono, T; Kubo, H; Masaki, K; Nakano, H; Shigematsu, T; Tanaka, M; Uchino, J | 1 |
| Al-Azmi, M; Al-Helal, B; Al-Hilali, N; Al-Humoud, H; Al-Kandari, NH; Johny, KV | 1 |
| Drueckler, E; Fischer, DC; Haffner, D; Kundt, G; Muscheites, J; Wigger, M | 1 |
| Bernheim, J; Glaser, B; Gonda, M; Kraiem, Z; Rotem, M; Sheinfeld, M | 1 |
| Bonjour, JP; Fleisch, H; Mühlbauer, RC | 1 |
| Bianchi, AR; Bianchini, G; Coen, G; Donato, G; Faedda, MR; Mancini, U; Massimetti, C; Mazzaferro, S; Sideri, G | 1 |
| Friesen, SR; Hermreck, AS; Iliopoulos, JI; Pierce, GE; Thomas, JH; Zdon, MJ | 1 |
| Berland, Y; Charhon, S; Meunier, PJ; Olmer, M | 1 |
| Harter, H; Horst, R; Martin, KJ; Slatopolsky, E; Thielan, J; Weerts, C | 1 |
| Andersen, RC; Blake, DP; Hitchcock, CR; O'Brien, TJ; Smith, CL | 1 |
| Archer, ME; Jorizzo, JL; Raimer, SS | 1 |
| Gilka, F; Sugden, EA | 1 |
| Kubota, M; Ohno, T | 1 |
| Cook, SD; Haddad, RJ; Skinner, HB | 1 |
| Goldstein, DA; Healy, MD; Malluche, HH; Massry, SG; Singer, FR | 1 |
| Flury, W; Haldimann, B | 1 |
| Caballero, A; Jofre, R; Pérez-García, R; Valderrábano, F; Vasconez, F | 1 |
| Barsotti, G; Ciardella, F; Giannoni, A; Giovannetti, S; Guiducci, A; Lupetti, S; Morelli, E | 1 |
| Burritt, M; Giacherio, D; Pierides, AM; Schniepp, B | 1 |
| Bernheim, J; Blum, M; Korzets, Z; Podjarny, E; Rathaus, M; Zevin, D | 1 |
| Chandler, JT; Diaz-Buxo, JA; Farmer, CD; Geissinger, WT; Holt, KL; Walker, PJ; Wolfe, P | 1 |
| Hirsch, FW; Müller, B; Offermann, G; Pieper, R; Rottka, H; Schäfer, K; von Herrath, D | 1 |
| Bourgoignie, JJ; Canterbury, J; Jacob, AI; Lanier, D | 1 |
| Brensilver, JM; Cortell, S; Lefavour, GS; Pierce, JC | 1 |
| Boner, G; Horensten, ML; Rosenfeld, JB | 1 |
| Burke, MD | 1 |
| Collier, VU; Mitch, WE; Walser, M | 1 |
| Anderson, CB; Etheredge, EE; Hruska, KA; Martin, KJ; Sicard, GA | 1 |
| Aparicio, M; Blanchetier, V; Bouchet, JL; Combe, C; de Précigout, V; Fournier, A; Morel, D; Potaux, L | 1 |
| Aparicio, A; Caravaca, F; Cid, MC; Cubero, JJ; Jimenez, F; Liso, J; López, JM; Pizarro, JL; Santos, I | 1 |
| Aparicio, M; Blanchetier, V; Combe, C; de Précigout, V; Larroumet, N; Pommereau, A; Potaux, L | 1 |
| Borràs, M; Fernández, E; Montoliu, J; Pais, B | 1 |
| Cortez, MS; Lobo, PI; Pruett, TL; Stevenson, W | 1 |
| Ardissino, GL; Assael, BM; Bettinelli, A; Castiglioni, G; Claris-Appiani, A; Cunazza, M; Daccò, V; Pecchio, F; Tirelli, AS; Tischer, MC | 1 |
| Algur, N; Drukker, A; Feinstein, S | 1 |
| Llach, F | 1 |
| Koide, K; Morio, K | 1 |
| Izumida, I; Morishita, T; Moriya, R; Nagaba, Y; Okubo, M; Tsukamoto, Y | 1 |
| Huttunen, K; Manelius, J; Przedlacki, J | 1 |
| Bunio, A; Kwieciński, R | 1 |
| Bacchella, L; Bellazzi, R; de Vincenzi, A; Gazo, A; Gini, A; Nai, M; Romanini, D; Santagostino, M | 1 |
| Belin, TR; Chon, Y; Gales, B; Goodman, WG; Ramirez, JA; Salusky, IB; Segre, GV | 1 |
| Balabolkin, MI; Khasanova, ER; Mkrtumian, AM | 1 |
| Baroni, M; Biscarini, G; Filipponi, P; Gubbiotti, G; Lemmi, A; Malaspina, C; Rizzo, F | 1 |
| Besancenot, JF; Corcelle, L; d'Athis, P; Escousse, A; Gambert, P; Gaudet, M; Monnier, V; Pfitzenmeyer, P | 1 |
| Bover, J; Felsenfeld, AJ; Jara, A; Llach, F; Machado, L; Martinez, ME; Rodriguez, M; Trinidad, P | 1 |
| Cohn, HE; Michael, HJ; Myrick, SR; Radomski, JS | 1 |
| Cabralda, T; Howell, N; Sokunbi, D; Solomon, M; Suh, H; Wadhwa, NK | 1 |
| Rahamimov, R; Silver, J | 1 |
| Hasegawa, T; Ikeda, M; Kawaguchi, Y; Momose, M; Sakai, O; Shigematsu, T; Unemura, S; Wakabayashi, Y; Yamamoto, H; Yokoyama, K | 1 |
| Choi, Y; Goodman, WG; Hawkins, RA; Hoh, CK; Messa, C; Nissenson, AR; Phelps, ME; Salusky, IB | 1 |
| Casez, JP; Descoeudres, C; Jaeger, P; Lippuner, K; Takkinen, R; Zehnder, HJ | 1 |
| Delmez, JA; Slatopolsky, E | 1 |
| Denda, M; Finch, J; Slatopolsky, E | 1 |
| Brandi, L; Daugaard, H; Egsmose, C; Jensen, LT; Nielsen, PK; Olgaard, K | 1 |
| Campistol Plana, JM; Casellas Bartumeus, J; Mas Mas, M; Montesinos Ballestena, M; Torregrosa Prats, JV | 1 |
| Callis, L; Escuder, A; Nieto, J; Regas, J; Ruiz-Cuevas, P | 1 |
| Llach, F; Martinez, I; Montenegro, J; Saracho, R | 1 |
| Boran, M; Cetin, S; Doruk, E; Gönenç, F | 1 |
| Aguilera, A; Bajo, MA; de Alvaro, F; Diaz, C; Martinez, ME; Possante, C; Sánchez, C; Selgas, R | 1 |
| Angeli, A; Berruti, A; Dogliotti, L; Fasolis, G; Fontana, D; Sperone, P; Torta, M | 1 |
| Boechat, I; Gales, B; Goodman, WG; Jüppner, H; Kuizon, BD; Nelson, P; Salusky, IB | 1 |
| Slatopolsky, E | 1 |
| Chesney, RW; Coburn, JW; Frazao, JM | 1 |
| Aparicio, M; Fournier, A | 1 |
| Falciglia, G; Greene, SV; Rademacher, R | 1 |
| Belin, TR; Gales, B; Goodman, WG; Kuizon, BD; Ramirez, JA; Salusky, IB; Segre, GV | 1 |
| Insogna, KL; Kerstetter, JE; O'Brien, KO | 1 |
| Llach, F; Yudd, M | 2 |
| Arruda, J; Delmez, J; Goldblat, MV; Keshav, G; Lau, A; Lindberg, JS; Llach, F; Sadler, R; Slatopolsky, E | 1 |
| Finch, J; Ritter, C; Slatopolsky, E; Takahashi, F | 1 |
| Abboud, H; Gellens, ME; González, EA; Hamm, LL; Lindberg, J; Martin, KJ | 1 |
| Indridason, OS; Pieper, CF; Quarles, LD | 1 |
| Bleyer, AJ; Burke, SK; Chertow, GM; Dillon, M; Domoto, DT; Garrett, BN; Slatopolsky, E; Steg, M; Wilkes, BM; Wombolt, DG | 1 |
| Friedler, RM; Geng, Z; Kubodera, N; Malluche, HH; Monier-Faugere, MC; Qi, Q; Slatopolsky, E | 1 |
| Brandi, L; Bro, S; Daugaard, H; Nielsen, PK; Olgaard, K | 1 |
| Felsenfeld, AJ; Rodriguez, M | 1 |
| Gonzalez, GB; Sakhaee, K | 1 |
| Brown, AJ; Dusso, A; Slatopolsky, E | 1 |
| Malluche, HH; Monier-Faugere, MC | 1 |
| Chou, FF; Ho, JC; Huang, SC; Sheen-Chen, SM | 1 |
| Funahashi, H; Hayakawa, Y; Imai, T; Kikumori, T; Mase, T; Matsuura, N; Nakao, A; Oiwa, M; Tanaka, Y; Tominaga, Y | 1 |
| Block, GA; Port, FK | 1 |
| Adamsone, I; Amerika, D; Babarykin, D; Folkmane, I; Rozental, R | 1 |
| Albu, AT; Dungaciu, M; El Esper, N; Fournier, A; Mornière, P; Oprisiu, R | 1 |
| Amin, N; Burke, SK; Chertow, GM; Dillon, MA | 1 |
| Bauss, F; Geng, Z; Malluche, HH; Monier-Faugere, MC | 1 |
| Acchiardo, SR; Bishop, CW; Bower, JD; Chesney, RW; Coburn, JW; Douglass, LL; Elangovan, L; Frazão, JM; Gentile, D; Goodman, WG; Kelley, BJ; Kyllo, DM; Levine, BS; Maung, HM; Mazess, RB; Norris, KC; Robertson, JA; Rodriguez, HJ | 1 |
| Arora, N; Gadallah, MF; Moles, K; Ramdeen, G; Schaeffer-Pautz, A; Torres, C | 1 |
| Burke, SK; Chertow, GM; Dillon, MA; Plone, M; Slatopolsky, E | 1 |
| Delmez, JA; Giles, KS; Kelber, J; Norwood, KY; Slatopolsky, E | 1 |
| Chen, JB; Chen, SH; Chou, FF; Lee, CH; Sheen-Chen, SM | 1 |
| Sanchez, CP | 1 |
| Acchiardo, SR; González, EA; Lindberg, J; Martin, KJ; Soltanek, C; Valdin, JR | 1 |
| Llach, F; Velasquez Forero, F | 1 |
| Andress, DL | 1 |
| Ben Maïz, H; Ben Taarit, C; el Younsi, F; Mestiri, M; Turki, S; Zlitni, M | 1 |
| Moe, SM | 1 |
| Lambert, LL; Reams, SM | 1 |
| Fernandez, MC; Ferretti, JL; Locatto, ME; Orsatti, MB; Puche, RC; Valenti, JL | 1 |
| Goldsmith, RS | 1 |
| Brickman, AS; Coburn, JW; Hartenbower, DL | 1 |
| Bell, NH; DeLuca, HF; Sinha, TK | 1 |
| Bonucci, E; D'Angelo, A; Fiaschi, E; Maschio, G; Messa, P; Tessitore, N | 1 |
| Giacchino, F; Giachino, G; Jeantet, A; Mangiarotti, G; Martini, PF; Messina, M; Segoloni, GP; Triolo, G | 1 |
| Gilli, G; Kreusser, W; Mehls, O; Ritz, E | 1 |
| Malhotra, KK | 1 |
| Bernheim, J; Rathaus, M | 1 |
| Frame, B | 1 |
| Meema, HE; Meindok, H; Ogilvie, R; Oreopoulos, DG; Rabinovich, S; Sutton, D; Velentzas, C | 1 |
| Cros, D; Pellissier, JF; Serratrice, G | 1 |
| Bernheim, J; David, L; Faivre, JM; Touraine, JL; Traeger, J | 1 |
| Bennett, D | 1 |
| Bernheim, J; Labeeuw, M; Pozet, N; Touraine, JL; Traeger, J | 1 |
| Bigos, ST; Goar, WT; Neer, RM | 1 |
| Bundaru, L; Ghergariu, S; Giuglea, M; Greblea, A; Païs, C; Stroia, S | 1 |
| Kawai, S; Kobayashi, A; Ohbe, Y; Utsunomiya, T | 1 |
| Bordier, PJ; Drüeke, T; Jungers, P; Man, NK; Marie, P | 1 |
| Kasali, OB; Krook, L; Pond, WG; Wasserman, RH | 1 |
| Britt, LG; Harmon, HC | 1 |
| Krook, L | 1 |
| Massry, SG | 2 |
| D'Angelo, A; Fiaschi, E; Maschio, G; Mioni, G; Ossi, E | 1 |
| Arnaud, CD; Goldsmith, RS; Johnson, WJ | 1 |
| Berens, DL; Krook, L; Lesser, GV; Whalen, JP | 1 |
| Frand, M; Rosenthal, T; Rotem, Y; Teicher, A; Yahav, J | 1 |
| Engle, JE; Schoolwerth, AC | 1 |
| Jaworski, ZF; Lok, E; Wellington, JL | 1 |
| Ben-Ari, J; Berlyne, GM; Galinsky, D; Hirsch, M; Idelman, A; Kushelevsky, A; Shainkin, R; Yagil, R; Zlotnik, M | 1 |
| Bouillon, R; Claes, JH; De Moor, P; Lissens, W; Reynaert, J | 1 |
| Behrend, AJ; Marks, C | 1 |
| Negri, AL; Spivacow, FR; Zanchetta, JR | 1 |
| Alexiewicz, JM; Chervu, I; Fadda, GZ; Kiersztejn, M; Massry, SG; Smogorzewski, M | 1 |
| Adler, RA; Downs, RW; McMurtry, CT; Young, SE | 1 |
| Johnston, JR; Muhammedi, MA; Piraino, B; Puschett, JB; Rault, R | 1 |
| Balabol'kin, MI; Khasanova, ER; Mkrtumian, AM | 1 |
| Comunale, R; Fadda, GZ; Lipson, LG; Massry, SG; Thanakitcharu, P | 1 |
| Morris, RC; Portale, AA | 1 |
| Emoto, M; Inoue, T; Miki, T; Morii, H; Morita, A; Nishizawa, Y; Shoji, S; Tabata, T | 1 |
| Emoto, M; Inoue, T; Matsushita, Y; Miki, T; Morii, H; Morita, A; Nakatsuka, K; Nishizawa, Y; Tabata, T | 1 |
| Ogura, Y | 1 |
| Kohara, N | 1 |
| Draibe, SA; Ferreira, SR; Peres, RB; Silva, MC; Vieira, JG; Zanella, MT | 1 |
| Ando, K; Marumo, F; Takahashi, N; Togashi, K; Tsukamoto, Y | 1 |
| Halbauer, M; Pasini, J; Pavlović, D; Tomić Brzac, H | 1 |
| Basile, C; Bourdeau, A; Bourdon, R; Drüeke, T; Dubost, C; Grateau, G; Lacour, B; Ureña, P; Vassault, A; Zingraff, J | 1 |
| Chen, DL; Cheng, CH; Lian, JD; Lu, YS; Shu, KH; Yang, YF | 1 |
| Drüeke, T | 1 |
| Arturi, A; Babini, JC; Babini, SM; Cocco, JA; de la Sota, M; Marcos, JC; Morteo, OG | 1 |
| Feinfeld, DA; Sherwood, LM | 1 |
| Del Piano, A; Garetto, A; Giacchino, F; Giachino, G; Jeantet, A; Pellerey, M; Piccoli, G | 1 |
| Campino, C; Generini, G; Michelsen, H; Palma, R; Pumarino, H | 1 |
| Korkor, AB | 1 |
| McKenzie, RA | 1 |
| Fröhling, PT; Kokot, F; Lindenau, K; Schmicker, R; Vetter, K | 1 |
| Ivanov, IA; Kalinin, AP; Shcherbakova, EO | 1 |
| Blais, D; Ciancioni, C; Delons, S; Garnier, PE; Poignet, JL; Reinhart, N | 1 |
| Almkuist, RD; Nixon, WP; White, KS; Wilkinson, CA | 1 |
| Baldrati, L; Docci, D; Turci, F | 1 |
| Favus, MJ; Friedman, HZ; Langman, CB | 1 |
| Greer, FR; Laskarzewski, P; Noguchi, A; Steichen, JJ; Tsang, RC; Venkataraman, PS | 1 |
| Arnaud, CD; Clark, OH; Duh, QY; Gooding, GA; Stark, DA | 1 |
| Coburn, JW; Crooks, PW | 1 |
| Brancaccio, D; Galmozzi, C; Pizzocaro, G | 1 |
| Zucchi, C | 1 |
| Cenciotti, L; del Vecchio, C; Docci, D; Pretolani, E; Salvi, G; Salvi, P; Turci, F | 1 |
| Akmal, M; Ansari, AN; Massry, SG; Telfer, N | 1 |
| Cabana, EC; Canterbury, JM; Lewy, JE; Reiss, E; Repetto, HA | 1 |
| Bricker, NS; Slatopolsky, E | 1 |
| Better, OS; Kleeman, CR | 1 |
| DeLuca, HF | 1 |
| Duckett, G; Gruskin, A; Reber, RM; Root, A; Stopa, A | 1 |
| Andersson, A; Ejerblad, S; Fredriksson, A; Grimelius, L; Johannsson, H; Stenberg, A | 1 |
| Bordier, P; Fournier, A; Gueris, J | 1 |
| Gröndahl, HG; Hugoson, A; Lindhe, J; Svanberg, G | 1 |
| Fine, RN; Grushkin, CM; Isaacson, AS; Payne, V | 1 |
| Konnak, J; McDonald, FD; Silber, SJ | 1 |
| Morii, H | 1 |
| Kawakami, K; Nagata, N; Nakamura, K | 1 |
| Bordier, PJ; de Wardener, HE; Eastwood, JB | 1 |
| Arnaud, CD | 1 |
| Baylink, DJ; Brickman, AS; Coburn, JW; Jowsey, J; Maloney, N; Massry, SG; Norman, AW; Sherrard, DJ; Singer, FR | 1 |
| Frame, B; Jackson, CE | 1 |
| Cangiano, JL; Ramírez-González, RE; Ramírez-Muxó, O | 1 |
| Bricker, NS; Caglar, S; Canterbury, J; Gradowska, L; Reiss, E; Slatopolsky, E | 1 |
| Myers, RT; Stubbs, AJ | 1 |
| Canterbury, JM; Coe, FL; Firpo, JJ; Reiss, E | 1 |
| Kaye, M | 1 |
| Ben-Arie, J; Berlyne, GM; Booth, EM; Epstein, N; Yagil, R | 1 |
| Baylink, D; Rich, C; Stauffer, M; Wergedal, J | 1 |
| Marsac, J; Meyrier, A; Richet, G | 1 |
| Guinn, GA; Jordan, PH; Savoy, GM; Yium, JJ | 1 |
| Cheigh, JS; Rubin, AL; Stenzel, KH; Whitsell, JC | 1 |
| Andersson, L; Bergdahl, L; Boquist, L | 1 |
| Burckhardt, PM; Potts, JT; Singer, FR | 1 |
| Caley, MT; Van Pelt, RW | 1 |
| Arnold, SA; Evans, H; Hintz, HF; Kram, MA; Krook, L | 1 |
| Gordan, GS; Piel, CF; Potter, D; Rames, L; Roof, BS | 1 |
| Bommer, J; Krempien, B; Malluche, H; Mehls, O; Ritz, E | 1 |
| Arnaud, CD; Beabout, JW; Goldsmith, RS; Johnson, WJ; Jowsey, J; Kelly, PJ | 1 |
| Coburn, JW; Kleeman, CR; Massry, SG; Maxwell, MH; Popovtzer, MM; Shinaberger, JH | 1 |
| Crutchlow, WP; David, DS | 1 |
| Hackeng, WH; Hartdegen, RG; Joffe, BI; Seftel, HC | 1 |
| Bartter, FC; Deftos, L; Delea, CS; Pak, CY; Wortsman, J | 1 |
| Baker, RK; Nicastri, A; Wallach, S | 1 |
| Grosshans, E; Jahn, H; Maleville, J | 1 |
| Gburek, Z; Japa, J; Jasieńska, A | 1 |
| Kleeman, CR; Massry, SG; Popovtzer, MM; Villamil, M | 1 |
| Baker, JM; Joyce, JR; Pierce, KR; Romane, WM | 1 |
| DePalma, JR; Gordon, A; Massry, SG; Parfitt, AM; Winfield, AC | 1 |
| Kunwar, KB; Teotia, M; Teotia, SP | 1 |
| Robinson, BH; Rushton, ML; Sammons, HG | 1 |
| Jowsey, J; Kuhlencordt, F | 1 |
| Canterbury, J; Coe, FL; Reiss, E | 1 |
| Marshall, RB; Roth, SI | 1 |
114 review(s) available for phosphorus and Hyperparathyroidism, Secondary
| Article | Year |
|---|---|
A Systematic Review and Meta-analysis of Efficacy and Safety of Calcimimetic Agents in the Treatment of Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease.
Topics: Calcimimetic Agents; Calcium; Humans; Hyperparathyroidism, Secondary; Naphthalenes; Parathyroid Hormone; Phosphorus; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic | 2022 |
Microwave ablation versus radiofrequency ablation for patients with primary and secondary hyperparathyroidism: a meta-analysis.
Topics: Ablation Techniques; Calcium; Catheter Ablation; Humans; Hyperparathyroidism, Secondary; Microwaves; Phosphorus; Radiofrequency Ablation; Retrospective Studies; Treatment Outcome | 2023 |
Full thermal ablation versus partial thermal ablation for secondary hyperparathyroidism: A meta-analysis.
Topics: Calcium; Calcium, Dietary; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Parathyroid Hormone; Phosphorus | 2023 |
Controversies in the Management of Secondary Hyperparathyroidism in Chronic Kidney Disease.
Topics: Calcimimetic Agents; Chelating Agents; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Hypocalcemia; Parathyroid Hormone; Phosphorus; Renal Insufficiency, Chronic; Vitamin D | 2019 |
Parathyroid Hormone: A Uremic Toxin.
Topics: Bone and Bones; Bone Remodeling; Calcium; Energy Metabolism; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperparathyroidism, Secondary; Parathyroid Hormone; Phosphorus; Renal Insufficiency, Chronic; Uremia | 2020 |
Development of evocalcet for unmet needs among calcimimetic agents.
Topics: Calcimimetic Agents; Calcium; Cinacalcet; Gastrointestinal Diseases; Humans; Hyperparathyroidism, Secondary; Japan; Naphthalenes; Phosphorus; Pyrrolidines; Receptors, Calcium-Sensing; Renal Dialysis; Renal Insufficiency, Chronic | 2020 |
Recent advances in understanding and managing secondary hyperparathyroidism in chronic kidney disease.
Topics: Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hyperparathyroidism, Secondary; Parathyroid Hormone; Phosphorus; Renal Insufficiency, Chronic; Vitamin D | 2020 |
Personalized Management of Bone and Mineral Disorders and Precision Medicine in End-Stage Kidney Disease.
Topics: Bone Diseases, Metabolic; Calcium; Cardiovascular Diseases; Humans; Hyperparathyroidism, Secondary; Intestinal Absorption; Kidney Failure, Chronic; Parathyroid Hormone; Phosphorus; Polymorphism, Genetic; Precision Medicine; Receptors, Calcium-Sensing; Vascular Calcification; Vitamin D; Vitamin D-Binding Protein | 2018 |
Secondary Hyperparathyroidism: Pathogenesis and Latest Treatment.
Topics: Bone Density Conservation Agents; Calcimimetic Agents; Calcium; Humans; Hyperparathyroidism, Secondary; Parathyroid Hormone; Phosphorus; Renal Dialysis; Renal Insufficiency; Vitamin D | 2019 |
[Role of vitamin D in the pathogenesis of chronic kidney disease].
Topics: Calcium; Cardiovascular Diseases; Chronic Disease; Diabetes Complications; Disease Progression; Early Diagnosis; Fibrosis; Homeostasis; Humans; Hyperparathyroidism, Secondary; Hypertension; Immune Tolerance; Inflammation; Kidney Diseases; Parathyroid Hormone; Phosphorus; Proteinuria; Receptors, Calcitriol; Vitamin D; Vitamin D Deficiency | 2013 |
Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients.
Topics: Calcimimetic Agents; Calcium; Cardiovascular Diseases; Cause of Death; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Phosphorus; Randomized Controlled Trials as Topic; Renal Dialysis | 2014 |
The pleiotropic effects of paricalcitol: Beyond bone-mineral metabolism.
Topics: Ergocalciferols; Humans; Hyperparathyroidism, Secondary; Minerals; Parathyroid Hormone; Phosphorus; Renal Insufficiency, Chronic | 2016 |
Impact of obesity on bone metabolism.
Topics: Adipokines; Adipose Tissue; Body Composition; Bone and Bones; Bone Density; Calcium; Disease Susceptibility; Fractures, Bone; Hormones; Humans; Hyperparathyroidism, Secondary; Insulin Resistance; Obesity; Osteoporosis; Phosphorus; Risk Factors; Sarcopenia | 2016 |
Treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
Topics: Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Japan; Naphthalenes; Parathyroid Hormone; Phosphorus; Practice Guidelines as Topic; Vitamin D | 2008 |
[Experimental advances in mineral metabolism].
Topics: Animals; Calcinosis; Calcium; Cardiovascular Diseases; Chelating Agents; Chelation Therapy; Chronic Disease; Drug Evaluation, Preclinical; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Intestinal Absorption; Kidney; Kidney Diseases; Lanthanum; Phosphorus; Sodium-Phosphate Cotransporter Proteins | 2008 |
Pathogenesis of bone and mineral related disorders in chronic kidney disease: key role of hyperphosphatemia.
Topics: Aluminum Hydroxide; Calcinosis; Calcitriol; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Diet, Protein-Restricted; Disease Progression; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Failure, Chronic; Phosphorus; Phosphorus, Dietary; Renal Dialysis; Risk Factors; Vascular Diseases | 2009 |
Oral phosphate binders for the management of serum phosphate levels in dialysis patients.
Topics: Acetates; Administration, Oral; Aluminum Hydroxide; Calcium Carbonate; Calcium Compounds; Cardiovascular Diseases; Chelating Agents; Drug Monitoring; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Magnesium; Nephrology; Patient Education as Topic; Phosphorus; Polyamines; Practice Guidelines as Topic; Renal Dialysis; Sevelamer; Treatment Outcome | 2009 |
Early initiation of phosphate lowering dietary therapy in non-dialysis chronic kidney disease: a critical review.
Topics: Cardiovascular Diseases; Chelating Agents; Disease Progression; Evidence-Based Practice; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Food Additives; Guideline Adherence; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Failure, Chronic; Menu Planning; Nephrology; Nutritive Value; Phosphorus; Phosphorus, Dietary; Practice Guidelines as Topic; Risk Factors; Treatment Outcome | 2009 |
[Chronic kidney disease (CKD) and bone. Chronic kidney disease--mineral and bone disorder in predialysis patients].
Topics: Bone Diseases, Metabolic; Calcium Carbonate; Chronic Disease; Dialysis; Disease Progression; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Kidney Diseases; Phosphorus; Vitamin D; Vitamin D Deficiency | 2009 |
Paricalcitol and outcome: a manual on how a vitamin D receptor activator (VDRA) can help us to get down the "U".
Topics: Calcium; Cinacalcet; Clinical Trials as Topic; Comorbidity; Ergocalciferols; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Phosphorus; Receptors, Calcitriol; Treatment Outcome; Vitamins | 2009 |
[Clinical aspect of recent progress in phosphate metabolism. Pathophysiology of secondary hyperparathyroidism in chronic kidney disease].
Topics: Animals; Chronic Disease; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Kidney Diseases; Parathyroid Hormone; Phosphorus; Vitamin D | 2009 |
Treatment options for hyperphosphatemia in feline CKD: what's out there?
Topics: Animals; Calcium Carbonate; Cat Diseases; Cats; Chelating Agents; Diet; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Failure, Chronic; Parathyroid Hormone; Phosphates; Phosphorus; Prognosis | 2009 |
Control of secondary hyperparathyroidism by vitamin D receptor agonists in chronic kidney disease.
Topics: Biomarkers; Calcium; Chronic Disease; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Parathyroid Hormone; Phosphorus; Receptors, Calcitriol; Renal Dialysis; Severity of Illness Index; Treatment Outcome; Vitamin D; Vitamin D Deficiency | 2010 |
Vitamin D in kidney disease: pathophysiology and the utility of treatment.
Topics: Animals; Calcium; Cardiovascular System; Chronic Disease; Dietary Supplements; Fractures, Bone; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Diseases; Mice; Phosphorus; Vitamin D; Vitamin D Deficiency | 2010 |
[CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Role of FGF23-Klotho axis in CKD-MBD].
Topics: Bone Density; Bone Diseases, Metabolic; Chronic Disease; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glucuronidase; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Klotho Proteins; Parathyroid Hormone; Phosphorus; Receptor, Fibroblast Growth Factor, Type 1; Vitamin D | 2010 |
[CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Atheroma and vascular calcification in hemodialysis patients].
Topics: Atherosclerosis; Bone Diseases, Metabolic; Calcinosis; Calcium; Chronic Disease; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Phosphorus; Renal Dialysis; Risk Factors; Vascular Diseases | 2010 |
[CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Role of cinacalcet in the treatment of CKD-MBD].
Topics: Bone Diseases, Metabolic; Calcinosis; Calcium; Chronic Disease; Cinacalcet; Clinical Trials as Topic; Drug Therapy, Combination; Fractures, Bone; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Naphthalenes; Parathyroid Hormone; Phosphorus; Vascular Diseases; Vitamin D | 2010 |
[Hypertension, CKD and bone metabolism].
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Bone and Bones; Bone Density; Calcium; Chronic Disease; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fractures, Bone; Humans; Hyperparathyroidism, Secondary; Hypertension; Kidney Diseases; Osteoclasts; Osteoporosis; Phosphorus; Receptor Activator of Nuclear Factor-kappa B; Renin-Angiotensin System; Thiazides | 2011 |
Cinacalcet: a pharmacoeconomic review of its use in secondary hyperparathyroidism in end-stage renal disease.
Topics: Calcium; Cinacalcet; Cost-Benefit Analysis; Drug Costs; Economics, Pharmaceutical; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Phosphorus; Renal Dialysis | 2011 |
Chronic kidney disease--mineral and bone disorder: a complex scenario.
Topics: Bone and Bones; Calcitriol; Calcium; Chronic Disease; Chronic Kidney Disease-Mineral and Bone Disorder; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Minerals; Parathyroid Hormone; Phosphorus; Vascular Calcification | 2011 |
The surgical management of renal hyperparathyroidism.
Topics: Calcium; Fibroblast Growth Factor-23; Humans; Hyperparathyroidism, Secondary; Kidney Transplantation; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Renal Insufficiency; Treatment Outcome | 2012 |
A brief review of external mass balance and internal calcium redistribution in dialysis patients--is calcium a uremic toxin?
Topics: Calcium; Calcium, Dietary; Heart Diseases; Humans; Hyperparathyroidism, Secondary; Phosphorus; Renal Dialysis; Uremia; Vascular Diseases; Vitamin D Deficiency | 2012 |
Effects and safety of calcimimetics in end stage renal disease patients with secondary hyperparathyroidism: a meta-analysis.
Topics: Calcimimetic Agents; Calcium; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Odds Ratio; Patient Safety; Phosphorus; Randomized Controlled Trials as Topic; Renal Dialysis; Treatment Outcome | 2012 |
Medical management of secondary hyperparathyroidism in chronic renal failure.
Topics: Administration, Oral; Calcium; Diet; Epoxy Compounds; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Parathyroid Hormone; Phosphorus; Polyamines; Polyethylenes; Sevelamer; Vitamin D | 2003 |
[Regulation of the calcium-sensing receptor. Influence of secondary hyperparathyroidism].
Topics: Amino Acids; Amyloid beta-Peptides; Animals; Calcitriol; Calcium; Calcium Signaling; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Kidney Failure, Chronic; Magnesium; Osmolar Concentration; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Rats; Receptors, Calcium-Sensing; Receptors, Cell Surface; Signal Transduction; Spermine | 2003 |
[Role of diet in the management of osteodystrophy during progressive renal insufficiency].
Topics: Calcinosis; Calcitriol; Calcium; Calcium, Dietary; Case Management; Chronic Kidney Disease-Mineral and Bone Disorder; Diet, Protein-Restricted; Dietary Proteins; Disease Progression; Glomerular Filtration Rate; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Parathyroid Hormone; Phosphorus; Phosphorus, Dietary; Risk; Severity of Illness Index | 2003 |
[Management of hyperphosphoremia].
Topics: Calcinosis; Calcium; Case Management; Chelating Agents; Chelation Therapy; Epoxy Compounds; Humans; Hyperparathyroidism, Secondary; Iron; Kidney Failure, Chronic; Lanthanum; Phosphorus; Polyamines; Polyethylenes; Sevelamer | 2003 |
[Importance of the "adequate blood phosphorus" concept as a risk factor for hyperphosphatemia].
Topics: Argentina; Attitude of Health Personnel; Blood Chemical Analysis; Calcinosis; Calcium; Chelation Therapy; Chronic Kidney Disease-Mineral and Bone Disorder; Culture; Diagnostic Tests, Routine; Health Surveys; Hemodialysis Units, Hospital; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Phosphates; Phosphorus; Physicians; Practice Patterns, Physicians'; Reference Values; Renal Dialysis; Risk Factors; Vitamin D | 2003 |
Calcium salts in the treatment of hyperphosphatemia in hemodialysis patients.
Topics: Acetates; Calcium Compounds; Cardiovascular Diseases; Clinical Trials as Topic; Drug Evaluation; Epoxy Compounds; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Phosphate-Binding Proteins; Phosphates; Phosphorus; Polyamines; Polyethylenes; Renal Dialysis; Sevelamer; Treatment Outcome | 2003 |
[Dementia in parathyroid disease].
Topics: Biomarkers; Calcium; Cholecalciferol; Dementia; Humans; Hypercalcemia; Hyperparathyroidism; Hyperparathyroidism, Secondary; Hypocalcemia; Hypothyroidism; Parathyroid Hormone; Parathyroidectomy; Phosphorus | 2004 |
[Calcium and phosphate metabolism in dialysis patients].
Topics: Bone Diseases, Metabolic; Calcinosis; Calciphylaxis; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Dialysis; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Osteomalacia; Phosphorus; Vascular Diseases | 2004 |
The clinical consequences of secondary hyperparathyroidism: focus on clinical outcomes.
Topics: Animals; Cardiovascular Diseases; Cause of Death; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Parathyroid Hormone; Phosphorus; Risk Factors; Uremia | 2004 |
[Pathogenesis of secondary hyperparathyroidism and renal bone disease].
Topics: Aluminum; Animals; Bone Diseases, Metabolic; Chronic Disease; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Kidney Diseases; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Practice Guidelines as Topic; Receptors, Calcitriol; Receptors, Calcium-Sensing; Vitamin D Deficiency | 2004 |
[Treatment of bone disease in chronic kidney disease and in renal transplant recipients under K/DOQI clinical practice guidelines].
Topics: Bone Density; Bone Diseases, Metabolic; Calcitonin; Chronic Disease; Diphosphonates; Epoxy Compounds; Furosemide; Humans; Hyperparathyroidism, Secondary; Ion Exchange Resins; Kidney Diseases; Kidney Transplantation; Pamidronate; Parathyroidectomy; Phosphorus; Phosphorus, Dietary; Polyamines; Polyethylenes; Practice Guidelines as Topic; Renal Dialysis; Sevelamer; Testosterone; United States; Vitamin D; Vitamin D Deficiency | 2004 |
[Clinical evidence and treatment for optimum concentration of parathyroid hormone, calcium and phosphate in chronic renal failure].
Topics: Calcinosis; Calcium; Calcium Carbonate; Calcium, Dietary; Chronic Kidney Disease-Mineral and Bone Disorder; Epoxy Compounds; Evidence-Based Medicine; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Parathyroid Hormone; Phosphorus; Phosphorus, Dietary; Polyamines; Polyethylenes; Practice Guidelines as Topic; Sevelamer | 2004 |
[Clinical application of calcimimetics].
Topics: Calcium; Cinacalcet; Clinical Trials as Topic; Humans; Hyperparathyroidism; Hyperparathyroidism, Secondary; Naphthalenes; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Practice Guidelines as Topic; Receptors, Calcium-Sensing | 2004 |
[Biological activity of FGF-23 and pathophysiologic role in chronic kidney disease].
Topics: Animals; Calcium; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperparathyroidism, Secondary; Hypophosphatasia; Kidney Failure, Chronic; Parathyroid Hormone; Phosphates; Phosphorus; Vitamin D | 2004 |
[Clinical practice guidelines for severe renal hyperparathyroidism].
Topics: Biomarkers; Calcium Carbonate; Diagnostic Imaging; Humans; Hydroxycholecalciferols; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Phosphorus Metabolism Disorders; Practice Guidelines as Topic; Severity of Illness Index; Thyroid Gland; Transplantation, Autologous | 2004 |
[Front line of management of hyperphosphatemia in hemodialysis patients].
Topics: Calcinosis; Calcium; Epoxy Compounds; Humans; Hyperparathyroidism, Secondary; Ion Exchange Resins; Kidney Failure, Chronic; Phosphorus; Phosphorus Metabolism Disorders; Polyamines; Polyethylenes; Renal Dialysis; Sevelamer; Vascular Diseases | 2004 |
[K/DOQI clinical practice guidelines for bone metabolism and disease in CKD].
Topics: Aluminum; Biomarkers; Bone and Bones; Bone Diseases, Metabolic; Calcium; Calcium, Dietary; Chronic Disease; Femoral Neck Fractures; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Diseases; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Practice Guidelines as Topic; Vitamin D; Vitamin D Deficiency | 2004 |
[Vitamin D therapy in renal osteodystrophy].
Topics: Administration, Oral; Calcinosis; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Dosage Forms; Half-Life; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Injections, Intravenous; Parathyroid Hormone; Phosphorus; Pulse Therapy, Drug; Severity of Illness Index; Vascular Diseases; Vitamin D | 2004 |
[Evolution in vitamin D treatment after debut of sevelamer hydrochloride in chronic renal failure patients].
Topics: Calcium; Digestive System Diseases; Drug Therapy, Combination; Epoxy Compounds; Humans; Hyperparathyroidism, Secondary; Ion Exchange Resins; Kidney Failure, Chronic; Phosphorus; Phosphorus Metabolism Disorders; Polyamines; Polyethylenes; Sevelamer; Vitamin D | 2004 |
[Vitamin D therapy in predialysis renal failure].
Topics: Administration, Oral; Calcitriol; Calcium; Drug Administration Schedule; Humans; Hydroxycholecalciferols; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Monitoring, Physiologic; Parathyroid Hormone; Phosphorus; Practice Guidelines as Topic; Pulse Therapy, Drug; Vitamin D Deficiency | 2004 |
[Serum calcium concentration and the safety of vitamin D therapy].
Topics: Administration, Oral; Calcitriol; Calcium; Drug Administration Schedule; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Infusions, Intravenous; Kidney Failure, Chronic; Monitoring, Physiologic; Parathyroid Hormone; Phosphorus; Pulse Therapy, Drug; Vitamin D; Vitamin D Deficiency | 2004 |
[Parathyroidectomy for advanced renal hyperparathyroidim in hemodialysis].
Topics: Cardiovascular Diseases; Forearm; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Muscle, Skeletal; Parathyroid Glands; Parathyroidectomy; Phosphorus; Prognosis; Renal Dialysis; Severity of Illness Index; Transplantation, Autologous | 2004 |
[Therapy for ROD and measurement of the bone mass].
Topics: Absorptiometry, Photon; Bone Density; Calcitriol; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Deferoxamine; Humans; Hyperparathyroidism, Secondary; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Vitamin K 2 | 2004 |
[Drugs inhibiting parathyroid hormone (PTH) secretion by control of the calcium receptor (calcimimetics)--effect on the set point of calcium-regulated PTH secretion].
Topics: Animals; Calcium; Cinacalcet; Clinical Trials as Topic; Depression, Chemical; Genes, Dominant; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Mutation; Naphthalenes; Parathyroid Hormone; Phosphorus; Rats; Receptors, Calcium-Sensing | 2005 |
Secondary hyperparathyroidism: review of the disease and its treatment.
Topics: Calcium; Cinacalcet; Glomerular Filtration Rate; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Renal Dialysis | 2004 |
Calcium, phosphorus and vitamin D disorders in uremia.
Topics: Animals; Calcium; Humans; Hyperparathyroidism, Secondary; Hyperplasia; Parathyroid Diseases; Phosphorus; Uremia; Vitamin D | 2005 |
Parathyroid hormone regulation in normal and uremic rats. Reversibility of secondary hyperparathyroidism after experimental kidney transplantation.
Topics: Animals; Calcium; Homeostasis; Hyperparathyroidism, Secondary; Kidney Transplantation; Parathyroid Glands; Parathyroid Hormone; Parathyroid Hormone-Related Protein; Phosphorus; Rats; Rats, Inbred Lew; Rats, Inbred Strains; Receptors, Calcitriol; Receptors, Parathyroid Hormone; Uremia | 2004 |
[New therapy strategies in secondary hyperparathyroidism on dialysis (I): new concepts, new treatments].
Topics: Algorithms; Bile Acids and Salts; Calcium; Cardiovascular Diseases; Disease Progression; Drug Therapy, Combination; Epoxy Compounds; Female; Ferric Compounds; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Lanthanum; Male; Multivariate Analysis; Niacinamide; Phosphate-Binding Proteins; Phosphates; Phosphorus; Polyamines; Polyethylenes; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Renal Dialysis; Risk Factors; Sevelamer; Time Factors | 2005 |
[New therapeutic strategies in secondary hyperparathyroidism on dialysis (II): vitamin D analogues and calcium-mimetics].
Topics: Animals; Bone Morphogenetic Protein 7; Bone Morphogenetic Proteins; Calcium; Cinacalcet; Diphosphonates; Drug Therapy, Combination; Ergocalciferols; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Phosphorus; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Renal Dialysis; Retrospective Studies; Teriparatide; Transforming Growth Factor beta; Vitamin D | 2005 |
[News in the management of calcium and phosphorus metabolism disorders for patient treated by hemodialysis].
Topics: Calcium; Chelation Therapy; Chronic Kidney Disease-Mineral and Bone Disorder; Ergocalciferols; Humans; Hyperparathyroidism, Secondary; Phosphorus; Renal Dialysis | 2005 |
Control of hyperphosphatemia among patients with ESRD.
Topics: Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Phosphate-Binding Proteins; Phosphates; Phosphorus; Renal Dialysis | 2005 |
[Management of secondary hyperparathyroidism].
Topics: Aniline Compounds; Calcinosis; Calcium; Cinacalcet; Clinical Trials as Topic; Drug Design; Drug Therapy, Combination; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Phenethylamines; Phosphorus; Polyamines; Practice Guidelines as Topic; Propylamines; Receptors, Calcium-Sensing; Sevelamer; Vascular Diseases; Vitamin D | 2005 |
[Secondary hyperparathyroidism].
Topics: Bone and Bones; Calcitriol; Calcium; Humans; Hyperparathyroidism, Secondary; Hyperplasia; Kidney; Kidney Failure, Chronic; Ossification, Heterotopic; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Pulse Therapy, Drug; Receptors, Calcium-Sensing | 2005 |
[FGF-23 in primary and secondary hyperparathyroidisms].
Topics: Animals; Calcitriol; Calcium; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Gene Expression; Humans; Hyperparathyroidism, Primary; Hyperparathyroidism, Secondary; Parathyroid Hormone; Phosphorus | 2005 |
Cinacalcet: An oral calcimimetic agent for the management of hyperparathyroidism.
Topics: Animals; Area Under Curve; Calcium; Cinacalcet; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Interactions; Half-Life; Humans; Hyperparathyroidism, Primary; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Transplantation; Naphthalenes; Parathyroid Hormone; Parathyroid Neoplasms; Phosphorus; Randomized Controlled Trials as Topic; Renal Dialysis | 2005 |
[Vitamin D metabolism and chronic kidney disease].
Topics: Bone and Bones; Bone Diseases, Metabolic; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Fibroblast Growth Factor-23; Humans; Hyperparathyroidism, Secondary; Kidney; Kidney Failure, Chronic; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Vitamin D | 2006 |
[Secondary hyperparathyroidism].
Topics: Adsorption; Blood Vessels; Calcinosis; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Diagnosis, Differential; Ethanol; Humans; Hyperparathyroidism, Secondary; Injections, Intralesional; Kidney Failure, Chronic; Naphthalenes; Osteitis; Parathyroidectomy; Phosphorus; Prognosis; Renal Dialysis; Vitamin D | 2006 |
Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients.
Topics: Calcium; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Parathyroid Hormone; Phosphorus; Randomized Controlled Trials as Topic; Renal Dialysis | 2006 |
[Progress in research on vitamin D].
Topics: Animals; Calcium; Endocytosis; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Homeostasis; Humans; Hyperparathyroidism, Secondary; Neoplasms; Phosphorus; Receptors, Calcitriol; Transcription, Genetic; Vitamin D; Vitamin D Deficiency | 2006 |
[Prevention and treatment of renal osteodystrophy: present and future].
Topics: Aluminum; Bone Remodeling; Calcitriol; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Disease Management; Disease Progression; Forecasting; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Osteomalacia; Parathyroid Hormone; Phosphorus; Practice Guidelines as Topic; Renal Dialysis; Vitamin D | 2006 |
Mineral metabolism disturbances in patients with chronic kidney disease.
Topics: Calcinosis; Calcium; Cardiovascular Diseases; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Parathyroid Hormone; Phosphorus; Renal Dialysis; Risk Factors; Vitamin D | 2007 |
Abnormal bone and mineral metabolism in kidney transplant patients--a review.
Topics: Biomarkers; Bone and Bones; Calcium; Disease Progression; Humans; Hyperparathyroidism, Secondary; Kidney; Kidney Diseases; Kidney Transplantation; Phosphorus; Time Factors; Treatment Outcome; Vitamin D | 2008 |
[Parathyroid and bone. Mineral and bone disorder and parathyroid function in chronic kidney disease].
Topics: Bone Diseases, Metabolic; Calcinosis; Chronic Disease; Glomerular Filtration Rate; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Oxidative Stress; Phosphorus; Vascular Diseases; Vitamin D Deficiency | 2007 |
[Disorders of calcium and phosphorus metabolism in renal failure and nephrotic syndrome].
Topics: Aluminum; Calcium; Calcium Metabolism Disorders; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Nephrotic Syndrome; Osteoporosis; Phosphorus; Phosphorus Metabolism Disorders; Vitamin D | 1982 |
Secondary hyperparathyroidism in renal failure: the trade-off hypothesis revisited.
Topics: Calcitriol; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Phosphorus | 1995 |
[Secondary hyperparathyroidism and tertiary hyperparathyroidism chronic renal failure, uremia].
Topics: Calcitriol; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Phosphorus; Uremia | 1995 |
The molecular basis of secondary hyperparathyroidism in chronic renal failure.
Topics: Calcitriol; Calcium; Calcium-Binding Proteins; Chronic Kidney Disease-Mineral and Bone Disorder; Gene Expression Regulation; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Parathyroid Hormone; Phosphorus; RNA, Messenger; Transcription, Genetic | 1994 |
Pathogenesis of secondary hyperparathyroidism.
Topics: Calcitriol; Calcium; Humans; Hyperparathyroidism, Secondary; Phosphorus; Renal Insufficiency; Vitamin D | 1996 |
The role of calcium, phosphorus and vitamin D metabolism in the development of secondary hyperparathyroidism.
Topics: Animals; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hyperparathyroidism, Secondary; Phosphorus; Vitamin D | 1998 |
Intermittent oral 1alpha-hydroxyvitamin D2 is effective and safe for the suppression of secondary hyperparathyroidism in haemodialysis patients. 1alphaD2 Study Group.
Topics: Administration, Oral; Clinical Trials as Topic; Ergocalciferols; Humans; Hyperparathyroidism, Secondary; Parathyroid Hormone; Phosphorus; Renal Dialysis | 1998 |
Pathogenic, clinical, and therapeutic aspects of secondary hyperparathyroidism in chronic renal failure.
Topics: Calcitriol; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Phosphorus | 1998 |
Phosphorus, regulation of plasma calcium, and secondary hyperparathyroidism: a hypothesis to integrate a historical and modern perspective.
Topics: Adaptation, Physiological; Adult; Age Factors; Aged; Animals; Bone Diseases, Metabolic; Calcium; Clinical Trials as Topic; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Phosphorus | 1999 |
Update on renal osteodystrophy: pathogenesis and clinical management.
Topics: Aluminum Compounds; Bone Density; Calcium Compounds; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hyperparathyroidism, Secondary; Magnesium Compounds; Osteomalacia; Parathyroidectomy; Phosphorus; Vitamin D | 1999 |
The role of phosphorus in the development of secondary hyperparathyroidism and parathyroid cell proliferation in chronic renal failure.
Topics: Animals; Calcitriol; Cell Division; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Parathyroid Glands; Phosphorus; Rats; Time Factors | 1999 |
Understanding and managing hyperphosphatemia in patients with chronic renal disease.
Topics: Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Phosphates; Phosphorus; Phosphorus Metabolism Disorders; Renal Dialysis | 1999 |
Pathogenesis of secondary hyperparathyroidism.
Topics: Animals; Calcium; Humans; Hyperparathyroidism, Secondary; Parathyroid Hormone; Phosphorus; Receptors, Calcitriol; Renal Insufficiency; Vitamin D | 1999 |
Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management.
Topics: Calcinosis; Calcium; Cardiovascular Diseases; Chronic Kidney Disease-Mineral and Bone Disorder; Evaluation Studies as Topic; Heart Arrest; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Parathyroid Hormone; Phosphates; Phosphorus; Renal Dialysis; Risk Factors; Vascular Diseases | 2000 |
Prevention and treatment of renal osteodystrophy in children with chronic renal insufficiency and end-stage renal disease.
Topics: Calcitriol; Calcium; Child; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Parathyroid Hormone; Phosphorus; Vitamin D | 2001 |
Secondary hyperparathyroidism in chronic renal failure: pathogenic and clinical aspects.
Topics: Animals; Calcitriol; Calcium-Binding Proteins; Humans; Hyperparathyroidism, Secondary; Kidney; Kidney Failure, Chronic; Parathyroid Hormone; Phosphorus; Rats; Receptors, Calcitriol; RNA, Messenger | 2001 |
Intravenous versus oral vitamin d therapy in dialysis patients: what is the question?
Topics: Administration, Oral; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Injections, Intravenous; Parathyroid Hormone; Patient Compliance; Phosphorus; Renal Dialysis; Vitamin D | 2001 |
Current issues in the management of secondary hyperparathyroidism and bone disease.
Topics: Bone Remodeling; Calcinosis; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Muscle, Smooth, Vascular; Parathyroid Hormone; Peritoneal Dialysis; Phosphorus; Renal Dialysis | 2001 |
The role of phosphorus in the management of secondary hyperparathyroidism.
Topics: Congresses as Topic; Humans; Hyperparathyroidism, Secondary; Phosphorus | 2001 |
The effects of calcium and phosphorus in hemodialysis.
Topics: Animals; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Dogs; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Hypophosphatemia, Familial; Kidney Failure, Chronic; Parathyroid Hormone; Phosphorus; Renal Dialysis | 1976 |
Growth in renal failure.
Topics: Acidosis, Renal Tubular; Anemia; Animals; Calcium; Growth; Growth Disorders; Hormones; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Kidney Failure, Chronic; Nutrition Disorders; Phosphorus; Rats; Uremia; Vitamin D | 1978 |
Azotaemic osteodystrophy-present position.
Topics: Absorptiometry, Photon; Bone and Bones; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hyperparathyroidism, Secondary; Phosphorus; Radionuclide Imaging; Renal Dialysis; Uremia | 1978 |
Nutrition and bone disease in the dog and cat.
Topics: Animals; Ascorbic Acid Deficiency; Bone Diseases, Developmental; Bone Resorption; Calcium; Cat Diseases; Cats; Dog Diseases; Dogs; Female; Hyperparathyroidism, Secondary; Male; Nutrition Disorders; Nutritional Requirements; Osteoporosis; Phosphorus; Rickets; Vitamin A; Vitamin A Deficiency | 1976 |
Calcium and phosphorus metabolism in chronic uremia.
Topics: Calcium; Chronic Disease; Chronic Kidney Disease-Mineral and Bone Disorder; Dihydroxycholecalciferols; Drug Resistance; Glomerular Filtration Rate; Humans; Hyperparathyroidism, Secondary; Hyperplasia; Intestinal Absorption; Kidney Failure, Chronic; Kinetics; Metabolic Diseases; Osteitis Fibrosa Cystica; Osteomalacia; Parathyroid Glands; Parathyroid Hormone; Phosphates; Phosphorus; Uremia; Vitamin D | 1975 |
Effects of calcium and phosphorus on patients maintained on dialysis.
Topics: Bone Resorption; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hyperparathyroidism, Secondary; Parathyroid Hormone; Phosphates; Phosphorus; Radioimmunoassay; Renal Dialysis; Uremia | 1975 |
Experimental studies on osteoporosis.
Topics: Adolescent; Adult; Alkaline Phosphatase; Animal Feed; Animals; Bone and Bones; Bone Resorption; Calcium; Calcium, Dietary; Carnivora; Disease Models, Animal; Dogs; Female; Gingivectomy; Horses; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Osteoporosis; Periodontal Diseases; Phosphorus; Radiography | 1975 |
[Corticoid-induced osteoporosis. Pathogenesis, diagnosis and treatment].
Topics: Adrenal Cortex Hormones; Adult; Bone and Bones; Calcium; Calcium, Dietary; Female; Humans; Hyperparathyroidism, Secondary; Incidence; Intestinal Absorption; Kidney Tubules; Male; Osteoporosis; Phosphorus; Prospective Studies; Risk Factors; Vitamin D | 1992 |
Pathogenesis of secondary hyperparathyroidism in chronic renal insufficiency.
Topics: Calcitriol; Calcium; Glomerular Filtration Rate; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Parathyroid Hormone; Phosphorus | 1991 |
Parathyroid hormone and 1,25(OH)2D3 in chronic renal failure.
Topics: Aluminum; Calcitriol; Calcium; Homeostasis; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Parathyroid Hormone; Phosphorus; Receptors, Calcitriol; Receptors, Steroid | 1988 |
[Secondary hyperparathyroidism in chronic kidney failure].
Topics: Animals; Bone and Bones; Calcium; Combined Modality Therapy; Humans; Hyperparathyroidism, Secondary; Intestinal Absorption; Kidney Failure, Chronic; Parathyroid Hormone; Phosphorus; Vitamin D | 1986 |
Management of bone disease in the dialysis patient.
Topics: Aluminum; Calcitriol; Calcium; Calcium, Dietary; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hydroxycholecalciferols; Hyperparathyroidism, Secondary; Osteitis Fibrosa Cystica; Osteomalacia; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Renal Dialysis | 1985 |
Disordered divalent ion metabolism in kidney disease: comments on pathogenesis and treatment.
Topics: Bicarbonates; Bone Resorption; Calcium; Cholecalciferol; Chronic Kidney Disease-Mineral and Bone Disorder; Diet Therapy; Dihydroxycholecalciferols; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Kidney Failure, Chronic; Kidney Tubules; Magnesium; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Renal Dialysis; Structure-Activity Relationship | 1973 |
The kidney as an endocrine organ involved in calcium homeostasis.
Topics: Animals; Bone and Bones; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Cyclic AMP; Diet Therapy; Dihydroxycholecalciferols; Homeostasis; Humans; Hyperparathyroidism, Secondary; Intestinal Absorption; Kidney; Kidney Cortex; Kidney Failure, Chronic; Kidney Tubules; Liver; Parathyroid Glands; Parathyroid Hormone; Phosphates; Phosphorus; Vitamin D | 1973 |
[Hyperparathyroidism].
Topics: Adolescent; Adult; Aged; Alkaline Phosphatase; Calcium; Child; Child, Preschool; Female; Humans; Hyperparathyroidism; Hyperparathyroidism, Secondary; Infant; Infant, Newborn; Male; Middle Aged; Phosphorus; Pseudohypoparathyroidism | 1972 |
[Calcium and the parathyroid gland in hemodialysis].
Topics: Animals; Calcium; Dogs; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Rats; Vitamin D | 1972 |
Some biochemical, histological, radiological and clinical features of renal osteodystrophy.
Topics: Bone and Bones; Bone Regeneration; Calcinosis; Calcium; Carbonates; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hyperparathyroidism, Secondary; Intestinal Absorption; Kidney Failure, Chronic; Magnesium; Osteosclerosis; Parathyroid Glands; Phosphorus; Radiography; Renal Dialysis; Vitamin D | 1973 |
Hyperparathyroidism and renal failure.
Topics: Amino Acid Sequence; Animals; Bone and Bones; Calcium; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Function Tests; Parathyroid Glands; Parathyroid Hormone; Phosphates; Phosphorus; Radioimmunoassay; Renal Dialysis; Secretory Rate; Species Specificity; Vitamin D | 1973 |
Secondary hyperparathyroidism in chronic renal failure. The clinical spectrum in uremia, during hemodialysis, and after renal transplantation.
Topics: Bone Diseases; Calcinosis; Calcium; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Transplantation; Parathyroid Glands; Phosphorus; Renal Dialysis; Uremia | 1969 |
88 trial(s) available for phosphorus and Hyperparathyroidism, Secondary
| Article | Year |
|---|---|
Current therapeutic options for the treatment of secondary hyperparathyroidism in end-stage renal disease patients treated with hemodialysis: a 12-month comparative study.
Topics: Calcimimetic Agents; Calcium; Cohort Studies; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Parathyroid Hormone; Phosphorus; Prospective Studies; Renal Dialysis; Retrospective Studies | 2022 |
Efficacy and safety of paricalcitol in children with stages 3 to 5 chronic kidney disease.
Topics: Adolescent; Bone Density Conservation Agents; Calcium; Child; Double-Blind Method; Ergocalciferols; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Failure, Chronic; Male; Parathyroid Hormone; Phosphorus; Renal Dialysis; Treatment Outcome | 2017 |
Pharmacodynamics of evocalcet for secondary hyperparathyroidism in Japanese hemodialysis patients.
Topics: Adult; Aged; Calcimimetic Agents; Calcium; Drug Administration Schedule; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperparathyroidism, Secondary; Japan; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Pyrrolidines; Renal Dialysis; Renal Insufficiency, Chronic; Treatment Outcome; Young Adult | 2019 |
An integrated analysis of safety and tolerability of etelcalcetide in patients receiving hemodialysis with secondary hyperparathyroidism.
Topics: Calcimimetic Agents; Calcium; Dose-Response Relationship, Drug; Female; Humans; Hyperparathyroidism, Secondary; Male; Maximum Tolerated Dose; Middle Aged; Peptides; Phosphorus; Prognosis; Renal Dialysis | 2019 |
The effectiveness of cinacalcet: a randomized, open label study in chronic hemodialysis patients with severe secondary hyperparathyroidism.
Topics: Adult; Calcimimetic Agents; Calcium; Cinacalcet; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Severity of Illness Index; Treatment Outcome; Young Adult | 2019 |
A prospective randomized pilot study on intermittent post-dialysis dosing of cinacalcet.
Topics: Adult; Aged; Alkaline Phosphatase; Calcimimetic Agents; Calcium; Cinacalcet; Drug Administration Schedule; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Medication Adherence; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Pilot Projects; Prospective Studies; Renal Dialysis; Severity of Illness Index | 2014 |
Efficacy and initial dose determination of paricalcitol for treatment of secondary hyperparathyroidism in Chinese subjects.
Topics: Adult; Aged; Calcium; Ergocalciferols; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Single-Blind Method | 2014 |
Paricalcitol- or cinacalcet-centred therapy affects markers of bone mineral disease in patients with secondary hyperparathyroidism receiving haemodialysis: results of the IMPACT-SHPT study.
Topics: Aged; Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcium; Cinacalcet; Dose-Response Relationship, Drug; Ergocalciferols; Female; Fibroblast Growth Factor-23; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Injections, Intravenous; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Treatment Outcome | 2014 |
Novel, selective vitamin D analog suppresses parathyroid hormone in uremic animals and postmenopausal women.
Topics: Animals; Bone Density Conservation Agents; Calcitriol; Calcium; Chromatography, High Pressure Liquid; Double-Blind Method; Female; Humans; Hyperparathyroidism, Secondary; Male; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Postmenopause; Rats; Renal Insufficiency, Chronic; Uremia | 2014 |
The incremental treatment of ESRD: a low-protein diet combined with weekly hemodialysis may be beneficial for selected patients.
Topics: Aged; Aged, 80 and over; Appointments and Schedules; Calcium; Combined Modality Therapy; Cost Savings; Diet, Protein-Restricted; Dietary Proteins; Female; Hospitalization; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Function Tests; Male; Middle Aged; Phosphorus; Phosphorus, Dietary; Prospective Studies; Renal Dialysis; Survival Rate; Treatment Outcome | 2014 |
Effect of raloxifene on parathyroid hormone in osteopenic and osteoporotic postmenopausal women with chronic kidney disease stage 5.
Topics: Administration, Oral; Alkaline Phosphatase; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcium; Female; Humans; Hyperparathyroidism, Secondary; Middle Aged; Osteoporosis, Postmenopausal; Parathyroid Hormone; Phosphorus; Raloxifene Hydrochloride; Renal Dialysis; Renal Insufficiency, Chronic | 2014 |
Effect of Cinacalcet and Vitamin D Analogs on Fibroblast Growth Factor-23 during the Treatment of Secondary Hyperparathyroidism.
Topics: Aged; Australia; Biomarkers; Calcimimetic Agents; Calcium; Canada; Chi-Square Distribution; Cinacalcet; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Logistic Models; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Prospective Studies; Renal Dialysis; Risk Factors; Russia; Time Factors; Treatment Outcome; United States; Vitamin D | 2015 |
Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study.
Topics: Adult; Biomarkers; Bone and Bones; Calcium; Europe; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Prognosis; Proportional Hazards Models; Prospective Studies; Renal Dialysis; Renal Insufficiency, Chronic; Survival Rate | 2015 |
Efficacy of microwave ablation for severe secondary hyperparathyroidism in subjects undergoing hemodialysis.
Topics: Ablation Techniques; Adult; Aged; Calcium; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Middle Aged; Outcome and Process Assessment, Health Care; Parathyroid Hormone; Phosphorus; Prospective Studies; Renal Dialysis; Severity of Illness Index | 2017 |
2MD (DP001), a Single Agent in the Management of Hemodialysis Patients: A Randomized Trial.
Topics: Adult; Aged; Calcitriol; Calcium; Double-Blind Method; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Treatment Outcome | 2017 |
A phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of etelcalcetide (ONO-5163/AMG 416), a novel intravenous calcimimetic, for secondary hyperparathyroidism in Japanese haemodialys
Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Calcium; Double-Blind Method; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Hormone; Peptides; Phosphorus; Receptors, Calcium-Sensing; Renal Dialysis; Renal Insufficiency, Chronic; Young Adult | 2017 |
Intravenous calcitriol therapy in an early stage prevents parathyroid gland growth.
Topics: Administration, Oral; Aged; Bone and Bones; Calcitriol; Calcium; Collagen Type I; Dose-Response Relationship, Drug; Female; Humans; Hyperparathyroidism, Secondary; Hyperplasia; Injections, Intravenous; Longitudinal Studies; Male; Middle Aged; Parathyroid Glands; Parathyroid Hormone; Peptides; Phosphorus; Renal Dialysis; Renal Insufficiency; Ultrasonography; Vitamin D | 2008 |
Cinacalcet HCl and concurrent low-dose vitamin D improves treatment of secondary hyperparathyroidism in dialysis patients compared with vitamin D alone: the ACHIEVE study results.
Topics: Adult; Aged; Calcium; Chronic Disease; Cinacalcet; Drug Therapy, Combination; Female; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Practice Guidelines as Topic; Prospective Studies; Renal Dialysis; Time Factors; Treatment Outcome; Vitamin D; Vitamins | 2008 |
A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet HCl in participants with CKD not receiving dialysis.
Topics: Aged; Calcium; Cinacalcet; Double-Blind Method; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Renal Dialysis | 2009 |
Response of different PTH assays to therapy with sevelamer or CaCO3 and active vitamin D sterols.
Topics: Adolescent; Adult; Alkaline Phosphatase; Calcium; Calcium Carbonate; Chelating Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Hyperparathyroidism, Secondary; Immunoassay; Male; Parathyroid Hormone; Phosphorus; Polyamines; Renal Dialysis; Sevelamer; Vitamin D | 2009 |
Impact of vitamin D dose on biochemical parameters in patients with secondary hyperparathyroidism receiving cinacalcet.
Topics: Adult; Calcium; Cinacalcet; Dose-Response Relationship, Drug; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Failure, Chronic; Male; Naphthalenes; Parathyroid Hormone; Phosphorus; Renal Dialysis; Vitamin D | 2009 |
Comparison of oral falecalcitriol and intravenous calcitriol in hemodialysis patients with secondary hyperparathyroidism: a randomized, crossover trial.
Topics: Administration, Oral; Alkaline Phosphatase; Biomarkers; Bone and Bones; Bone Density Conservation Agents; Calcitriol; Calcium; Collagen Type I; Cross-Over Studies; Female; Humans; Hyperparathyroidism, Secondary; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Osteocalcin; Parathyroid Hormone; Peptides; Phosphorus; Renal Dialysis; Treatment Outcome | 2009 |
Simultaneous control of PTH and CaxP Is sustained over three years of treatment with cinacalcet HCl.
Topics: Adult; Aged; Biomarkers; Calcium; Canada; Chelating Agents; Chronic Disease; Cinacalcet; Double-Blind Method; Drug Therapy, Combination; Europe; Female; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Peritoneal Dialysis; Phosphates; Phosphorus; Renal Dialysis; Time Factors; Treatment Outcome; United States; Vitamin D | 2009 |
Can cinacalcet replace parathyroid intervention in severe secondary hyperparathyroidism?
Topics: Adult; Aged; Calcium; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Renal Dialysis; Severity of Illness Index; Treatment Outcome | 2009 |
Vitamin D receptor activator reduces oxidative stress in hemodialysis patients with secondary hyperparathyroidism.
Topics: Aged; Aged, 80 and over; Calcitriol; Calcium; Chronic Disease; Female; Free Radical Scavengers; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Male; Middle Aged; Oxidative Stress; Parathyroid Hormone; Phosphorus; Receptors, Calcitriol; Renal Dialysis; Serum Albumin | 2011 |
No difference between alfacalcidol and paricalcitol in the treatment of secondary hyperparathyroidism in hemodialysis patients: a randomized crossover trial.
Topics: Adult; Aged; Calcium; Cross-Over Studies; Ergocalciferols; Female; Humans; Hydroxycholecalciferols; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis | 2011 |
Decreases in PTH in Japanese hemodialysis patients with secondary hyperparathyroidism: associations with changing practice patterns.
Topics: Aged; Calcium; Cinacalcet; Cohort Studies; Female; Humans; Hyperparathyroidism, Secondary; Longitudinal Studies; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Practice Patterns, Physicians'; Renal Dialysis | 2011 |
Exposure-clinical response analysis of paricalcitol in patients with chronic kidney disease (stage 5) on hemodialysis or peritoneal dialysis.
Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Biological Availability; Calcium; Capsules; Double-Blind Method; Ergocalciferols; Female; Humans; Hyperparathyroidism, Secondary; Injections; Male; Middle Aged; Parathyroid Hormone; Peritoneal Dialysis; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Young Adult | 2012 |
Efficacy and safety of cinacalcet for the treatment of secondary hyperparathyroidism in patients with advanced chronic kidney disease before initiation of regular dialysis.
Topics: Adult; Aged; Calcimimetic Agents; Calcium; Chronic Disease; Cinacalcet; Compassionate Use Trials; Drug Therapy, Combination; Female; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Severity of Illness Index; Treatment Outcome; Vitamin D | 2012 |
Cinacalcet hydrochloride therapy for secondary hyperparathyroidism in hemodialysis patients.
Topics: Absorptiometry, Photon; Adult; Aged; Bone Density; Bone Density Conservation Agents; Chelating Agents; Cinacalcet; Female; Femur; Humans; Hyperparathyroidism, Secondary; Lumbar Vertebrae; Male; Middle Aged; Naphthalenes; Phosphorus; Prospective Studies; Pruritus; Renal Dialysis; Treatment Outcome; Vitamin D | 2011 |
Effects of cinacalcet treatment on serum soluble Klotho levels in haemodialysis patients with secondary hyperparathyroidism.
Topics: Aged; Calcimimetic Agents; Calcium; Cinacalcet; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glucuronidase; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Klotho Proteins; Longitudinal Studies; Male; Middle Aged; Naphthalenes; Phosphorus; Renal Dialysis; Treatment Outcome | 2012 |
Microalbuminuria, another use for paricalcitol? Our experience in advanced chronic kidney disease.
Topics: Albuminuria; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Calcifediol; Calcium; Drug Therapy, Combination; Ergocalciferols; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Parathyroid Hormone; Phosphorus; Renal Dialysis | 2012 |
Is serum phosphorus control related to parathyroid hormone control in dialysis patients with secondary hyperparathyroidism?
Topics: Adult; Aged; Causality; Comorbidity; Dialysis; Europe; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Prevalence; Renal Insufficiency; Risk Factors | 2012 |
Relationship between reductions in parathyroid hormone and serum phosphorus during the management of secondary hyperparathyroidism with calcimimetics in hemodialysis patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Calcimimetic Agents; Comorbidity; Female; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Prevalence; Renal Dialysis; Risk Factors; Tennessee; Young Adult | 2012 |
Efficacy of cinacalcet with low-dose vitamin D in incident haemodialysis subjects with secondary hyperparathyroidism.
Topics: Adult; Aged; Calcium; Case-Control Studies; Cinacalcet; Cohort Studies; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; International Agencies; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Prognosis; Renal Dialysis; Renal Insufficiency, Chronic; Vitamin D; Vitamins | 2013 |
Progression of aortic valve stenosis is associated with bone remodelling and secondary hyperparathyroidism in elderly patients--the COFRASA study.
Topics: Aged; Aortic Valve Stenosis; Biomarkers; Bone Remodeling; Calcium; Collagen Type I; Creatinine; Female; Humans; Hyperparathyroidism, Secondary; Male; Osteocalcin; Parathyroid Hormone; Peptides; Phosphorus; Prospective Studies; Vitamin D | 2013 |
Intravenous alfacalcidol once versus twice or thrice weekly in hemodialysis patients.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Calcium; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hydroxycholecalciferols; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Practice Guidelines as Topic; Prospective Studies; Renal Dialysis; Treatment Outcome; Young Adult | 2013 |
Renoprotection following treatment of secondary hyperparathyroidism with percutaneous ethanol injection in pre-dialysis patients.
Topics: Administration, Cutaneous; Adult; Calcitriol; Calcium Channel Agonists; Central Nervous System Depressants; Creatinine; Ethanol; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Phosphorus; Renal Dialysis; Treatment Outcome; Ultrasonography | 2002 |
[Calcitriol dose optimization in the treatment of secondary hyperparathyroidism during dialysis. Results at 6 months].
Topics: Adult; Calcitriol; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Dose-Response Relationship, Drug; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Hormone; Patient Compliance; Phosphorus; Renal Dialysis; Severity of Illness Index | 2002 |
The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism.
Topics: Adult; Aged; Calcitriol; Calcium; Calcium Channel Agonists; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Renal Dialysis; Titrimetry | 2003 |
Double-phase parathyroid 99mTc-Sestamibi scintigraphy in chronic haemodialysis patients: correlation with biochemical markers of parathyroid function.
Topics: Age Factors; Biomarkers; Calcium; Dihydroxycholecalciferols; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Radionuclide Imaging; Radiopharmaceuticals; Renal Dialysis; Reproducibility of Results; Sensitivity and Specificity; Sex Factors; Statistics as Topic; Technetium Tc 99m Sestamibi; Vitamin D | 2003 |
The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end-stage renal disease.
Topics: Adult; Calcium; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Receptors, Calcium-Sensing; Receptors, Cell Surface; Renal Dialysis; Vitamin D | 2003 |
Time course of change in calcium x phosphorus product after percutaneous ethanol injection therapy.
Topics: Administration, Oral; Adult; Aged; Calcitriol; Calcium; Ethanol; Female; Humans; Hyperparathyroidism, Secondary; Injections, Intralesional; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Osmolar Concentration; Phosphorus; Renal Dialysis; Time Factors; Treatment Outcome | 2003 |
[Early treatment of secondary hyperparathyroidism in moderate renal insufficiency: low-phosphorus diet versus calcium carbonate].
Topics: Aged; Calcifediol; Calcitriol; Calcium; Calcium Carbonate; Calcium, Dietary; Chelating Agents; Chelation Therapy; Creatinine; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Phosphorus, Dietary; Treatment Outcome | 2003 |
Nicotinamide suppresses hyperphosphatemia in hemodialysis patients.
Topics: Aged; Calcium; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; NAD; Niacinamide; Parathyroid Hormone; Phosphorus; Phosphorus Metabolism Disorders; Renal Dialysis | 2004 |
Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis.
Topics: Calcium; Cinacalcet; Double-Blind Method; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Logistic Models; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Renal Dialysis | 2004 |
Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4.
Topics: Aged; Calcium; Chronic Disease; Double-Blind Method; Ergocalciferols; Female; Glomerular Filtration Rate; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Male; Middle Aged; Parathyroid Hormone; Phosphorus | 2004 |
Comparison of the effects of calcitriol and maxacalcitol on secondary hyperparathyroidism in patients on chronic haemodialysis: a randomized prospective multicentre trial.
Topics: Alkaline Phosphatase; Bone and Bones; Calcitriol; Calcium; Calcium Channel Agonists; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Prospective Studies; Renal Dialysis | 2004 |
Achieving NKF-K/DOQI bone metabolism and disease treatment goals with cinacalcet HCl.
Topics: Adult; Aged; Bone and Bones; Calcium; Cinacalcet; Double-Blind Method; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus | 2005 |
Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter study.
Topics: Administration, Oral; Adult; Calcium; Cinacalcet; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Peritoneal Dialysis; Phosphorus; Renal Dialysis; Vitamin D | 2005 |
Control of parathyroid function in patients with a short history of hemodialysis.
Topics: Administration, Oral; Calcitriol; Calcium; Calcium Carbonate; Female; Follow-Up Studies; Humans; Hydroxycholecalciferols; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Prospective Studies; Renal Dialysis; Time Factors | 2005 |
Cinacalcet hydrochloride is an effective treatment for secondary hyperparathyroidism in patients with CKD not receiving dialysis.
Topics: Calcium; Chronic Disease; Cinacalcet; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Treatment Outcome; Vitamin D | 2005 |
Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HCl.
Topics: Adult; Aged; Calcium; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Receptors, Calcium-Sensing; Time Factors | 2005 |
[Clinical analysis of time-course changes in minerals and parathyroid hormone levels during treatment with phosphate binders in hemodialysis patients with secondary hyperparathyroidism].
Topics: Aged; Calcium; Calcium Carbonate; Drug Therapy, Combination; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Polyamines; Renal Dialysis; Sevelamer; Time Factors | 2005 |
[Sevelamer hydrochloride and K/DOQI guidelines].
Topics: Alkaline Phosphatase; Calcium; Calcium Carbonate; Cholecalciferol; Chronic Kidney Disease-Mineral and Bone Disorder; Dialysis; Drug Therapy, Combination; Female; Humans; Hyperparathyroidism, Secondary; Male; Parathyroid Hormone; Phosphorus; Polyamines; Practice Guidelines as Topic; Sevelamer | 2005 |
A comparison of dosing regimens of paricalcitol capsule for the treatment of secondary hyperparathyroidism in CKD stages 3 and 4.
Topics: Adult; Aged; Aged, 80 and over; Calcium; Capsules; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Ergocalciferols; Female; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Prospective Studies; Vitamins | 2006 |
Differential effects of very high doses of doxercalciferol and paricalcitol on serum phosphorus in hemodialysis patients.
Topics: Adult; Aged; Bone Density Conservation Agents; Calcium; Ergocalciferols; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Phosphorus; Prospective Studies; Renal Dialysis | 2006 |
A randomized trial of intermittent versus continuous oral alfacalcidol treatment of hyperparathyroidism in end-stage renal disease.
Topics: Administration, Oral; Adult; Alkaline Phosphatase; Calcium; Drug Administration Schedule; Female; Humans; Hydroxycholecalciferols; Hyperparathyroidism; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis | 2006 |
Effects of 22-oxacalcitriol and calcitriol on PTH secretion and bone mineral metabolism in a crossover trial in hemodialysis patients with secondary hyperparathyroidism.
Topics: Adolescent; Adult; Aged; Alkaline Phosphatase; Bone and Bones; Bone Density Conservation Agents; Calcitriol; Calcium; Cross-Over Studies; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Prospective Studies; Renal Dialysis | 2007 |
Influence of sevelamer on mineral metabolism and hyperparathyroidism in Japanese hemodialysis patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Calcium; Chelating Agents; Female; Humans; Hyperparathyroidism, Secondary; Japan; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Polyamines; Prospective Studies; Renal Dialysis; Sevelamer | 2007 |
Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Calcium; Ergocalciferols; Female; Humans; Hyperparathyroidism, Secondary; Kaplan-Meier Estimate; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Peritoneal Dialysis; Phosphorus; Placebos; Receptors, Calcitriol; Renal Dialysis; Treatment Outcome | 2008 |
The OPTIMA study: assessing a new cinacalcet (Sensipar/Mimpara) treatment algorithm for secondary hyperparathyroidism.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Calcium; Chelating Agents; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Treatment Outcome; Vitamin D | 2008 |
Combined therapy with cinacalcet and low doses of vitamin D sterols in patients with moderate to severe secondary hyperparathyroidism.
Topics: Adult; Aged; Calcium; Cinacalcet; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Hyperphosphatemia; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Severity of Illness Index; Sterols; Treatment Outcome; Vitamin D | 2008 |
Dose determination of cinacalcet hydrochloride in Japanese hemodialysis patients with secondary hyperparathyroidism.
Topics: Acid Phosphatase; Aged; Asian People; Calcium; Cinacalcet; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Isoenzymes; Japan; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Osteocalcin; Parathyroid Hormone; Phosphorus; Renal Dialysis; Tartrate-Resistant Acid Phosphatase | 2008 |
Comparison of sevelamer hydrochloride with colestimide, administered alone or in combination with calcium carbonate, in patients on hemodialysis.
Topics: Adult; Aged; Calcium; Calcium Carbonate; Chelating Agents; Drug Therapy, Combination; Epichlorohydrin; Female; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Imidazoles; Japan; Kidney Failure, Chronic; Male; Middle Aged; Phosphorus; Polyamines; Prospective Studies; Renal Dialysis; Resins, Synthetic; Sevelamer | 2008 |
Intravenous alfacalcidol once weekly suppresses parathyroid hormone in hemodialysis patients.
Topics: Adenoma; Adult; Aged; Alkaline Phosphatase; Bone Density Conservation Agents; Calcium; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hydroxycholecalciferols; Hyperparathyroidism, Secondary; Injections, Intravenous; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Prospective Studies; Renal Dialysis; Severity of Illness Index | 2008 |
[Prospective study of the effect of propanolol on Ca-P metabolism in chronic renal insufficiency].
Topics: Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Phosphorus; Propranolol; Prospective Studies | 1982 |
Effect of the mode of calcitriol administration on PTH-ionized calcium relationship in uraemic patients with secondary hyperparathyroidism.
Topics: Administration, Oral; Calcitriol; Calcium; Chronic Disease; Female; Humans; Hyperparathyroidism, Secondary; Injections, Intravenous; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Prospective Studies; Uremia | 1995 |
Effect of administering calcium carbonate to treat secondary hyperparathyroidism in nondialyzed patients with chronic renal failure.
Topics: Administration, Oral; Calcitriol; Calcium; Calcium Carbonate; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Time Factors | 1995 |
Bone mineral density evaluated by dual-energy X-ray absorptiometry after one-year treatment with calcitriol started in the predialysis phase of chronic renal failure.
Topics: Absorptiometry, Photon; Adult; Aged; Bone Density; Calcitriol; Double-Blind Method; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Osteocalcin; Parathyroid Hormone; Peritoneal Dialysis, Continuous Ambulatory; Phosphorus; Time Factors | 1995 |
[Attempt at evaluation of alfacalcidol administered by an oral pulsatile method to chronically dialysed patients with advanced secondary hyperparathyroidism].
Topics: Administration, Oral; Adult; Alkaline Phosphatase; Calcium; Drug Administration Schedule; Humans; Hydroxycholecalciferols; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Middle Aged; Phosphorus; Renal Dialysis | 1994 |
Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy.
Topics: Adolescent; Bone Diseases; Bone Remodeling; Calcitriol; Calcium; Child; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Osteitis; Parathyroid Hormone; Peritoneal Dialysis; Phosphorus | 1994 |
Suppression of secondary hyperparathyroidism in chronic dialysis patients by single oral weekly dose of 1,25-dihydroxycholecalciferol.
Topics: Administration, Oral; Adult; Aged; Alkaline Phosphatase; Calcitriol; Calcium; Drug Administration Schedule; Female; Humans; Hyperparathyroidism, Secondary; Magnesium; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis | 1993 |
Long-term effects of intravenous 1 alpha (OH)D3 combined with CaCO3 and low-calcium dialysis on secondary hyperparathyroidism and biochemical bone markers in patients on chronic hemodialysis.
Topics: Adult; Alkaline Phosphatase; Aluminum; Biomarkers; Bone and Bones; Bone Density; Calcium; Calcium Carbonate; Chronic Disease; Dialysis Solutions; Diaphyses; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Femur Neck; Humans; Hydrogen-Ion Concentration; Hydroxycholecalciferols; Hyperparathyroidism, Secondary; Injections, Intravenous; Lumbar Vertebrae; Male; Middle Aged; Osteocalcin; Parathyroid Hormone; Peptide Fragments; Phosphates; Phosphorus; Procollagen; Radiography; Renal Dialysis | 1996 |
The importance of dietary calcium and phosphorous in the secondary hyperparathyroidism of patients with early renal failure.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Calcitriol; Calcium; Calcium, Dietary; Creatinine; Diet, Protein-Restricted; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Phosphorus, Dietary | 1997 |
Intermittent oral 1alpha-hydroxyvitamin D2 is effective and safe for the suppression of secondary hyperparathyroidism in haemodialysis patients. 1alphaD2 Study Group.
Topics: Administration, Oral; Clinical Trials as Topic; Ergocalciferols; Humans; Hyperparathyroidism, Secondary; Parathyroid Hormone; Phosphorus; Renal Dialysis | 1998 |
Intermittent calcitriol therapy in secondary hyperparathyroidism: a comparison between oral and intraperitoneal administration.
Topics: Administration, Oral; Adolescent; Bone and Bones; Calcitriol; Calcium; Child; Female; Humans; Hyperparathyroidism, Secondary; Injections, Intraperitoneal; Male; Phosphorus; Prospective Studies | 1998 |
Dietary protein affects intestinal calcium absorption.
Topics: Adult; Amino Acids; Calcium; Diet; Dietary Carbohydrates; Dietary Fiber; Dietary Proteins; Female; Glomerular Filtration Rate; Humans; Hyperparathyroidism, Secondary; Intestinal Absorption; Phosphorus | 1998 |
Suppression of parathyroid hormone secretion in hemodialysis patients by a novel vitamin D analogue: 19-nor-1,25-dihydroxyvitamin D2.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Calcium; Double-Blind Method; Ergocalciferols; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Vitamin D | 1998 |
Therapy of secondary hyperparathyroidism with 19-nor-1alpha,25-dihydroxyvitamin D2.
Topics: Calcium; Double-Blind Method; Ergocalciferols; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Parathyroid Hormone; Phosphorus | 1998 |
Predictors of short-term changes in serum intact parathyroid hormone levels in hemodialysis patients: role of phosphorus, calcium, and gender.
Topics: Adult; Aged; Calcium; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Predictive Value of Tests; Prospective Studies; Regression Analysis; Renal Dialysis; Sex Characteristics; Time Factors | 1998 |
A randomized trial of sevelamer hydrochloride (RenaGel) with and without supplemental calcium. Strategies for the control of hyperphosphatemia and hyperparathyroidism in hemodialysis patients.
Topics: Calcium; Calcium Carbonate; Cholesterol; Female; Gels; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Polyamines; Sevelamer | 1999 |
Sevelamer with and without calcium and vitamin D: observations from a long-term open-label clinical trial.
Topics: Adult; Aged; Aged, 80 and over; Calcium; Epoxy Compounds; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphates; Phosphorus; Polyamines; Polyethylenes; Renal Dialysis; Sevelamer; Vitamin D | 2000 |
Intermittent doxercalciferol (1alpha-hydroxyvitamin D(2)) therapy for secondary hyperparathyroidism.
Topics: Adult; Aged; Alkaline Phosphatase; Calcium; Double-Blind Method; Drug Administration Schedule; Ergocalciferols; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Hormone; Phosphorus | 2000 |
Pulse oral versus pulse intraperitoneal calcitriol: a comparison of efficacy in the treatment of hyperparathyroidism and renal osteodystrophy in peritoneal dialysis patients.
Topics: Administration, Oral; Alkaline Phosphatase; Calcitriol; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Parathyroid Hormone; Peritoneal Dialysis; Phosphorus; Prospective Studies; Pulse Therapy, Drug | 2000 |
A controlled trial of the early treatment of secondary hyperparathyroidism with calcitriol in hemodialysis patients.
Topics: Calcitriol; Calcium; Humans; Hyperparathyroidism, Secondary; Phosphorus; Renal Dialysis; Time Factors | 2000 |
A long-term, multicenter study of the efficacy and safety of paricalcitol in end-stage renal disease.
Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Calcium; Ergocalciferols; Female; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Kidney Failure, Chronic; Male; Middle Aged; Nausea; Parathyroid Hormone; Phosphorus; Taste Disorders; Time Factors; Vomiting | 2001 |
1,25-dihydroxycholecalciferol. Effect on skeletal lesions and plasma parathyroid hormone levels in uremic osteodystrophy.
Topics: Adult; Antigens; Biopsy; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Clinical Trials as Topic; Dihydroxycholecalciferols; Drug Evaluation; Female; Humans; Hydroxycholecalciferols; Hypercalcemia; Hyperparathyroidism, Secondary; Ilium; Male; Middle Aged; Osteomalacia; Parathyroid Hormone; Phosphorus | 1974 |
356 other study(ies) available for phosphorus and Hyperparathyroidism, Secondary
| Article | Year |
|---|---|
Factors affecting vitamin D status in outpatients with abdominal aortic aneurysm and peripheral artery disease- a single centre study.
Topics: Aged; Aged, 80 and over; Aortic Aneurysm, Abdominal; Biomarkers; Calcium; Case-Control Studies; Cross-Sectional Studies; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Outpatients; Parathyroid Hormone; Peripheral Arterial Disease; Phosphorus; Poland; Risk Assessment; Risk Factors; Stroke; Vitamin D; Vitamin D Deficiency | 2021 |
Activation of the Calcium Receptor by Calcimimetic Agents Is Preserved Despite Modest Attenuating Effects of Hyperphosphatemia.
Topics: Aged; Calcimimetic Agents; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Male; Middle Aged; Parathyroid Hormone; Peptides; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Retrospective Studies | 2022 |
A single-center experience of parathyroidectomy in 1500 cases for secondary hyperparathyroidism: a retrospective study.
Topics: Adult; Calcium; China; Female; Humans; Hyperkalemia; Hyperparathyroidism, Secondary; Hypocalcemia; Logistic Models; Male; Middle Aged; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Postoperative Complications; Renal Dialysis; Renal Insufficiency, Chronic; Retrospective Studies | 2022 |
The value of clinical-ultrasonographic feature model to predict the severity of secondary hyperparathyroidism.
Topics: Adult; Aged; Calcium; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Logistic Models; Male; Middle Aged; Multivariate Analysis; Nomograms; Parathyroid Glands; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Renal Dialysis; Retrospective Studies; Treatment Outcome; Ultrasonography, Doppler, Color | 2022 |
Efficacy and safety of radiofrequency ablation versus parathyroidectomy for secondary hyperparathyroidism in dialysis patients: a single-center retrospective study.
Topics: Calcium; Humans; Hyperparathyroidism, Secondary; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Radiofrequency Ablation; Renal Dialysis; Retrospective Studies | 2022 |
Relationship between serum parathyroid hormone levels and abdominal aortic calcification in patients starting hemodialysis who have never taken calcium tablets, calcitriol, or vitamin D analogs.
Topics: Calcitriol; Calcium; Humans; Hyperparathyroidism, Secondary; Parathyroid Hormone; Phosphorus; Renal Dialysis; Tablets; Vascular Calcification; Vitamin D | 2022 |
Semiquantitative assessment of
Topics: Alkaline Phosphatase; Calcitriol; Calcium; Creatinine; Cysteine Proteinase Inhibitors; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Parathyroid Hormone; Phosphorus; Technetium Tc 99m Sestamibi; Uric Acid | 2022 |
Effect of total parathyroidectomy in patients with secondary hyperparathyroidism: a retrospective study.
Topics: Calcium; Humans; Hyperparathyroidism, Secondary; Pain; Parathyroid Glands; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Retrospective Studies; Transplantation, Autologous | 2023 |
Upacicalcet, a positive allosteric modulator of the calcium-sensing receptor, prevents vascular calcification and bone disorder in a rat adenine-induced secondary hyperparathyroidism model.
Topics: Adenine; Animals; Bone Diseases; Calcium; Hyperparathyroidism, Secondary; Hyperplasia; Parathyroid Hormone; Phosphorus; Rats; Receptors, Calcium-Sensing; Renal Insufficiency; Renal Insufficiency, Chronic; Vascular Calcification | 2023 |
Bone metabolism characteristics and gender differences in patients with COPD: a cross-sectional study.
Topics: Biomarkers; Calcium; Cross-Sectional Studies; Female; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Male; Osteocalcin; Parathyroid Hormone; Phosphorus; Pulmonary Disease, Chronic Obstructive; Sex Factors | 2023 |
Different outcomes following parathyroidectomy in patients with uremic tumoral calcinosis: two case reports.
Topics: Calcinosis; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Renal Dialysis | 2023 |
RPS15A Mediates PI3K/AKT Signaling-Induced Parathyroid Cell Proliferation in Rats with Secondary Hyperparathyroidism.
Topics: Animals; Apoptosis; Calcium; Cell Proliferation; Hyperparathyroidism, Secondary; Hyperplasia; Parathyroid Hormone; Phosphatidylinositol 3-Kinases; Phosphorus; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction | 2023 |
Complications after radiofrequency ablation of hyperparathyroidism secondary to chronic kidney disease.
Topics: Age Distribution; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Phosphorus; Postoperative Complications; Radiofrequency Ablation; Recurrent Laryngeal Nerve Injuries; Renal Insufficiency, Chronic; Renal Replacement Therapy; Retrospective Studies | 2023 |
The impact of cinacalcet in the mineral metabolism markers of patients on dialysis with severe secondary hyperparathyroidism.
Topics: Adult; Aged; Alkaline Phosphatase; Calcimimetic Agents; Calcium; Cinacalcet; Female; Follow-Up Studies; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Hyperphosphatemia; Hypocalcemia; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Retrospective Studies; Treatment Outcome; Vitamin D | 2019 |
Evaluation of laboratory parameters and symptoms after parathyroidectomy in dialysis patients with secondary hyperparathyroidism.
Topics: Adolescent; Adult; Aged; Alkaline Phosphatase; Calcium; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Glands; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Postoperative Period; Renal Dialysis; Retrospective Studies; Treatment Outcome; Young Adult | 2019 |
Pregnant Patient on Hemodialysis Who Showed Remarkable Improvement of Severe Hyperparathyroidism by Strict Serum Phosphorus Control.
Topics: Calcium; Female; Humans; Hyperparathyroidism; Hyperparathyroidism, Secondary; Parathyroid Hormone; Phosphorus; Pregnancy; Renal Dialysis; Severity of Illness Index | 2020 |
Biochemical spectrum of parathyroid disorders diagnosed at a tertiary care setting.
Topics: Adolescent; Adult; Aged; Alkaline Phosphatase; Calcium; Child; Child, Preschool; Creatinine; Female; Humans; Hyperparathyroidism, Primary; Hyperparathyroidism, Secondary; Hypoparathyroidism; Infant; Magnesium; Magnesium Deficiency; Male; Middle Aged; Pakistan; Parathyroid Hormone; Phosphorus; Renal Insufficiency, Chronic; Sex Distribution; Tertiary Care Centers; Vitamin D; Vitamin D Deficiency; Young Adult | 2020 |
Fibroblast Growth Factor 23 and the Last Mile.
Topics: Animals; Biomarkers; Chronic Kidney Disease-Mineral and Bone Disorder; Fibroblast Growth Factor-23; Humans; Hyperparathyroidism, Secondary; Kidney; Phosphorus; Renal Agents; Renal Insufficiency, Chronic; Vitamin D | 2020 |
Clinical Study on Safety and Efficacy of Microwave Ablation for Primary Hyperparathyroidism.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Calcium; Female; Humans; Hyperparathyroidism, Primary; Hyperparathyroidism, Secondary; Hyperplasia; Male; Microwaves; Middle Aged; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Plastic Surgery Procedures; Prospective Studies; Radiofrequency Ablation; Young Adult | 2020 |
Severe chronic kidney disease environment reduced calcium-sensing receptor expression in parathyroid glands of adenine-induced rats even without high phosphorus diet.
Topics: Animals; Diet; Disease Models, Animal; Gene Expression; Hyperparathyroidism, Secondary; Male; Nuclear Proteins; Parathyroid Glands; Phosphorus; Rats; Rats, Wistar; Receptors, Calcitriol; Receptors, Calcium-Sensing; Renal Insufficiency, Chronic; RNA, Messenger; Transcription Factors | 2020 |
Changes in 3-month mineral and bone disorder patterns were associated with all-cause mortality in prevalent hemodialysis patients with secondary hyperparathyroidism.
Topics: Aged; Bone Diseases; Calcium; Cause of Death; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Prognosis; Prospective Studies; Renal Dialysis | 2020 |
The risk of medically uncontrolled secondary hyperparathyroidism depends on parathyroid hormone levels at haemodialysis initiation.
Topics: Aged; Biomarkers; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Prospective Studies; Renal Dialysis; Risk Factors | 2021 |
Effect of Parathyroid Hormone on Intestinal Mucosal Sodium Dependent Phosphorus Transporter.
Topics: Animals; Calcium; Hyperparathyroidism, Secondary; Intestinal Mucosa; Mice; Mice, Inbred BALB C; Parathyroid Hormone; Phosphorus; Renal Dialysis; Sodium | 2021 |
Intensive calcium monitoring improves outcomes on hungry bone syndrome in hyperparathyroidism.
Topics: Administration, Intravenous; Adult; Aged; Calcium; Clinical Protocols; Humans; Hyperparathyroidism; Hyperparathyroidism, Secondary; Hypocalcemia; Longitudinal Studies; Middle Aged; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Postoperative Care; Renal Insufficiency, Chronic; Syndrome; Vitamin D | 2021 |
Microwave ablation as an efficient therapy for primary hyperparathyroidism: Efficacy and predictors of treatment success.
Topics: Calcium; Humans; Hyperparathyroidism, Primary; Hyperparathyroidism, Secondary; Microwaves; Parathyroid Hormone; Phosphorus | 2021 |
Evaluation of a TPTX model induced by ischemia.
Topics: Animals; Calcium; Disease Models, Animal; Drinking; Hyperparathyroidism, Secondary; Ischemia; Male; Parathyroid Glands; Parathyroidectomy; Phosphorus; Rats, Sprague-Dawley; Severity of Illness Index | 2017 |
Elderly patients with chronic kidney disease have higher risk of hyperparathyroidism.
Topics: Age Factors; Aged; Aged, 80 and over; Calcium; Cross-Sectional Studies; Diuretics; Female; Furosemide; Glomerular Filtration Rate; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Prevalence; Protective Factors; Renal Insufficiency, Chronic; Risk Factors; Sodium Chloride Symporter Inhibitors; Vitamin D | 2017 |
Effects of parathyroidectomy on bone metabolism in haemodialysis patients with secondary hyperparathyroidism.
Topics: Alkaline Phosphatase; Biomarkers; Bone and Bones; Bone Density; Calcium; Demography; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Renal Dialysis | 2017 |
Etelcalcetide (AMG 416), a peptide agonist of the calcium-sensing receptor, preserved cortical bone structure and bone strength in subtotal nephrectomized rats with established secondary hyperparathyroidism.
Topics: Animals; Biomechanical Phenomena; Blood Urea Nitrogen; Calcium; Cortical Bone; Creatinine; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Hyperparathyroidism, Secondary; Hyperplasia; Kidney Function Tests; Male; Nephrectomy; Osteocalcin; Parathyroid Glands; Parathyroid Hormone; Peptides; Phosphorus; Rats, Sprague-Dawley; Receptors, Calcium-Sensing; Tartrate-Resistant Acid Phosphatase | 2017 |
[Effect of cinacalcet combined with low-dose calcitriol on clinical outcome and bone metabolism in patients with severe secondary hyperparathyroidism].
Topics: Alkaline Phosphatase; Bone and Bones; Bone Density; Bone Density Conservation Agents; Calcimimetic Agents; Calcitriol; Calcium; Cinacalcet; Drug Therapy, Combination; Humans; Hyperparathyroidism, Secondary; Osteocalcin; Parathyroid Hormone; Phosphorus; Renal Dialysis; Treatment Outcome | 2017 |
Total parathyroidectomy with forearm auto-transplantation improves the quality of life and reduces the recurrence of secondary hyperparathyroidism in chronic kidney disease patients.
Topics: Adult; Aged; Alkaline Phosphatase; Calcium; Combined Modality Therapy; Female; Follow-Up Studies; Forearm; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Glands; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Quality of Life; Recurrence; Renal Insufficiency, Chronic; Transplantation, Autologous; Treatment Outcome; Young Adult | 2017 |
Sevelamer hydrochloride suppresses proliferation of parathyroid cells during the early phase of chronic renal failure in rats.
Topics: Animals; Blood Urea Nitrogen; Calcium; Cell Proliferation; Chelating Agents; Creatinine; Diet, Protein-Restricted; Disease Models, Animal; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Proliferating Cell Nuclear Antigen; Rats, Wistar; Sevelamer; Time Factors | 2019 |
Risk Factors for Elevated Preoperative Alkaline Phosphatase in Patients with Refractory Secondary Hyperparathyroidism.
Topics: Adult; Age Factors; Aged; Alkaline Phosphatase; Biomarkers; Female; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Length of Stay; Male; Middle Aged; Parathyroidectomy; Phosphorus; Predictive Value of Tests; Risk Factors | 2017 |
[Dystrophic Calcinosis Cutis: a rare fearsome issue of Chronic Kidney Disease].
Topics: Calcinosis; Chelation Therapy; Cinacalcet; Female; Glomerulonephritis, Membranous; Hand Deformities, Acquired; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Middle Aged; Peritoneal Dialysis; Phosphorus; Skin Diseases; Vitamin D | 2018 |
A rat model of SHPT with bone abnormalities in CKD induced by adenine and a high phosphorus diet.
Topics: Adenine; Animals; Bone and Bones; Bone Density; Bone Diseases; Bone Diseases, Metabolic; Diet; Disease Models, Animal; Hyperparathyroidism, Secondary; Kidney; Kidney Failure, Chronic; Male; Phosphorus; Rats; Rats, Sprague-Dawley; X-Ray Microtomography | 2018 |
Effects of FGF-23-mediated ERK/MAPK signaling pathway on parathyroid hormone secretion of parathyroid cells in rats with secondary hyperparathyroidism.
Topics: Alkaline Phosphatase; Animals; Apoptosis; Calcium; Cell Cycle; Cell Proliferation; Creatinine; Disease Models, Animal; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glucuronidase; Hyperparathyroidism, Secondary; Klotho Proteins; Male; MAP Kinase Signaling System; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Rats, Sprague-Dawley; RNA, Messenger | 2018 |
Treatment of secondary hyperparathyroidism in patients on hemodialysis using a novel synthetic peptide calcimimetic, etelcalcetide: a short-term clinical study.
Topics: Aged; Alkaline Phosphatase; Calcimimetic Agents; Calcium; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Hormone; Peptides; Phosphorus; Renal Dialysis | 2018 |
Pruritus in hemodialysis patients: association with phosphorus intake and serum calcium level.
Topics: Adult; Aged; Calcium; Combined Modality Therapy; Cross-Sectional Studies; Diet, Protein-Restricted; Diet, Sodium-Restricted; Exanthema; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Patient Compliance; Phosphorus; Phosphorus, Dietary; Pruritus; Quality of Life; Renal Dialysis; Socioeconomic Factors | 2018 |
Treatment of secondary hyperparathyroidism with paricalcitol in patients with end-stage renal disease undergoing hemodialysis in Turkey: an observational study.
Topics: Bone Density Conservation Agents; Calcium; Drug Monitoring; Ergocalciferols; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Prospective Studies; Renal Dialysis; Turkey | 2019 |
Evaluating real-world use of cinacalcet and biochemical response to therapy in US hemodialysis patients.
Topics: Adolescent; Adult; Aged; Calcium; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Injections, Intravenous; Male; Middle Aged; Naphthalenes; Parathyroid Neoplasms; Phosphorus; Renal Dialysis; United States; Vitamin D; Young Adult | 2013 |
Two novel vitamin D receptor modulators with similar structures exhibit different hypercalcemic effects in 5/6 nephrectomized uremic rats.
Topics: Animals; Aorta, Thoracic; Calcitriol; Calcium; Dose-Response Relationship, Drug; Heart Ventricles; Hypercalcemia; Hyperparathyroidism, Secondary; In Vitro Techniques; Male; Nephrectomy; Organ Size; Parathyroid Hormone; Phosphorus; Rats; Rats, Sprague-Dawley; Receptors, Calcitriol; Secosteroids; Uremia; Vasoconstriction; Vasodilation | 2013 |
[Observational studies: the hazard and other gods].
Topics: Aged; Causality; Chelating Agents; Chelation Therapy; Cohort Studies; Data Collection; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Multicenter Studies as Topic; Observational Studies as Topic; Phosphorus; Propensity Score; Proportional Hazards Models; Renal Dialysis; Research Design | 2014 |
High prevalence of secondary hyperparathyroidism in chronic kidney disease patients on dialysis in Argentina.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Argentina; Biomarkers; Bone and Bones; Calcitriol; Calcium; Child; Child, Preschool; Chronic Disease; Diabetic Nephropathies; Female; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Male; Middle Aged; Parathyroid Hormone; Peritoneal Dialysis; Phosphorus; Prevalence; Renal Dialysis; Young Adult | 2013 |
Compliance with objectives based on different guidelines (KDIGO/S.E.N.) and analysis of the individual variability of mineral metabolism in haemodialysis patients in the medium term.
Topics: Aged; Calcium; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Ergocalciferols; Female; Follow-Up Studies; Goals; Guideline Adherence; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Parathyroidectomy; Peritoneal Dialysis; Phosphorus; Postoperative Complications; Practice Guidelines as Topic; Renal Dialysis; Retrospective Studies | 2013 |
Abnormal mineral metabolism and mortality in hemodialysis patients with secondary hyperparathyroidism: evidence from marginal structural models used to adjust for time-dependent confounding.
Topics: Aged; Calcium; Confounding Factors, Epidemiologic; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Risk Assessment; Survival Analysis | 2014 |
Short- and long-term impact of subtotal parathyroidectomy on the achievement of bone and mineral parameters recommended by clinical practice guidelines in dialysis patients: a 12-year single-center experience.
Topics: Adult; Aged; Bone and Bones; Bone Diseases; Calcium; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Minerals; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Practice Guidelines as Topic; Renal Dialysis; Retrospective Studies; Time Factors | 2013 |
Disordered FGF23 and mineral metabolism in children with CKD.
Topics: Adolescent; Age Factors; Biomarkers; Calcium; Canada; Child; Child, Preschool; Creatinine; Cross-Sectional Studies; Cystatin C; Early Diagnosis; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glomerular Filtration Rate; Humans; Hyperparathyroidism, Secondary; Infant; Kidney; Parathyroid Hormone; Phosphorus; Predictive Value of Tests; Renal Insufficiency, Chronic; Severity of Illness Index; United States; Vitamin D; Vitamin D Deficiency | 2014 |
Radioguided parathyroidectomy in patients with secondary hyperparathyroidism due to chronic renal failure.
Topics: Adult; Aged; Calcium; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Glands; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Preoperative Period; Radionuclide Imaging; Surgery, Computer-Assisted; Technetium Tc 99m Sestamibi; Treatment Outcome | 2014 |
Cinacalcet for hypercalcaemic secondary hyperparathyroidism after renal transplantation: a multicentre, retrospective, 3-year study.
Topics: Adult; Aged; Calcium; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Transplantation; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Retrospective Studies | 2014 |
Paricalcitol treatment of secondary hyperparathyroidism in hemodialysis patients: a German-Austrian, single-arm, open-label, prospective, noninterventional, observational study.
Topics: Aged; Alkaline Phosphatase; Austria; Bone Density Conservation Agents; Calcimimetic Agents; Calcium; Cinacalcet; Ergocalciferols; Female; Germany; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Prospective Studies; Renal Dialysis; Renal Insufficiency, Chronic | 2014 |
[Diagnostics and treatment of primary and secondary hyperparathyroidism].
Topics: Adenoma; Adult; Aged; Calcium; Female; Humans; Hyperparathyroidism, Primary; Hyperparathyroidism, Secondary; Male; Middle Aged; Minimally Invasive Surgical Procedures; Parathyroid Glands; Parathyroid Hormone; Parathyroid Neoplasms; Parathyroidectomy; Perioperative Care; Phosphorus; Radionuclide Imaging; Treatment Outcome; Ultrasonography | 2013 |
Evaluation of parathyroid function and mineral metabolism in psychiatric patients using lithium salts.
Topics: Adult; Aged; Alkaline Phosphatase; Bipolar Disorder; Calcium; Case-Control Studies; Creatinine; Cross-Sectional Studies; Female; Humans; Hyperparathyroidism, Secondary; Lithium Compounds; Male; Mental Disorders; Middle Aged; Minerals; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Serum Albumin; Urea; Vitamin D | 2014 |
Mineral metabolism in European children living with a renal transplant: a European society for paediatric nephrology/european renal association-European dialysis and transplant association registry study.
Topics: Adolescent; Calcium; Child; Child, Preschool; Europe; Female; Glomerular Filtration Rate; Graft Survival; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Hyperphosphatemia; Hypocalcemia; Hypophosphatemia; Infant; Infant, Newborn; Kidney Transplantation; Male; Parathyroid Hormone; Phosphorus; Prevalence; Registries | 2015 |
Current recommended 25-hydroxyvitamin D targets for chronic kidney disease management may be too low.
Topics: Aged; Algorithms; Biomarkers; Calcium; Cross-Sectional Studies; Decision Support Techniques; Dietary Supplements; Female; Glomerular Filtration Rate; Humans; Hyperparathyroidism, Secondary; Least-Squares Analysis; Linear Models; Male; Middle Aged; Nonlinear Dynamics; Parathyroid Hormone; Phosphorus; Practice Guidelines as Topic; Prognosis; Renal Insufficiency, Chronic; Risk Factors; United States; Vitamin D; Vitamin D Deficiency | 2016 |
Parathyroidectomy and survival among Japanese hemodialysis patients with secondary hyperparathyroidism.
Topics: Aged; Calcium; Cardiovascular Diseases; Cause of Death; Female; Humans; Hyperparathyroidism, Secondary; Japan; Kaplan-Meier Estimate; Kidney Failure, Chronic; Male; Middle Aged; Parathyroidectomy; Phosphorus; Propensity Score; Registries; Renal Dialysis; Survival Rate | 2015 |
Impact of phosphorus restriction and vitamin D-substitution on secondary hyperparathyroidism in a proteinuric mouse model.
Topics: Animals; Doxorubicin; Fibroblast Growth Factor-23; Glucuronidase; Hyperparathyroidism, Secondary; Kidney; Klotho Proteins; Mice; Phosphorus; Proteinuria; Renal Insufficiency; Vitamin D; Vitamin D3 24-Hydroxylase; Vitamins | 2015 |
Risk factors for severe hypocalcemia after parathyroidectomy in prevalent dialysis patients with secondary hyperparathyroidism.
Topics: Adult; Alkaline Phosphatase; Biomarkers; Calcium; Female; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Male; Middle Aged; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Predictive Value of Tests; Preoperative Period; Prognosis; Renal Dialysis; Renal Insufficiency, Chronic; Reproducibility of Results; Retrospective Studies; Risk Factors; Severity of Illness Index | 2015 |
Changes in secondary hyperparathyroidism-related biochemical parameters and medication use following parathyroidectomy.
Topics: Adult; Aged; Calcium; Combined Modality Therapy; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Renal Dialysis; Retrospective Studies; Young Adult | 2016 |
EARLIER: an observational study to evaluate the use of cinacalcet in incident hemodialysis patients with secondary hyperparathyroidism in daily clinical practice.
Topics: Adult; Aged; Austria; Calcium; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Product Surveillance, Postmarketing; Renal Dialysis | 2015 |
Effect of paricalcitol on mineral bone metabolism in kidney transplant recipients with secondary hyperparathyroidism.
Topics: Adult; Aged; Alkaline Phosphatase; Bone and Bones; Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcitriol; Calcium; Cinacalcet; Drug Substitution; Drug Therapy, Combination; Ergocalciferols; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Postoperative Complications; Retrospective Studies | 2015 |
Administration of calcimimetics after dialysis: same effectiveness, better gastrointestinal tolerability.
Topics: Aged; Ambulatory Care; Calcimimetic Agents; Calcium; Cinacalcet; Drug Administration Schedule; Female; Gastrointestinal Diseases; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Patient Satisfaction; Phosphorus; Prospective Studies; Renal Dialysis; Therapeutic Equivalency; Visual Analog Scale | 2015 |
Survival after parathyroidectomy in chronic hemodialysis patients with severe secondary hyperparathyroidism.
Topics: Adult; Aged; Alkaline Phosphatase; C-Reactive Protein; Calcium; Female; Hemoglobins; Humans; Hyperparathyroidism, Secondary; Kaplan-Meier Estimate; Kidney Failure, Chronic; Longitudinal Studies; Male; Middle Aged; Muscle Weakness; Pain; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Proportional Hazards Models; Prospective Studies; Pruritus; Renal Dialysis; Severity of Illness Index; Survival Rate | 2015 |
Dynamics of cinacalcet use and biochemical control in hemodialysis patients: a retrospective New-user cohort design.
Topics: Adult; Aged; Calcimimetic Agents; Calcium; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Income; Insurance Coverage; Kidney Failure, Chronic; Male; Medicare Part D; Middle Aged; Parathyroid Hormone; Phosphorus; Public Assistance; Renal Dialysis; Retreatment; Retrospective Studies; Serum Albumin; United States; Withholding Treatment | 2015 |
Predicting postoperative total calcium requirements after parathyroidectomy in secondary hyperparathyroidism.
Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Biomarkers; Calcium; Calcium Carbonate; Calcium Compounds; Calcium Gluconate; Decision Support Techniques; Dietary Supplements; Female; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Lactates; Linear Models; Male; Middle Aged; Models, Biological; Multivariate Analysis; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Recurrence; Republic of Korea; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Young Adult | 2015 |
Safety and efficiency of microwave ablation for recurrent and persistent secondary hyperparathyroidism after parathyroidectomy: A retrospective pilot study.
Topics: Ablation Techniques; Adult; Aged; Alkaline Phosphatase; Calcium; Female; Humans; Hyperparathyroidism, Secondary; Male; Microwaves; Middle Aged; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Pilot Projects | 2016 |
[Therapeutic evaluation of surgical procedure in treatment of secondary hyperparathyroidism].
Topics: Calcium; Humans; Hyperparathyroidism, Secondary; Parathyroid Glands; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Postoperative Period; Recurrence; Retrospective Studies; Transplantation, Autologous; Treatment Outcome | 2015 |
Use of cinacalcet for the management of hyperparathyroidism in patients with different degrees of renal failure.
Topics: Adult; Aged; Calcimimetic Agents; Calcium; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis | 2016 |
Frequent monitoring of mineral metabolism in hemodialysis patients with secondary hyperparathyroidism: associations with achievement of treatment goals and with adjustments in therapy.
Topics: Aged; Biomarkers; Calcimimetic Agents; Calcitriol; Calcium; Cinacalcet; Cohort Studies; Female; Humans; Hyperparathyroidism, Secondary; Japan; Kidney Failure, Chronic; Male; Middle Aged; Minerals; Parathyroid Hormone; Patient Care Planning; Phosphorus; Renal Dialysis; Vitamins | 2017 |
Successful Conversion From Parenteral Paricalcitol to Pulse Oral Calcitriol for the Management of Secondary Hyperparathyroidism in Hemodialysis Patients.
Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Alkaline Phosphatase; Calcitriol; Calcium; Disease Management; Ergocalciferols; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Hormone; Parenteral Nutrition; Phosphorus; Receptors, Calcitriol; Renal Dialysis; Retrospective Studies; Treatment Outcome | 2016 |
Efficacy and its predictor in microwave ablation for severe secondary hyperparathyroidism in patients undergoing haemodialysis.
Topics: Ablation Techniques; Adult; Aged; Calcium; Female; Humans; Hyperparathyroidism, Secondary; Male; Microwaves; Middle Aged; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Renal Dialysis; Treatment Outcome | 2016 |
Effectiveness of Cinacalcet in Patients with Chronic Kidney Disease and Secondary Hyperparathyroidism Not Receiving Dialysis.
Topics: Aged; Aged, 80 and over; Calcimimetic Agents; Calcium; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Off-Label Use; Parathyroid Hormone; Phosphorus; Renal Insufficiency, Chronic; Retrospective Studies; Treatment Outcome | 2016 |
Conversion of oral alfacalcidol to oral calcitriol in the treatment of secondary hyperparathyroidism in chronic hemodialysis patients.
Topics: Adult; Aged; Calcitriol; Calcium; Canada; Drug Monitoring; Drug Substitution; Female; Humans; Hydroxycholecalciferols; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Patient Outcome Assessment; Phosphorus; Renal Dialysis; Retrospective Studies | 2017 |
Extended-release calcifediol (Rayaldee) for secondary hyperparathyroidism.
Topics: Biomarkers; Calcifediol; Calcium; Delayed-Action Preparations; Humans; Hyperparathyroidism, Secondary; Parathyroid Hormone; Phosphorus; Treatment Outcome | 2017 |
Differences in corrective mode for divalent ions and parathyroid hormone between standard- and low-calcium dialysate in patients on continuous ambulatory peritoneal dialysis--result of a nationwide survey in Japan.
Topics: Adult; Aged; Antacids; Calcium; Calcium Carbonate; Dialysis Solutions; Drug Prescriptions; Health Surveys; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Hyperphosphatemia; Japan; Middle Aged; Parathyroid Hormone; Peritoneal Dialysis, Continuous Ambulatory; Phosphorus; Surveys and Questionnaires; Vitamin D; Vitamins | 2008 |
Pharmacodynamic effects of cinacalcet after kidney transplantation: once- versus twice-daily dose.
Topics: Adult; Aged; Calcium; Cinacalcet; Cyclosporine; Dose-Response Relationship, Drug; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Transplantation; Longitudinal Studies; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Prospective Studies; Tacrolimus | 2008 |
Differential effects of vitamin D receptor activators on aortic calcification and pulse wave velocity in uraemic rats.
Topics: Animals; Aorta; Blood Flow Velocity; Calcinosis; Calcium; Ergocalciferols; Hyperparathyroidism, Secondary; Male; Nephrectomy; Parathyroid Hormone; Phosphorus; Rats; Rats, Sprague-Dawley; Receptors, Calcitriol; Renal Insufficiency, Chronic; Uremia; Vascular Resistance | 2008 |
Real-world doxercalciferol treatment in SHPT CKD stage 3 and 4: an analysis of change in iPTH and accordance to KDOQI recommendations.
Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Calcium; Ergocalciferols; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Logistic Models; Male; Middle Aged; Multivariate Analysis; Parathyroid Hormone; Phosphorus; Practice Guidelines as Topic; Registries | 2009 |
Case 16-2008: A woman with bone pain.
Topics: Bone Diseases; Calcium; Celiac Disease; Diagnosis, Differential; Female; Humans; Hyperparathyroidism, Primary; Hyperparathyroidism, Secondary; Pain; Parathyroid Hormone; Phosphorus; Vitamin D Deficiency | 2008 |
Race is a major determinant of secondary hyperparathyroidism in uremic patients: comparative study of Blacks and Hispanics.
Topics: Black or African American; Bone Density; Chi-Square Distribution; Cross-Sectional Studies; Female; Hispanic or Latino; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Logistic Models; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Serum Albumin; Uremia | 2008 |
Cinacalcet treatment in dialysis patients with secondary hyperparathyroidism: effects and open issues.
Topics: Animals; Biomarkers; Calcium; Cinacalcet; Clinical Trials as Topic; Drug Evaluation, Preclinical; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Phosphorus; Renal Dialysis; Treatment Outcome | 2008 |
Role of cinacalcet in management of mineral bone disorder in chronic kidney disease (control of calcium, phosphorus and parathyroid hormone).
Topics: Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Drug Therapy, Combination; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Phosphorus; Practice Guidelines as Topic; Renal Dialysis; Treatment Outcome; Vitamin D | 2008 |
Parathyroidectomy for secondary hyperparathyroidism in the era of calcimimetics.
Topics: Calcium; Cinacalcet; Cost-Benefit Analysis; Ethanol; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Glands; Parathyroidectomy; Phosphorus; Quality of Life; Survival Rate | 2008 |
Impact of cinacalcet hydrochloride on the achievement of the Japanese Society for Dialysis Therapy (JSDT) guideline targets: a post-hoc analysis of the KRN1493 study.
Topics: Calcium; Cinacalcet; Guidelines as Topic; Humans; Hyperparathyroidism, Secondary; Japan; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Phosphorus; Randomized Controlled Trials as Topic; Renal Dialysis; Societies, Medical | 2008 |
Cinacalcet use patterns and effect on laboratory values and other medications in a large dialysis organization, 2004 through 2006.
Topics: Adolescent; Adult; Biomarkers; Calcium; Centers for Medicare and Medicaid Services, U.S.; Cinacalcet; Databases as Topic; Drug Prescriptions; Drug Therapy, Combination; Drug Utilization; Drug Utilization Review; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Outcome and Process Assessment, Health Care; Parathyroid Hormone; Phosphorus; Practice Guidelines as Topic; Practice Patterns, Physicians'; Renal Dialysis; Time Factors; Treatment Outcome; United States; Vitamin D; Young Adult | 2009 |
Is it worth correcting hyperparathyroidism if hyperphosphatemia and hypocalcemia worsen? A cinacalcet story.
Topics: Calcium; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Hypocalcemia; Kidney Failure, Chronic; Naphthalenes; Phosphorus | 2009 |
An unusual case of autonomous hyperparathyroidism in a patient with X-linked hypophosphatemic rickets and Kallmann syndrome.
Topics: Adolescent; Alkaline Phosphatase; Calcium; Familial Hypophosphatemic Rickets; Genetic Diseases, X-Linked; Humans; Hyperparathyroidism, Secondary; Kallmann Syndrome; Male; Parathyroid Hormone; Phosphates; Phosphorus; Time Factors | 2009 |
Total parathyroidectomy without autotransplantation in dialysis patients and renal transplant recipients, long-term follow-up evaluation.
Topics: Alkaline Phosphatase; Arthralgia; Calcinosis; Calcium; Drug Resistance; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Liver Transplantation; Male; Middle Aged; Muscle Weakness; Parathyroid Glands; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Pruritus; Renal Dialysis | 2009 |
Vitamin D insufficiency and deficiency in children with early chronic kidney disease.
Topics: Adolescent; Calcium; Child; Child, Preschool; Female; Florida; Glomerular Filtration Rate; Humans; Hyperparathyroidism, Secondary; Infant; Male; Obesity; Overweight; Phosphorus; Renal Insufficiency, Chronic; Vitamin D; Vitamin D Deficiency; Young Adult | 2009 |
Caring for chronic kidney disease patients: focus on mineral and bone disorders.
Topics: Calcium; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Diet Therapy; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Failure, Chronic; Metabolic Diseases; Middle Aged; Naphthalenes; Parathyroid Hormone; Pharmaceutical Services; Phosphorus; Receptors, Calcium-Sensing; Renal Dialysis; Vitamin D | 2009 |
Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).
Topics: Age Factors; Aged; Blood Pressure; Calcium; Cardiovascular Diseases; Comorbidity; Cross-Sectional Studies; Female; Glomerular Filtration Rate; Health Surveys; Hemoglobinometry; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Mass Screening; Middle Aged; Parathyroid Hormone; Phosphorus; Risk Factors; United States | 2009 |
Cinacalcet and achievement of the NKF/K-DOQI recommended target values for bone and mineral metabolism in real-world clinical practice--the ECHO observational study.
Topics: Adult; Aged; Bone and Bones; Calcium; Cinacalcet; Europe; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Minerals; Naphthalenes; Parathyroid Hormone; Phosphorus; Renal Dialysis; Vitamin D | 2009 |
[Hyperparathyroidism in patients on long-term hemodialysis].
Topics: Adult; Calcium; Humans; Hyperparathyroidism, Secondary; Male; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Time Factors | 2009 |
Bone metabolism after cinacalcet administration in patients with secondary hyperparathyroidism.
Topics: Acid Phosphatase; Alkaline Phosphatase; Biomarkers; Bone and Bones; Bone Regeneration; Bone Remodeling; Bone Resorption; Calcium; Cinacalcet; Drug Administration Schedule; Female; Hormone Antagonists; Humans; Hyperparathyroidism, Secondary; Isoenzymes; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Renal Dialysis; Tartrate-Resistant Acid Phosphatase; Time Factors | 2010 |
Association of secondary hyperparathyroidism with CKD progression, health care costs and survival in diabetic predialysis CKD patients.
Topics: Aged; Ambulatory Care; Chelation Therapy; Cohort Studies; Comorbidity; Diabetic Nephropathies; Disease Progression; Drug Costs; Female; Health Care Costs; Health Resources; Hospital Costs; Hospitalization; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Insurance, Health, Reimbursement; Longevity; Male; Middle Aged; Phosphorus; Retrospective Studies; Survival Analysis | 2009 |
Outcomes predicted by phosphorous in chronic kidney disease: a retrospective CKD-inception cohort study.
Topics: Aged; Aged, 80 and over; Biomarkers; Chronic Disease; Cohort Studies; Female; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Male; Middle Aged; Phosphorus; Predictive Value of Tests; Prognosis; Renal Replacement Therapy; Retrospective Studies; Survival Analysis | 2010 |
Cinacalcet hydrochloride in chronic kidney disease-mineral bone disorder.
Topics: Biomarkers; Calcium; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Phosphorus; Renal Dialysis; Time Factors; Treatment Outcome; Vitamin D | 2009 |
Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
Topics: Attitude of Health Personnel; Biomarkers; Bone Diseases, Metabolic; Calcium; Chelating Agents; Chronic Disease; Cinacalcet; Evidence-Based Medicine; Glomerular Filtration Rate; Guideline Adherence; Health Care Surveys; Health Knowledge, Attitudes, Practice; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Diseases; Naphthalenes; Parathyroid Hormone; Phosphorus; Practice Guidelines as Topic; Practice Patterns, Physicians'; Renal Dialysis; Saudi Arabia; Surveys and Questionnaires; Treatment Outcome; Vitamin D; Vitamin D Deficiency | 2010 |
Incidence of secondary hyperparathyroidism among postmenopausal women with end-stage knee osteoarthritis.
Topics: Aged; Aged, 80 and over; Biomarkers; Calcium; Creatinine; Female; Greece; Humans; Hyperparathyroidism, Secondary; Incidence; Middle Aged; Osteoarthritis, Knee; Parathyroid Hormone; Phosphorus; Postmenopause; Regression Analysis; Wound Healing | 2009 |
Effectiveness of weekly percutaneous maxacalcitol injection therapy in patients with secondary hyperparathyroidism.
Topics: Aged; Alkaline Phosphatase; Anticarcinogenic Agents; Biomarkers; Calcitriol; Calcium; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Osteocalcin; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Renal Dialysis; Treatment Outcome; Ultrasonography | 2010 |
Reduction of whole PTH/intact PTH ratio as a predictor of bone metabolism in cinacalcet treatment of hemodialysis patients with secondary hyperparathyroidism.
Topics: Acid Phosphatase; Adult; Aged; Bone Remodeling; Calcium; Cinacalcet; Collagen Type I; Female; Humans; Hyperparathyroidism, Secondary; Isoenzymes; Longitudinal Studies; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Peptides; Phosphorus; Renal Dialysis; Tartrate-Resistant Acid Phosphatase; Uremia | 2011 |
Increased parathyroid expression of klotho in uremic rats.
Topics: Animals; Calcitriol; Calcium; Disease Models, Animal; Fibroblast Growth Factors; Glucuronidase; Hyperparathyroidism, Secondary; Hyperphosphatemia; Klotho Proteins; Male; Nephrectomy; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Rats; Rats, Wistar; Receptor, Fibroblast Growth Factor, Type 1; Receptors, Calcitriol; Receptors, Calcium-Sensing; RNA, Messenger; Sodium-Potassium-Exchanging ATPase; Up-Regulation; Uremia | 2010 |
Effectiveness of cinacalcet in patients with recurrent/persistent secondary hyperparathyroidism following parathyroidectomy: results of the ECHO study.
Topics: Aged; Calcium; Cinacalcet; Cohort Studies; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Recurrence; Renal Dialysis; Survival Rate; Treatment Outcome; Vitamin D | 2011 |
Klotho, FGF23, and FGF receptors in chronic kidney disease: a yin-yang situation?
Topics: Animals; Calcium; Chronic Disease; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glucuronidase; Humans; Hyperparathyroidism, Secondary; Kidney; Kidney Diseases; Klotho Proteins; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Receptors, Fibroblast Growth Factor; Sodium-Potassium-Exchanging ATPase | 2010 |
Phosphate-binding efficacy of crushed vs. chewed lanthanum carbonate in hemodialysis patients.
Topics: Administration, Oral; Female; Humans; Hyperparathyroidism, Secondary; Lanthanum; Male; Middle Aged; Phosphates; Phosphorus; Renal Dialysis; Tablets | 2011 |
Cinacalcet may reduce arterial stiffness in patients with chronic renal disease and secondary hyperparathyroidism - results of a small-scale, prospective, observational study.
Topics: Adult; Aged; Alkaline Phosphatase; Aorta; Aortic Diseases; Biomarkers; Blood Pressure; Calcimimetic Agents; Calcium; Cinacalcet; Elasticity; Female; Humans; Hyperparathyroidism, Secondary; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Prospective Studies; Pulsatile Flow; Renal Dialysis; Spain; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Function, Left | 2011 |
Cinacalcet in the treatment of persistent hyperparathyroidism after kidney transplantation.
Topics: Adult; Aged; Analysis of Variance; Biomarkers; Calcimimetic Agents; Calcium; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Transplantation; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Retrospective Studies; Time Factors; Treatment Outcome | 2011 |
[Secondary hyperparathyroidism and anemia. Effects of a calcimimetic on the control of anemia in chronic hemodialysed patients. Pilot Study].
Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Anemia, Iron-Deficiency; Biomarkers; Calcium; Calcium Phosphates; Cinacalcet; Drug Resistance; Drug Therapy, Combination; Female; Hematinics; Hemoglobins; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Phosphorus; Pilot Projects; Prospective Studies; Renal Dialysis; Treatment Outcome | 2011 |
Achievement of recommended treatment targets for bone and mineral metabolism in haemodialysis patients using paricalcitol: an observational study.
Topics: Aged; Biomarkers, Pharmacological; Bone and Bones; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcium; Chronic Disease; Ergocalciferols; Female; Humans; Hyperparathyroidism, Secondary; Injections, Intravenous; Kidney Diseases; Male; Middle Aged; Observation; Parathyroid Hormone; Phosphorus; Prospective Studies; Renal Dialysis; Sweden | 2011 |
Spanish Society of Nephrology recommendations for controlling mineral and bone disorder in chronic kidney disease patients (S.E.N.-M.B.D.).
Topics: Algorithms; Biomarkers; Bone Density Conservation Agents; Bone Diseases, Metabolic; Bone Remodeling; Calcinosis; Calciphylaxis; Calcium; Chelation Therapy; Chronic Disease; Combined Modality Therapy; Diagnostic Imaging; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Kidney Transplantation; Minerals; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Receptors, Cell Surface; Reference Values; Renal Dialysis; Renal Insufficiency, Chronic; Vitamin D | 2011 |
Early initiation of cinacalcet for the treatment of secondary hyperparathyroidism in hemodialysis patients: a three-year clinical experience.
Topics: Adult; Aged; Aged, 80 and over; Calcium; Cinacalcet; Drug Administration Schedule; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Renal Dialysis | 2011 |
Development and prevention of morphologic and ultrastructural changes in uremia-induced hyperplastic parathyroid gland.
Topics: Animals; Calcitriol; Capillaries; Cinacalcet; Disease Models, Animal; Hyperparathyroidism, Secondary; Hyperplasia; Male; Naphthalenes; Nephrectomy; Organelles; Parathyroid Glands; Phosphorus; Phosphorus, Dietary; Rats; Rats, Sprague-Dawley; Uremia | 2011 |
A mathematical model of calcium and phosphorus metabolism in two forms of hyperparathyroidism.
Topics: Algorithms; Bone and Bones; Calcimimetic Agents; Calcitriol; Calcium; Computer Simulation; Feedback, Physiological; Female; Humans; Hyperparathyroidism, Primary; Hyperparathyroidism, Secondary; Kidney; Male; Middle Aged; Models, Biological; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Renal Insufficiency, Chronic; Retrospective Studies | 2012 |
Regression of vascular calcification in a patient treated with cinacalcet: a case report.
Topics: Breast; Calcimimetic Agents; Calcitriol; Calcium Carbonate; Chelating Agents; Cinacalcet; Drug Therapy, Combination; Female; Graft Rejection; Hand; Humans; Hydroxycholecalciferols; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Transplantation; Mammography; Middle Aged; Naphthalenes; Nephritis, Interstitial; Phosphorus; Polyamines; Renal Dialysis; Reoperation; Sevelamer; Vascular Calcification | 2011 |
Effectiveness and cost-efficacy of phosphate binders in hemodialysis.
Topics: Adult; Aged; Calcium; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Cost Savings; Health Care Costs; Hemodialysis Solutions; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Hyperphosphatemia; Lanthanum; Parathyroid Hormone; Phosphorus; Polyamines; Renal Dialysis; Renal Insufficiency, Chronic; Sevelamer; Technology Assessment, Biomedical | 2011 |
Optimal frequency of parathyroid hormone monitoring in chronic hemodialysis patients.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Calcium; Chi-Square Distribution; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Retrospective Studies; Statistics, Nonparametric; Treatment Outcome | 2011 |
Number of enlarged parathyroid glands might be a predictor of cinacalcet response in advanced secondary hyperparathyroidism.
Topics: Adolescent; Adult; Aged; Calcium; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Naphthalenes; Parathyroid Diseases; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Prospective Studies; Treatment Outcome; Ultrasonography; Young Adult | 2012 |
High-intensity focussed ultrasound (HIFU) treatment in uraemic secondary hyperparathyroidism.
Topics: Adult; Alkaline Phosphatase; Calcium; Female; Follow-Up Studies; High-Intensity Focused Ultrasound Ablation; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Prognosis; Renal Dialysis; Uremia | 2012 |
Cinacalcet HCl prevents development of parathyroid gland hyperplasia and reverses established parathyroid gland hyperplasia in a rodent model of CKD.
Topics: Animals; Calcium; Cell Proliferation; Cinacalcet; Cyclin-Dependent Kinase Inhibitor p21; Disease Models, Animal; Hyperparathyroidism, Secondary; Hyperplasia; Kidney Failure, Chronic; Male; Naphthalenes; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Rats; Rats, Sprague-Dawley; Uremia | 2012 |
Effectiveness of treatment with oral paricalcitol in patients with pre-dialysis chronic kidney disease.
Topics: Aged; Aged, 80 and over; Body Mass Index; Calcium; Chronic Disease; Diabetic Nephropathies; Dose-Response Relationship, Drug; Drug Evaluation; Endpoint Determination; Ergocalciferols; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Diseases; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Retrospective Studies; Severity of Illness Index; Treatment Outcome | 2011 |
Parathyroidectomy for the attainment of NKF-K/DOQI™ and KDIGO recommended values for bone and mineral metabolism in dialysis patients with uncontrollable secondary hyperparathyroidism.
Topics: Bone and Bones; Calcium; Comorbidity; Guideline Adherence; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Practice Guidelines as Topic; Renal Dialysis | 2012 |
Contribution of calcium, phosphorus and 25-hydroxyvitamin D to the excessive severity of secondary hyperparathyroidism in African-Americans with CKD.
Topics: Aged; Black or African American; Calcium; Cohort Studies; Cross-Sectional Studies; Ethnicity; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Phosphorus; Prognosis; Renal Insufficiency, Chronic; Vitamin D | 2012 |
Relationship between aortic mineral elements and osteodystrophy in mice with chronic kidney disease.
Topics: Animals; Aorta, Thoracic; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Disease Resistance; Early Diagnosis; Hyperparathyroidism, Secondary; Hyperphosphatemia; Magnesium; Male; Mice; Mice, Inbred ICR; Phosphorus; Renal Insufficiency, Chronic; Severity of Illness Index; Spectrophotometry, Atomic; Spectrophotometry, Infrared; Thoracic Vertebrae; Tomography, X-Ray Computed; Vascular Calcification | 2012 |
Cinacalcet for hemodialyzed patients with or without a high PTH level to control serum calcium and phosphorus: ECO (evaluation of cinacalcet HCl outcome) study.
Topics: Calcium; Cinacalcet; Cohort Studies; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Prospective Studies; Renal Dialysis | 2012 |
Racial differences in parathyroid hormone levels in CKD.
Topics: Black or African American; Calcium; Female; Humans; Hyperparathyroidism, Secondary; Male; Phosphorus; Renal Insufficiency, Chronic; Vitamin D | 2012 |
Prescription patterns and mineral metabolism abnormalities in the cinacalcet era: results from the MBD-5D study.
Topics: Aged; Biomarkers; Bone Diseases, Metabolic; Calcimimetic Agents; Calcium; Cinacalcet; Drug Prescriptions; Drug Utilization; Drug Utilization Review; Female; Humans; Hyperparathyroidism, Secondary; Japan; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Practice Patterns, Physicians'; Prevalence; Prospective Studies; Receptors, Calcitriol; Renal Dialysis; Renal Insufficiency, Chronic; Time Factors; Treatment Outcome; Vitamin D | 2012 |
Cinacalcet de novo in persistent hypercalcemia after kidney transplantation secondary to hyperparathyroidism: long-term follow-up and effect of withdrawal.
Topics: Adult; Aged; Biomarkers; Calcimimetic Agents; Calcium; Cinacalcet; Creatinine; Drug Administration Schedule; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Time Factors; Treatment Outcome | 2012 |
Early development of secondary hyperparathyroidism following renal transplantation.
Topics: Adult; Aged; Alkaline Phosphatase; Calcium; Female; Fractures, Bone; Humans; Hyperparathyroidism, Secondary; Kidney Transplantation; Linear Models; Male; Middle Aged; Multivariate Analysis; Parathyroid Hormone; Phosphorus; Postoperative Period; Preoperative Period; Retrospective Studies; Statistics, Nonparametric; Sweden; Time Factors | 2012 |
Cinacalcet treatment for stable kidney transplantation patients with hypercalcemia due to persistent secondary hyperparathyroidism: a long-term follow-up.
Topics: Alkaline Phosphatase; Biomarkers; Calcimimetic Agents; Calcium; Cinacalcet; Creatinine; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Immunosuppressive Agents; Kidney Transplantation; Male; Naphthalenes; Parathyroid Hormone; Phosphorus; Radioimmunoassay; Retrospective Studies; Time Factors; Treatment Outcome | 2012 |
Parathyroid enlargement at dialysis initiation in patients with chronic kidney diseases.
Topics: Adult; Aged; Bone Diseases, Metabolic; Calcium; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Ultrasonography | 2013 |
Severe secondary hyperparathyroidism.
Topics: Aged; Calcium; Drug Monitoring; Ergocalciferols; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Parathyroid Hormone; Phosphorus; Treatment Outcome | 2001 |
The negative Ca(2+) balance is involved in the stimulation of PTH secretion.
Topics: Calcium; Dialysis Solutions; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Magnesium; Parathyroid Hormone; Phosphorus; Renal Dialysis | 2002 |
The effects of sevelamer hydrochloride and calcium carbonate on kidney calcification in uremic rats.
Topics: Animals; Antacids; Calcinosis; Calcium; Calcium Carbonate; Creatinine; Epoxy Compounds; Female; Hyperparathyroidism, Secondary; Kidney; Liver; Myocardium; Organ Size; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Polyamines; Polyethylenes; Rats; Rats, Sprague-Dawley; Sevelamer; Uremia | 2002 |
Impact of subtotal parathyroidectomy and in situ preservation of the remnant on the metabolic and cardiac manifestations of secondary hyperparathyroidism.
Topics: Adult; Alkaline Phosphatase; Calcium; Creatinine; Echocardiography, Doppler; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Male; Parathyroid Hormone; Phosphorus; Renal Dialysis; Time Factors; Urea; Ventricular Function, Left | 2002 |
RenaGel efficacy in severe secondary hyperparathyroidism.
Topics: Adult; Aged; Aluminum; Aluminum Hydroxide; Calcium; Calcium Carbonate; Chelating Agents; Drug Costs; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Lipids; Male; Middle Aged; Parathyroid Hormone; Patient Selection; Phosphorus; Polyamines; Renal Dialysis; Sevelamer; Treatment Outcome | 2002 |
Treatment of refractory secondary hyperparathyroidism with ethanol injection: the importance of glandular volume.
Topics: Alkaline Phosphatase; Biomarkers; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Ethanol; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Parathyroid Glands; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Radionuclide Imaging; Radiopharmaceuticals; Recurrence; Technetium Tc 99m Sestamibi | 2003 |
[Prevalence of vertebral fractures and aortic calcifications in hemodialysis patients: comparison with a population of the same age and sex].
Topics: Aged; Aged, 80 and over; Aortic Diseases; Calcinosis; Calcium; Comorbidity; Female; Fractures, Spontaneous; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Lipids; Male; Middle Aged; Odds Ratio; Phosphorus; Prevalence; Random Allocation; Renal Dialysis; Risk Factors; Sampling Studies; Spain; Spinal Fractures | 2003 |
Osteoporosis after renal transplantation.
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Age Factors; Biomarkers; Bone Density; Calcium; Creatinine; Cross-Sectional Studies; Female; Graft Rejection; Humans; Hyperparathyroidism, Secondary; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Osteoporosis; Phosphorus; Postoperative Complications; Prevalence; Renal Dialysis; Risk Factors; Smoking; Time Factors; Turkey | 2003 |
Spermatogenesis after parathyroidectomy in patients with symptomatic secondary hyperparathyroidism.
Topics: Adult; Alkaline Phosphatase; Calcium; Follicle Stimulating Hormone; Humans; Hyperparathyroidism, Secondary; Infertility, Male; Kidney Failure, Chronic; Kidney Transplantation; Luteinizing Hormone; Male; Middle Aged; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Prolactin; Renal Dialysis; Sperm Count; Sperm Motility; Spermatogenesis; Testosterone | 2003 |
Tumoral calcinosis in a dog with chronic renal failure.
Topics: Animals; Calcinosis; Dog Diseases; Dogs; Fatal Outcome; Forelimb; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Lameness, Animal; Male; Phosphorus | 2003 |
Long-term therapy with paricalcitol for secondary hyperparathyroidism in hemodialysis patients.
Topics: Adult; Calcium; Ergocalciferols; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Phosphorus Metabolism Disorders; Renal Dialysis | 2003 |
Nutritional secondary hyperparathyroidism in the cat.
Topics: Calcium, Dietary; Cat Diseases; Cats; Hyperparathyroidism; Hyperparathyroidism, Secondary; Phosphorus; Phosphorus, Dietary | 1963 |
Changes of bone remodeling immediately after parathyroidectomy for secondary hyperparathyroidism.
Topics: Adult; Biopsy; Bone Density; Bone Remodeling; Bone Resorption; Calcium; Female; Humans; Hyperparathyroidism, Secondary; Ilium; Male; Middle Aged; Osteoblasts; Osteoclasts; Osteogenesis; Parathyroid Hormone; Parathyroidectomy; Phosphorus | 2003 |
Clinical experience with percutaneous ethanol injection therapy in hemodialysis patients with renal hyperparathyroidism.
Topics: Adult; Aged; Alkaline Phosphatase; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Drug Resistance; Ethanol; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Osteocalcin; Parathyroid Glands; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Renal Dialysis; Uremia | 2003 |
Dynamics of PTH secretion in hemodialysis patients as determined by the intact and whole PTH assays.
Topics: Aged; Calcium; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis | 2003 |
Parathyroid hormone and mineral metabolism do not have significant impact on pulse pressure in patients undergoing peritoneal dialysis.
Topics: Adult; Aged; Blood Pressure; Calcium; Cross-Sectional Studies; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Peritoneal Dialysis, Continuous Ambulatory; Phosphorus | 2003 |
1,25-(OH)2-16ene-23yne-D3 reduces secondary hyperparathyroidism in uremic rats with little calcemic effect.
Topics: Animals; Calcitriol; Calcium; Hypercalcemia; Hyperparathyroidism, Secondary; Injections, Intraperitoneal; Male; Parathyroid Hormone; Phosphorus; Phosphorus, Dietary; Rats; Rats, Wistar; Uremia | 2004 |
Fooling the parathyroid gland--will there be health benefits?
Topics: Calcium; Cinacalcet; Drug Therapy, Combination; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Phosphorus; Renal Dialysis; Vitamin D | 2004 |
Hyperparathyroidism secondary to hypovitaminosis D in hypoalbuminemic is less intense than in normoalbuminemic patients: a prevalence study in medical inpatients in southern Brazil.
Topics: Albumins; Brazil; Calcium; Cross-Sectional Studies; Female; Humans; Hyperparathyroidism, Secondary; Hypoalbuminemia; Luminescent Measurements; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Prevalence; Radioimmunoassay; Vitamin D; Vitamin D Deficiency | 2004 |
Clinical significance of the K/DOQI bone guidelines in Japan.
Topics: Blood Specimen Collection; Bone Diseases, Metabolic; Humans; Hyperparathyroidism, Secondary; Japan; Kidney Diseases; Parathyroid Hormone; Phosphorus; Practice Guidelines as Topic; Reference Values; Time Factors; United States; Vitamin D | 2004 |
Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.
Topics: Aged; Arteriovenous Shunt, Surgical; Calcium; Cardiovascular Diseases; Female; Fractures, Bone; Hospitalization; Humans; Hyperparathyroidism, Secondary; Infections; Kidney Failure, Chronic; Male; Middle Aged; Minerals; Morbidity; Parathyroid Hormone; Phosphorus; Renal Dialysis; Risk Factors | 2004 |
Clinical experience with cinacalcet HCl.
Topics: Alkaline Phosphatase; Cinacalcet; Clinical Trials, Phase III as Topic; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Glands; Phosphorus; Randomized Controlled Trials as Topic; Renal Dialysis | 2004 |
[MIBI and parathyroid gland function in secondary hyperparathyroidism].
Topics: Acetates; Adult; Aged; Calcitriol; Calcium; Calcium Carbonate; Calcium Compounds; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Radionuclide Imaging; Radiopharmaceuticals; Renal Dialysis; Secretory Rate; Technetium Tc 99m Sestamibi; Uremia | 2004 |
Adverse effects of hyperphosphatemia on myocardial hypertrophy, renal function, and bone in rats with renal failure.
Topics: Animals; Body Weight; Bone and Bones; Cardiomegaly; Chronic Kidney Disease-Mineral and Bone Disorder; Eating; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Myocardium; Organ Size; Phosphorus; Phosphorus Metabolism Disorders; Rats; Rats, Wistar | 2004 |
[Evaluation of coronary artery calcification in ESRD patients].
Topics: Blood Flow Velocity; Calcinosis; Calcium; Carotid Arteries; Coronary Disease; Epoxy Compounds; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Phosphorus; Polyamines; Polyethylenes; Practice Guidelines as Topic; Prognosis; Pulse; Renal Dialysis; Sevelamer; Tomography, Spiral Computed; Ultrasonography | 2004 |
Daily or intermittent calcitriol administration during growth hormone therapy in rats with renal failure and advanced secondary hyperparathyroidism.
Topics: Animals; Calcitriol; Calcium Channel Agonists; Drug Administration Schedule; Drug Therapy, Combination; Growth; Growth Hormone; Growth Plate; Hyperparathyroidism, Secondary; Insulin-Like Growth Factor I; Male; Parathyroid Hormone; Phosphorus; Rats; Rats, Sprague-Dawley; Renal Insufficiency | 2005 |
Unchanged hypovitaminosis D and secondary hyperparathyroidism in morbid obesity after bariatric surgery.
Topics: Adult; Alkaline Phosphatase; Bariatrics; Body Mass Index; Calcifediol; Calcium; Creatinine; Cross-Sectional Studies; Diabetes Complications; Female; Follow-Up Studies; Gastric Bypass; Humans; Hyperparathyroidism, Secondary; Male; Obesity, Morbid; Parathyroid Hormone; Phosphorus; Vitamin D Deficiency; Weight Loss | 2005 |
Combination therapy with sevelamer hydrochloride and calcium carbonate in Japanese patients with long-term hemodialysis: alternative approach for optimal mineral management.
Topics: Antacids; Bone and Bones; Bone Density; Calcium; Calcium Carbonate; Calcium, Dietary; Chronic Kidney Disease-Mineral and Bone Disorder; Drug Therapy, Combination; Epoxy Compounds; Humans; Hyperparathyroidism, Secondary; Japan; Kidney Failure, Chronic; Parathyroid Hormone; Phosphorus; Polyamines; Polyethylenes; Renal Dialysis; Sevelamer; Time Factors | 2005 |
The influence of dialysate calcium on the therapeutic effects of sevelamer hydrochloride in hemodialysis patients with secondary hyperparathyroidism under treatment of intravenous vitamin d metabolites.
Topics: Calcitriol; Calcium; Calcium Channel Agonists; Case-Control Studies; Epoxy Compounds; Female; Hemodialysis Solutions; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Polyamines; Polyethylenes; Renal Dialysis; Sevelamer; Time Factors | 2005 |
Efficacy of percutaneous ethanol injection therapy for secondary hyperparathyroidism in patients on hemodialysis as evaluated by parathyroid hormone levels according to K/DOQI guidelines.
Topics: Calcium; Case-Control Studies; Ethanol; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Practice Guidelines as Topic; Renal Dialysis; Time Factors; Ultrasonography | 2005 |
[Study of calcium-phosphorous metabolism and intact parathyroid hormone levels in end stage renal disease patients].
Topics: Adolescent; Adult; Aged; Calcium; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Phosphorus Metabolism Disorders | 2005 |
1,25-Dihydroxyvitamin D3 but not cinacalcet HCl (Sensipar/Mimpara) treatment mediates aortic calcification in a rat model of secondary hyperparathyroidism.
Topics: Animals; Aortic Diseases; Calcinosis; Calcitriol; Calcium; Calcium Channel Agonists; Chronic Disease; Cinacalcet; Disease Models, Animal; Hyperparathyroidism, Secondary; Kidney Diseases; Male; Naphthalenes; Parathyroid Hormone; Phosphorus; Rats; Rats, Sprague-Dawley | 2005 |
[Surgical treatment of secondary hyperparathyroidism (The first experience in Klaipeda region)].
Topics: Adult; Aged; Calcium; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Hormone; Parathyroidectomy; Patient Selection; Phosphorus; Renal Dialysis; Time Factors; Treatment Outcome | 2005 |
Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States.
Topics: Adult; Aged; Black or African American; Calcifediol; Calcium; Chronic Disease; Comorbidity; Cross-Sectional Studies; Female; Glomerular Filtration Rate; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Prevalence; Prospective Studies; Risk Factors; Seasons; Sunlight; Topography, Medical; United States; Vitamin D Deficiency; White People | 2005 |
Vitamin D deficiency in CKD: why should we care?
Topics: Calcitriol; Calcium; Chronic Disease; Chronic Kidney Disease-Mineral and Bone Disorder; Cohort Studies; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Phosphorus; Vitamin D Deficiency | 2005 |
Once-weekly intravenous paricalcitol in the treatment of secondary hyperparathyroidism in hemodialysis patients.
Topics: Calcium; Dose-Response Relationship, Drug; Drug Administration Schedule; Ergocalciferols; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Prospective Studies; Renal Dialysis; Treatment Outcome | 2005 |
Management of secondary hyperparathyroidism.
Topics: Calcium; Humans; Hyperparathyroidism, Secondary; Phosphorus | 2005 |
Combination therapy of intravenous maxacalcitol and percutaneous ethanol injection therapy lowers serum parathyroid hormone level and calcium x phosphorus product in secondary hyperparathyroidism.
Topics: Adult; Alkaline Phosphatase; Antineoplastic Agents; Bone Density; Calcitriol; Calcium; Comorbidity; Drug Therapy, Combination; Ethanol; Female; Humans; Hyperparathyroidism, Secondary; Injections, Intralesional; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus | 2006 |
[Defining the role of sevelamer chloride as a therapeutic agent for management of phosphate in patient with hemodialysis].
Topics: Aged; Calcium; Calcium Carbonate; Diet Therapy; Drug Therapy, Combination; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Phosphorus Metabolism Disorders; Polyamines; Renal Dialysis; Sevelamer; Vitamin D | 2005 |
[Effects of intermittent treatment with sevelamer hydrochloride on parathyroid hyperplasia and vascular calcification in rats with chronic kidney disease].
Topics: Adenine; Animals; Aortic Diseases; Calcinosis; Calcium; Disease Models, Animal; Drug Administration Schedule; Fibroblast Growth Factors; Hyperparathyroidism, Secondary; Hyperplasia; Kidney Failure, Chronic; Male; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Polyamines; Rats; Rats, Sprague-Dawley; Sevelamer | 2005 |
[Influence of serum phosphate level for effects of OCT pulse therapy in hyper-PTH HD patients].
Topics: Calcitriol; Humans; Hyperparathyroidism, Secondary; Phosphorus; Pulse Therapy, Drug; Renal Dialysis; Retrospective Studies | 2005 |
[Control of calcium and phosphate in hemodialysis patients].
Topics: Calcium; Calcium Carbonate; Combined Modality Therapy; Diet Therapy; Female; Humans; Hyperparathyroidism, Secondary; Male; Parathyroid Hormone; Phosphorus; Polyamines; Practice Guidelines as Topic; Renal Dialysis; Sevelamer | 2005 |
[Suitable examination intervals for hemodialysis patients with secondary hyperparathyroidism treated with maxacalcitol].
Topics: Aged; Alkaline Phosphatase; Biomarkers; Calcitriol; Calcium; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Practice Guidelines as Topic; Renal Dialysis; Retrospective Studies; Time Factors | 2005 |
[Sevelamer hydrochloride and vitamin D for controlling serum calcium, phosphorus and bone metabolism in patients undergoing hemodialysis].
Topics: Aged; Aortic Diseases; Bone and Bones; Calcinosis; Calcium; Female; Humans; Hyperparathyroidism, Secondary; Hypoparathyroidism; Male; Middle Aged; Phosphorus; Polyamines; Pulse Therapy, Drug; Renal Dialysis; Sevelamer; Vitamin D | 2005 |
[Present status and problems in vitamin D and sevelamer therapy (discussion)].
Topics: Calcium; Drug Therapy, Combination; Ethanol; Humans; Hyperparathyroidism, Secondary; Hypoparathyroidism; Injections, Intralesional; Parathyroidectomy; Phosphorus; Polyamines; Practice Guidelines as Topic; Receptors, Calcium-Sensing; Sevelamer; Vitamin D | 2005 |
Progressive accumulation of lanthanum in the liver of normal and uremic rats.
Topics: Animal Feed; Animals; Creatinine; Female; Femur; Hyperparathyroidism, Secondary; Kidney; Kidney Failure, Chronic; Lanthanum; Liver; Phosphorus; Rats; Rats, Sprague-Dawley; Uremia | 2005 |
PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis.
Topics: Aged; Calcium; Comorbidity; Databases, Factual; Diabetes Mellitus; Female; Fractures, Bone; Fractures, Spontaneous; Health Care Costs; Hip Fractures; Humans; Hyperparathyroidism, Secondary; Hypertension; Incidence; International Classification of Diseases; Kidney Failure, Chronic; Male; Medicare; Middle Aged; Parathyroid Hormone; Pelvic Bones; Phosphorus; Proportional Hazards Models; Renal Dialysis; Risk; Smoking; Spinal Fractures; United States | 2006 |
An unusual case of generalized soft-tissue mineralization in a suckling foal.
Topics: Animals; Blood Vessels; Calcinosis; Calcium; Diet; Food Analysis; Horse Diseases; Horses; Hyperparathyroidism, Secondary; Hypocalcemia; Parathyroid Hormone; Phosphorus; Phosphorus Metabolism Disorders; Spain | 2006 |
Oral feeding acutely down-regulates serum PTH in hemodialysis patients.
Topics: Adult; Down-Regulation; Eating; Female; Food; Glucose; Humans; Hyperparathyroidism, Secondary; Injections, Intravenous; Male; Parathyroid Hormone; Phosphorus; Renal Dialysis; Sodium Chloride; Solutions | 2006 |
Paricalcitol for treatment of secondary hyperparathyroidism in CKD patients.
Topics: Acetates; Calcitriol; Calcium; Calcium Compounds; Chronic Disease; Cinacalcet; Clinical Trials, Phase III as Topic; Ergocalciferols; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Naphthalenes; Parathyroid Hormone; Phosphorus; Randomized Controlled Trials as Topic | 2006 |
Cinacalcet: new drug. Secondary hyperparathyroidism: where are the clinical data?
Topics: Calcium; Clinical Trials as Topic; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Parathyroid Neoplasms; Phosphorus; Renal Dialysis; Treatment Outcome | 2006 |
Does cinacalcet safely and effectively maintain long-term PTH control in secondary hyperparathyroidism?
Topics: Adult; Aged; Calcium; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Receptors, Calcium-Sensing; Time Factors; Vitamin D | 2006 |
Mortality risk among hemodialysis patients receiving different vitamin D analogs.
Topics: Adult; Aged; Aged, 80 and over; Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcitriol; Calcium; Ergocalciferols; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Retrospective Studies; Risk Factors; Survival Analysis; Vitamin D | 2006 |
Achieving targets for bone and mineral metabolism: the impact of cinacalcet HCl in clinical practice.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Bone and Bones; Calcium; Cinacalcet; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Renal Dialysis; Retrospective Studies; Treatment Outcome | 2006 |
Effect of on-line hemodiafiltration with endogenous reinfusion (HFR) on the calcium-phosphorus metabolism: medium-term effects.
Topics: Aged; Alkaline Phosphatase; beta 2-Microglobulin; C-Reactive Protein; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Hemodiafiltration; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Multivariate Analysis; Nutritional Status; Online Systems; Phosphorus; Treatment Outcome; Uremia | 2006 |
Neuro-fuzzy technology as a predictor of parathyroid hormone level in hemodialysis patients.
Topics: Aged; Algorithms; Alkaline Phosphatase; Blood Chemical Analysis; Calcium; Female; Fuzzy Logic; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Neural Networks, Computer; Parathyroid Hormone; Phosphorus; Radioimmunoassay; Regression Analysis; Renal Dialysis; Renal Insufficiency; Serum Albumin | 2007 |
Preliminary experience with cinacalcet use in persistent secondary hyperparathyroidism after kidney transplantation.
Topics: Adult; Aged; Calcium; Cinacalcet; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Kidney Transplantation; Male; Middle Aged; Naphthalenes; Phosphorus; Retrospective Studies | 2007 |
Effect of 2-methylene-19-nor-(20S)-1 alpha-hydroxy-bishomopregnacalciferol (2MbisP), an analog of vitamin D, on secondary hyperparathyroidism.
Topics: Animals; Calcinosis; Calcitriol; Calcium; Chronic Disease; Dihydroxycholecalciferols; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Humans; Hyperparathyroidism, Secondary; Phosphorus; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Calcitriol; Uremia; Vascular Diseases; Vitamin D-Binding Protein; Vitamins | 2007 |
Cinacalcet is effective in relapses of secondary hyperparathyroidism after parathyroidectomy.
Topics: Adult; Calcium; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Prospective Studies; Recurrence; Retreatment; Treatment Outcome | 2007 |
Japanese Society of Dialysis Therapy treatment guidelines for secondary hyperparathyroidism.
Topics: Aged; Calcium; Humans; Hyperparathyroidism, Secondary; Japan; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Practice Guidelines as Topic; Renal Dialysis; Societies, Medical; Survival Rate; Treatment Outcome; Vitamin D | 2007 |
Attainment of the Japanese Society for Dialysis Therapy guidelines for the management of secondary hyperparathyroidism in chronic hemodialysis patients in our clinic.
Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care Facilities; Calcium; Collagen Type I; Female; Humans; Hyperparathyroidism, Secondary; Japan; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Peptides; Phosphorus; Practice Guidelines as Topic; Renal Dialysis; Retrospective Studies; Societies, Medical; Time Factors | 2007 |
Calcium and phosphorus control in patients undergoing hemodialysis: from the view-points of activities of daily living.
Topics: Activities of Daily Living; Adult; Aged; Aged, 80 and over; Calcium; Chelating Agents; Female; Guideline Adherence; Hospitals; Humans; Hyperparathyroidism, Secondary; Japan; Kidney Failure, Chronic; Male; Middle Aged; Phosphorus; Polyamines; Practice Guidelines as Topic; Renal Dialysis; Retrospective Studies; Risk Factors; Sevelamer; Societies, Medical; Survival Rate | 2007 |
Achievement of the Japanese Society for Dialysis Therapy guideline targets for mineral metabolism measures: one Japanese university center result.
Topics: Adult; Aged; Aged, 80 and over; Calcium; Cross-Sectional Studies; Female; Guideline Adherence; Hospitals, University; Humans; Hyperparathyroidism, Secondary; Japan; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Practice Guidelines as Topic; Renal Dialysis; Retrospective Studies; Societies, Medical; Time Factors | 2007 |
The effect of calcitriol, paricalcitol, and a calcimimetic on extraosseous calcifications in uremic rats.
Topics: Animals; Aorta; Calcinosis; Calcitriol; Calcium; Calcium Channel Agonists; Ergocalciferols; Hyperparathyroidism, Secondary; Male; Phosphorus; Rats; Rats, Wistar; Uremia | 2008 |
Effects of cinacalcet on gastrointestinal hormone release in patients with secondary hyperparathyroidism undergoing dialysis.
Topics: Calcium; Cinacalcet; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Gastrointestinal Hormones; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Radioimmunoassay; Renal Dialysis; Severity of Illness Index; Substance P; Treatment Outcome; Vasoactive Intestinal Peptide | 2008 |
Parathyroid hormone status does not influence blood and bone lead levels in dialysis patients.
Topics: Adult; Black or African American; Bone and Bones; Bone Remodeling; Calcium; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Lead; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Serum Albumin; Sex Factors; Tibia | 2007 |
Highly concentrated calcitriol and its analogues induce apoptosis of parathyroid cells and regression of the hyperplastic gland--study in rats.
Topics: Animals; Apoptosis; Calcitriol; Calcium; Disease Models, Animal; Humans; Hyperparathyroidism, Secondary; Hyperplasia; Male; Microscopy, Electron, Transmission; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Rats; Rats, Sprague-Dawley | 2008 |
[Basic and clinical aspects of calcimimetics. The clinical effect and usefulness of Cinacalcet as a calcimimetics on three CKD-5D patients undergoing hemodialysis with refractory secondary hyperparathyroidism].
Topics: Aged; Calcium; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Receptors, Calcium-Sensing; Renal Dialysis | 2008 |
Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD.
Topics: Adult; Aged; Calcium; Case-Control Studies; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Postprandial Period | 2008 |
Cinacalcet for secondary hyperparathyroidism in children with end-stage renal disease.
Topics: Adolescent; Adult; Calcium; Child; Child, Preschool; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Infant; Kidney Failure, Chronic; Male; Naphthalenes; Parathyroid Hormone; Phosphorus | 2008 |
Effect of acute cimetidine administration on indices of parathyroid hormone action in healthy subjects and patients with primary and secondary hyperparathyroidism.
Topics: Adult; Aged; Calcium; Cimetidine; Cyclic AMP; Female; Humans; Hyperparathyroidism; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Hormone; Phosphorus | 1984 |
Decrease in the tubular reabsorption of calcium with evidence for compensatory hyperparathyroidism in X-linked hypophosphataemia in mice.
Topics: Absorption; Animals; Calcium; Cyclic AMP; Diet; Hyperparathyroidism, Secondary; Hypophosphatemia, Familial; Kidney Tubules; Male; Mice; Mice, Inbred Strains; Phosphorus | 1982 |
[Calcium-phosphorus changes in chronic anticonvulsant therapy: effects of the administration of 25-hydroxyvitamin D3 on secondary hyperparathyroidism].
Topics: Adolescent; Adult; Anticonvulsants; Calcifediol; Calcium; Cyclic AMP; Female; Humans; Hydroxyproline; Hyperparathyroidism, Secondary; Male; Middle Aged; Phosphorus; Seasons | 1983 |
Subtotal parathyroidectomy for secondary hyperparathyroidism.
Topics: Adult; Aged; Alkaline Phosphatase; Calcium; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Transplantation, Autologous | 1984 |
Changes following parathyroidectomy in hemodialyzed patients.
Topics: Adult; Alkaline Phosphatase; Aluminum; Bone Diseases; Bone Resorption; Calcium; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kinetics; Male; Middle Aged; Osteogenesis; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Renal Dialysis | 1984 |
Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.
Topics: Administration, Oral; Adult; Aged; Calcitriol; Calcium; Calcium Carbonate; Female; Humans; Hyperparathyroidism, Secondary; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Time Factors; Uremia | 1984 |
Surgical treatment of renal hyperparathyroidism.
Topics: Adenoma; Adult; Aged; Calcium; Female; Humans; Hyperparathyroidism, Secondary; Hyperplasia; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Glands; Parathyroid Hormone; Parathyroid Neoplasms; Phosphorus; Retrospective Studies | 1983 |
Metastatic calcinosis cutis.
Topics: Calcinosis; Calcium; Female; Humans; Hyperparathyroidism, Secondary; Hyperplasia; Kidney Failure, Chronic; Middle Aged; Parathyroid Glands; Phosphorus; Skin Diseases | 1983 |
Ectopic mineralization and nutritional hyperparathyroidism in boars.
Topics: Animals; Calcinosis; Calcium; Calcium, Dietary; Cattle; Cattle Diseases; Diet; Endocardium; Hyperparathyroidism, Secondary; Male; Parathyroid Glands; Phosphates; Phosphorus; Pleura | 1984 |
A quantitative histologic study of osteoporosis produced by nutritional secondary hyperparathyroidism in dogs.
Topics: Animals; Calcium; Calcium, Dietary; Dogs; Femur; Femur Head; Hyperparathyroidism, Secondary; Male; Microscopy, Electron; Nutrition Disorders; Osteoclasts; Osteoporosis; Parathyroid Hormone; Phosphorus | 1983 |
Effects of long-term therapy with calcitriol in patients with moderate renal failure.
Topics: Adult; Bone and Bones; Calcitriol; Calcium; Dihydroxycholecalciferols; Female; Humans; Hydroxycholecalciferols; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Magnesium; Middle Aged; Osteomalacia; Parathyroid Hormone; Phosphorus | 1980 |
[Disturbances of the calcium-phosphorus metabolism and skeletal diseases following kidney transplantation].
Topics: Adult; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Femur Head Necrosis; Humans; Hyperparathyroidism, Secondary; Kidney Transplantation; Male; Osteomalacia; Osteonecrosis; Osteoporosis; Phosphorus; Postoperative Complications; Radius; Tibia; Transplantation, Homologous | 1981 |
Reversal of hyperparathyroidism in severe uremics following very low-protein and low-phosphorus diet.
Topics: Adult; Aged; Amino Acids, Essential; Calcium; Calcium Carbonate; Calcium, Dietary; Dietary Proteins; Female; Humans; Hyperparathyroidism, Secondary; Keto Acids; Male; Middle Aged; Parathyroid Hormone; Phosphates; Phosphorus; Uremia | 1982 |
Calcium, phosphorus and parathyroid hormone metabolism in chronic hemofiltration.
Topics: Blood; Calcium; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Osteomalacia; Parathyroid Hormone; Phosphorus; Ultrafiltration; Vitamin D | 1982 |
Is anemia of chronic renal failure related to secondary hyperparathyroidism?
Topics: Adolescent; Adult; Aged; Anemia; Calcium; Female; Hematocrit; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Glands; Parathyroid Hormone; Phosphorus | 1981 |
Total parathyroidectomy and autotransplantation.
Topics: Adolescent; Adult; Aged; Alkaline Phosphatase; Calcium; Female; Forearm; Graft Survival; Humans; Hyperparathyroidism, Secondary; Hyperplasia; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Postoperative Complications; Transplantation, Autologous | 1981 |
The influence of the calcium/phosphorus ratio in the diet on human bone disease, the role of nutritive secondary hyperparathyroidism.
Topics: Calcium; Calcium, Dietary; Diet; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Hormone; Periodontal Diseases; Phosphates; Phosphorus | 1981 |
Reduction by cimetidine of serum parathyroid hormone levels in uremic patients.
Topics: Adult; Aged; Calcium; Cimetidine; Female; Guanidines; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Uremia | 1980 |
Persistent hypophosphatemia following parathyroidectomy in end-stage renal disease: report of three patients.
Topics: Adult; Aged; Alkaline Phosphatase; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Parathyroid Glands; Phosphates; Phosphorus | 1980 |
The shrinking man. A manifestation of severe renal osteodystrophy.
Topics: Adult; Amino Acids; Body Height; Body Weight; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kyphosis; Male; Phosphorus; Renal Dialysis; Scoliosis; Spinal Diseases | 1980 |
Calcium and phosphorus studies: interpretation of results and strategies for further testing.
Topics: Bone Diseases, Metabolic; Calcium; Humans; Hypercalcemia; Hyperparathyroidism; Hyperparathyroidism, Secondary; Hypocalcemia; Parathyroid Hormone; Phosphorus | 1980 |
Calcium and phosphorus in chronic renal failure during nutritional therapy.
Topics: Animals; Calcium; Creatinine; Diet; Dietary Proteins; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Phosphorus | 1980 |
Parathormone levels after subtotal and total (autotransplantation) parathyroidectomy for secondary hyperparathyroidism.
Topics: Adult; Aged; Alkaline Phosphatase; Calcium; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Transplantation, Autologous | 1980 |
Long-term control of hyperparathyroidism in advanced renal failure by low-phosphorus low-protein diet supplemented with calcium (without changes in plasma calcitriol).
Topics: Adult; Aged; Calcitriol; Calcium; Calcium Carbonate; Creatinine; Dietary Proteins; Female; Humans; Hyperparathyroidism, Secondary; Intestinal Absorption; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphates; Phosphorus; Retrospective Studies; Time Factors | 1995 |
Correction of chronic metabolic acidosis in haemodialysed patients by acetate-free biofiltration does not influence parathyroid function.
Topics: Acidosis; Bicarbonates; Calcium; Chronic Disease; Hemofiltration; Humans; Hyperparathyroidism, Secondary; Infusions, Intravenous; Kidney Diseases; Parathyroid Hormone; Phosphorus; Renal Dialysis | 1995 |
Low-calcium dialysate stimulates parathormone secretion and its long-term use worsens secondary hyperparathyroidism.
Topics: Adolescent; Adult; Aged; Alkaline Phosphatase; Calcium; Female; Hemodialysis Solutions; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Time Factors | 1995 |
Normocalcemic hyperparathyroidism associated with relatively low 1:25 vitamin D levels post-renal transplant can be successfully treated with oral calcitriol.
Topics: Adolescent; Adult; Aged; Azathioprine; Calcitriol; Calcium; Child; Child, Preschool; Chronic Kidney Disease-Mineral and Bone Disorder; Creatinine; Cyclosporine; Female; Follow-Up Studies; Glucocorticoids; Humans; Hyperparathyroidism, Secondary; Immunosuppressive Agents; Kidney Transplantation; Liver; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Prednisone | 1995 |
Intramuscular calcitriol for uraemic children with severe hyperparathyroidism and hypercalcaemia.
Topics: Administration, Oral; Adolescent; Calcitriol; Calcium; Child; Child, Preschool; Chronic Disease; Creatinine; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Immunoenzyme Techniques; Infant; Injections, Intramuscular; Male; Parathyroid Hormone; Phosphorus; Uremia | 1994 |
Oral pulse therapy with vitamin D3 for control of secondary hyperparathyroidism.
Topics: Administration, Oral; Adolescent; Adult; Alkaline Phosphatase; Calcium; Child; Child, Preschool; Cholecalciferol; Female; Humans; Hyperparathyroidism, Secondary; Immunoradiometric Assay; Kidney Failure, Chronic; Male; Parathyroid Hormone; Peritoneal Dialysis, Continuous Ambulatory; Phosphorus; Renal Dialysis | 1994 |
Calcium mass balance and behavior of intact immunoreactive parathyroid hormone in acetate-free biofiltration: acute and one-year evaluation.
Topics: Acetates; Adult; Aged; Aluminum Hydroxide; Bicarbonates; Calcitriol; Calcium; Calcium Carbonate; Female; Follow-Up Studies; Hemodiafiltration; Hemodialysis Solutions; Humans; Hydrogen-Ion Concentration; Hyperparathyroidism, Secondary; Magnesium Hydroxide; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Secretory Rate; Uremia | 1994 |
[Phosphorus-calcium metabolism and the secretion of calcium-regulating hormones in diabetic nephropathy].
Topics: Adult; Aged; Calcitonin; Calcitriol; Calcium; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Hyperparathyroidism, Secondary; Middle Aged; Parathyroid Hormone; Phosphorus | 1994 |
[Percutaneous alcohol injection in hyperparathyroidism. Experience in 11 cases with an 18-month follow-up].
Topics: Adenoma; Alkaline Phosphatase; Calcium; Ethanol; Follow-Up Studies; Humans; Hyperparathyroidism; Hyperparathyroidism, Secondary; Parathyroid Glands; Parathyroid Hormone; Parathyroid Neoplasms; Phosphorus; Time Factors; Ultrasonography | 1994 |
[Secondary hyperparathyroidism in the elderly. Apropos of 200 assays of intact parathormone].
Topics: Aged; Aged, 80 and over; Aging; Calcium; Female; Femoral Fractures; Humans; Hydroxycholecalciferols; Hyperparathyroidism, Secondary; Kidney Function Tests; Male; Nutritional Status; Parathyroid Hormone; Phosphorus; Risk Factors | 1995 |
Factors in the development of secondary hyperparathyroidism during graded renal failure in the rat.
Topics: Animals; Calcitriol; Calcium; Creatinine; Diet; Disease Models, Animal; Hyperparathyroidism, Secondary; Infusion Pumps, Implantable; Infusions, Parenteral; Male; Parathyroid Hormone; Phosphorus; Rats; Rats, Wistar; Renal Insufficiency | 1994 |
Surgical treatment of secondary hyperparathyroidism in patients with chronic renal failure by sub-total parathyroidectomy.
Topics: Adult; Aged; Calcium; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Hyperplasia; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Glands; Parathyroid Hormone; Parathyroidectomy; Phosphorus | 1994 |
Pulse intravenous calcitriol therapy of secondary hyperparathyroidism in peritoneal dialysis patients.
Topics: Adult; Aged; Bone Density; Calcitriol; Calcium; Female; Humans; Hyperparathyroidism, Secondary; Infusions, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Peritoneal Dialysis, Continuous Ambulatory; Phosphorus | 1993 |
Bone metabolic activity measured with positron emission tomography and [18F]fluoride ion in renal osteodystrophy: correlation with bone histomorphometry.
Topics: Adolescent; Adult; Alkaline Phosphatase; Bone and Bones; Bone Resorption; Calcitriol; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Fluorine Radioisotopes; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Models, Theoretical; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Regression Analysis; Tomography, Emission-Computed | 1993 |
Effect of calcium-channel blockers on calcium-phosphate metabolism in patients with end-stage renal disease.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Calcifediol; Calcium; Calcium Channel Blockers; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Magnesium; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis | 1996 |
Phosphorus accelerates the development of parathyroid hyperplasia and secondary hyperparathyroidism in rats with renal failure.
Topics: Animals; Body Weight; Calcium; Female; Hyperparathyroidism, Secondary; Hyperplasia; Kidney Failure, Chronic; Nephrectomy; Organ Size; Parathyroid Glands; Phosphorus; Phosphorus, Dietary; Rats; Rats, Sprague-Dawley | 1996 |
[Usefulness of calcium acetate as a chelating of phosphorus in patients in hemodialysis with secondary hyperthyroidism].
Topics: Acetic Acid; Chelating Agents; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Phosphorus; Prospective Studies; Renal Dialysis | 1995 |
Tertiary hyperparathyroidism after renal transplantation.
Topics: Adenoma; Adolescent; Adult; Calcium; Child; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Transplantation; Male; Parathyroid Hormone; Parathyroid Neoplasms; Parathyroidectomy; Phosphorus | 1997 |
1.25(OH)2 cholecalciferol pulse therapy and the effects of different dialysis membranes on serum PTH levels of haemodialysis patients.
Topics: Adult; Biocompatible Materials; Calcitriol; Calcium; Cellulose; Dose-Response Relationship, Drug; Drug Administration Routes; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Male; Membranes, Artificial; Parathyroid Hormone; Phosphorus; Polymers; Renal Dialysis; Sulfones; Treatment Outcome | 1997 |
Frequent recurrence of secondary hyperparathyroidism after pulse oral calcitriol withdrawal in PD patients.
Topics: Administration, Oral; Adult; Aged; Calcitriol; Calcium; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Hormone; Peritoneal Dialysis; Phosphorus; Recurrence | 1997 |
Pamidronate administration improves the secondary hyperparathyroidism due to "Bone Hunger Syndrome" in a patient with osteoblastic metastases from prostate cancer.
Topics: Aged; Alkaline Phosphatase; Bone and Bones; Bone Neoplasms; Calcium; Collagen; Diphosphonates; Humans; Hyperparathyroidism, Secondary; Male; Metabolic Diseases; Osteoblastoma; Pain Measurement; Pamidronate; Parathyroid Hormone; Phosphorus; Prostate-Specific Antigen; Prostatic Neoplasms; Syndrome | 1997 |
Diminished linear growth during intermittent calcitriol therapy in children undergoing CCPD.
Topics: Adolescent; Alkaline Phosphatase; Calcitriol; Calcium; Child; Female; Growth; Humans; Hyperparathyroidism, Secondary; Male; Parathyroid Hormone; Peritoneal Dialysis; Phosphorus | 1998 |
[Letter to the authors of the "Recommendations for clinical practice" concerning the prevention of renal osteodystrophy before extra-renal purification].
Topics: Adult; Aluminum; Amino Acids; Calcifediol; Calcitriol; Child; Chronic Kidney Disease-Mineral and Bone Disorder; Dietary Proteins; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Hypocalcemia; Infant; Kidney Failure, Chronic; Nutrition Disorders; Osteomalacia; Peritoneal Dialysis, Continuous Ambulatory; Phosphorus; Practice Guidelines as Topic; Renal Replacement Therapy; Vitamin D Deficiency | 1998 |
Relationship between serum phosphorus levels and various outcome measures in adult hemodialysis patients.
Topics: Adult; Calcium; Humans; Hyperparathyroidism, Secondary; Nutritional Status; Parathyroid Hormone; Phosphorus; Renal Dialysis; Serum Albumin; Treatment Outcome | 1998 |
Effects of 19-nor-1,25(OH)2D2, a new analogue of calcitriol, on secondary hyperparathyroidism in uremic rats.
Topics: Animals; Calcitriol; Calcium; Cattle; Cells, Cultured; Dose-Response Relationship, Drug; Ergocalciferols; Female; Hyperparathyroidism, Secondary; Intestine, Small; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Rats; Rats, Sprague-Dawley; Receptors, Calcitriol; Uremia | 1998 |
22-oxacalcitriol suppresses secondary hyperparathyroidism without inducing low bone turnover in dogs with renal failure.
Topics: Animals; Bone Diseases, Metabolic; Bone Remodeling; Calcitriol; Calcium; Disease Models, Animal; Dogs; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Nephrectomy; Parathyroid Hormone; Phosphorus; Time Factors | 1999 |
Long-term effects of intermittent oral alphacalcidol, calcium carbonate and low-calcium dialysis (1.25 mmol L-1) on secondary hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis.
Topics: Albumins; Calcium; Calcium Carbonate; Creatinine; Dialysis Solutions; Female; Glucose; Humans; Hydrogen-Ion Concentration; Hydroxycholecalciferols; Hypercalcemia; Hyperparathyroidism, Secondary; Lactic Acid; Magnesium; Male; Middle Aged; Osmolar Concentration; Peritoneal Dialysis, Continuous Ambulatory; Phosphorus; Time Factors; Treatment Outcome; Urea | 1998 |
A study on pruritus after parathyroidectomy for secondary hyperparathyroidism.
Topics: Adult; Biopsy; Calcium; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hyperparathyroidism, Secondary; Male; Parathyroidectomy; Phosphorus; Postoperative Period; Pruritus; Skin; Uremia | 2000 |
Hyperphosphatemia accelerates parathyroid cell proliferation and parathyroid hormone secretion in severe secondary parathyroid hyperplasia.
Topics: Animals; Bromodeoxyuridine; Cell Division; Diet; Female; Humans; Hyperparathyroidism, Secondary; Immunohistochemistry; Mice; Mice, Nude; Parathyroid Glands; Parathyroid Hormone; Phosphorus | 1999 |
Disorders of calcium metabolism at various times after renal transplantation.
Topics: Adult; Age Factors; Aged; Bone and Bones; Bone Diseases, Metabolic; Calcium; Creatinine; Cross-Sectional Studies; Female; Humans; Hyperparathyroidism, Secondary; Kidney Transplantation; Male; Middle Aged; Osteocalcin; Parathyroid Hormone; Phosphorus; Time Factors | 1999 |
The crossover comparative trial of calcium acetate versus sevelamer hydrochloride (Renagel) as phosphate binders in dialysis patients.
Topics: Acetates; Calcifediol; Calcinosis; Calcium; Calcium Compounds; Capsules; Cardiovascular Diseases; Cross-Over Studies; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Phosphates; Phosphorus; Polyamines; Renal Dialysis; Sevelamer | 2000 |
Short-term administration of the bisphosphonate ibandronate increases bone volume and prevents hyperparathyroid bone changes in mild experimental renal failure.
Topics: Alkaline Phosphatase; Animals; Bone and Bones; Bone Resorption; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Creatinine; Diphosphonates; Female; Hyperparathyroidism, Secondary; Ibandronic Acid; Kidney Failure, Chronic; Osteocalcin; Parathyroid Hormone; Phosphorus; Rats; Rats, Sprague-Dawley | 2000 |
Hyperparathyroidism and dialysis vintage.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Calcium; Female; Humans; Hyperparathyroidism, Secondary; Linear Models; Male; Middle Aged; Multivariate Analysis; Phosphorus; Renal Dialysis; Severity of Illness Index | 2000 |
Parathyroidectomy can improve bone mineral density in patients with symptomatic secondary hyperparathyroidism.
Topics: Absorptiometry, Photon; Adult; Alkaline Phosphatase; Bone Density; Calcium; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Osteoporosis; Parathyroid Glands; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Transplantation, Autologous | 2001 |
Paricalcitol in dialysis patients with calcitriol-resistant secondary hyperparathyroidism.
Topics: Calcitriol; Calcium; Dietary Proteins; Drug Resistance; Ergocalciferols; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Prospective Studies; Renal Dialysis; Serum Albumin | 2001 |
[Tumorous calcinosis in hemodialysis: anatomo-clinical study apropos of 3 cases].
Topics: Adult; Calcinosis; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Fingers; Hip Joint; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Joint Diseases; Kidney Failure, Chronic; Male; Middle Aged; Phosphorus; Renal Dialysis; Shoulder Joint | 2001 |
The effects of long term feeding of Solanum glaucophyllum to growing rats on Ca, Mg, P and bone metabolism.
Topics: Alkaline Phosphatase; Alkaloids; Animal Feed; Animals; Bone and Bones; Calcium; Calcium, Dietary; Dihydroxycholecalciferols; Diphosphates; Female; Growth; Hydroxyproline; Hyperparathyroidism, Secondary; Kinetics; Magnesium; Male; Phosphorus; Plants; Rats | 1976 |
Advances in vitamin D metabolism as they pertain to chronic renal disease.
Topics: Calcium; Cholecalciferol; Chronic Kidney Disease-Mineral and Bone Disorder; Dihydroxycholecalciferols; Humans; Hydroxycholecalciferols; Hyperparathyroidism, Secondary; Kidney; Kidney Failure, Chronic; Phosphorus; Vitamin D | 1976 |
Evidence for a defect in the formation of 1alpha,25-dihydroxyvitamin D in pseudohypoparathyroidism.
Topics: Adult; Calcium; Cyclic AMP; Dihydroxycholecalciferols; Female; Humans; Hydroxycholecalciferols; Hyperparathyroidism, Secondary; Male; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Pseudohypoparathyroidism; Tissue Extracts | 1977 |
Low-protein diets and bone disease in chronic renal failure.
Topics: Adult; Dietary Proteins; Follow-Up Studies; Humans; Hyperparathyroidism; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Middle Aged; Osteomalacia; Phosphorus | 1978 |
[Hyperparathyroidism in endocrinology and nephrology].
Topics: Bone Diseases; Calcification, Physiologic; Calcitonin; Calcium; Diagnosis, Differential; History, 19th Century; History, 20th Century; Humans; Hydroxylation; Hyperparathyroidism; Hyperparathyroidism, Secondary; Hypocalcemia; Kidney; Kidney Diseases; Liver; Parathyroid Hormone; Phosphorus; Vitamin D | 1977 |
Anemia and secondary hyperparathyroidism in chronically hemodialyzed patients.
Topics: Adolescent; Adult; Aged; Alkaline Phosphatase; Anemia; Calcium; Female; Hematocrit; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Renal Dialysis | 1979 |
Concepts of osteomalacia in 1979.
Topics: Calcium; Humans; Hyperparathyroidism, Secondary; Intestinal Absorption; Osteomalacia; Phosphorus; Vitamin D; Vitamin D Deficiency | 1979 |
Detection and pathogenesis of visceral calcification in dialysis patients and patients with malignant disease.
Topics: Adult; Aged; Calcinosis; Calcium; Female; Humans; Hyperparathyroidism; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Lung; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Peritoneal Dialysis; Phosphorus; Radionuclide Imaging; Renal Dialysis; Stomach; Technetium | 1978 |
[Muscular involvement in osteomalacia: clinical, hystoenzymologic and ultrastructural study in 10 cases].
Topics: Apyrase; Avitaminosis; Electromyography; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Muscular Diseases; Osteomalacia; Phosphorus; Saccharopine Dehydrogenases | 1978 |
Evolution of secondary hyperparathyroidism after renal transplantation.
Topics: Creatinine; Glomerular Filtration Rate; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney; Kidney Failure, Chronic; Kidney Transplantation; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Transplantation, Homologous | 1976 |
Blood parathormone levels and sensitivity of parathyroid glands to hypercalcaemia after successful renal transplantation.
Topics: Calcium; Glomerular Filtration Rate; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Transplantation; Parathyroid Hormone; Phosphorus; Postoperative Complications; Time Factors; Transplantation, Homologous | 1976 |
Hypercalcemia of seven years' duration after kidney transplantation.
Topics: Adult; Animals; Calcium; Creatinine; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Transplantation; Male; Nephrectomy; Parathyroid Glands; Phosphorus; Postoperative Complications; Pyelonephritis; Rats | 1976 |
[Deficiency periodontopathy in dogs].
Topics: Animal Feed; Animals; Calcium; Dog Diseases; Dogs; Hyperparathyroidism, Secondary; Periodontal Diseases; Phosphorus | 1975 |
Hyperparathyroidism in hepatobiliary disease in infancy.
Topics: Alkaline Phosphatase; Biliary Tract; Biliary Tract Diseases; Biliary Tract Surgical Procedures; Calcium; Child, Preschool; Humans; Hyperparathyroidism, Secondary; Infant; Infant, Newborn; Jaundice, Neonatal; Liver Diseases; Magnesium; Phosphorus | 1975 |
Effects of high dialysate calcium concentration on bone remodelling, serum biochemistry, and parathyroid hormone in patients with renal osteodystrophy.
Topics: Adult; Antigens; Bone and Bones; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Humans; Hyperparathyroidism, Secondary; Intestinal Absorption; Kidney Failure, Chronic; Male; Middle Aged; Osteoclasts; Parathyroid Hormone; Phosphorus; Renal Dialysis | 1977 |
Cestrum diurnum intoxication in normal and hyperparathyroid pigs.
Topics: Alkaline Phosphatase; Animals; Bone Resorption; Calcinosis; Calcium; Cartilage, Articular; Female; Humerus; Hyperparathyroidism, Secondary; Magnesium; Male; Osteonecrosis; Osteopetrosis; Parathyroid Glands; Phosphorus; Plant Poisoning; Swine; Swine Diseases | 1977 |
Diagnosis and management of hyperparathyroidism.
Topics: Adenoma; Adult; Aged; Alkaline Phosphatase; Calcium; Female; Humans; Hyperparathyroidism; Hyperparathyroidism, Secondary; Hyperplasia; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Parathyroid Neoplasms; Phosphorus | 1976 |
Periodontal disease in dogs and man.
Topics: Animal Nutritional Physiological Phenomena; Animals; Bone Resorption; Calcium; Calcium, Dietary; Dog Diseases; Dogs; Food Analysis; Gingivitis; Humans; Hyperparathyroidism, Secondary; Milk; Nutritional Requirements; Osteolysis; Periodontal Diseases; Phosphorus; United States | 1976 |
Skeletal resistance to the calcaemic action of parathyroid hormone in uraemia: a mechanism for the hypocalcaemia and secondary hyperparathyroidism of chronic renal failure.
Topics: Acute Kidney Injury; Animals; Bone and Bones; Calcium; Dogs; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Kidney Failure, Chronic; Nephrectomy; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Tissue Extracts; Uremia; Ureter | 1976 |
A case of maternal hyperparathyroidism presenting as neonatal tetany.
Topics: Adenoma; Adult; Calcium; Creatinine; Female; Humans; Hyperparathyroidism, Secondary; Infant, Newborn; Maternal-Fetal Exchange; Phosphates; Phosphorus; Pregnancy; Tetany; Thyroid Neoplasms | 1975 |
Calcium and phosphorus in diet therapy of uremia.
Topics: Bone and Bones; Calcium; Calcium, Dietary; Chronic Kidney Disease-Mineral and Bone Disorder; Glomerular Filtration Rate; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Kidney Failure, Chronic; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Renal Dialysis; Uremia; Vitamin D | 1975 |
Impaired osteoclastic function and linear bone erosion rate in secondary hyperparathyroidism associated with chronic renal failure.
Topics: Alkaline Phosphatase; Animals; Antigens; Autopsy; Biopsy; Blood Urea Nitrogen; Bone Resorption; Dogs; Haversian System; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Nephrectomy; Osteoblasts; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Ribs; Uremia | 1975 |
[Classification, diagnosis and treatment of primary hyperparathyroidism during crisis].
Topics: Alkaline Phosphatase; Biopsy; Calcium; Diagnosis, Differential; Humans; Hypercalcemia; Hyperparathyroidism; Hyperparathyroidism, Secondary; Osteomalacia; Osteoporosis; Parathyroid Hormone; Phosphorus; Postoperative Complications; Tetany; Urinary Calculi | 1975 |
The aetiology of senile osteoporosis: secondary hyperparathyroidism due to renal failure.
Topics: Adolescent; Adult; Aged; Calcitonin; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Lumbar Vertebrae; Male; Metacarpus; Osteoporosis; Parathyroid Hormone; Phosphorus; Radiography; Thoracic Vertebrae | 1975 |
The effect of anticonvulsant therapy on serum levels of 25-hydroxy-vitamin D, calcium, and parathyroid hormone.
Topics: Calcium; Cholesterol; Epilepsy; Female; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Parathyroid Hormone; Phenytoin; Phosphorus; Time Factors; Triglycerides; Vitamin D; Vitamin D Deficiency | 1975 |
Subtotal parathyroidectomy in chronic renal failure.
Topics: Adult; Alkaline Phosphatase; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Parathyroid Glands; Phosphorus; Postoperative Complications | 1976 |
Impaired phagocytosis in chronic renal failure is mediated by secondary hyperparathyroidism.
Topics: Animals; Calcium; Hyperparathyroidism, Secondary; In Vitro Techniques; Kidney Failure, Chronic; Male; Neutrophils; Parathyroid Hormone; Phagocytosis; Phosphorus; Rats; Rats, Inbred Strains; Verapamil | 1992 |
Mild vitamin D deficiency and secondary hyperparathyroidism in nursing home patients receiving adequate dietary vitamin D.
Topics: 25-Hydroxyvitamin D 2; Aged; Calcitriol; Calcium; Calcium, Dietary; Case-Control Studies; Energy Intake; Hospitals, Veterans; Humans; Hyperparathyroidism, Secondary; Length of Stay; Male; Middle Aged; Nursing Homes; Nutrition Surveys; Nutritional Requirements; Nutritional Status; Parathyroid Hormone; Phosphorus; Seasons; Serum Albumin; Sunlight; Virginia; Vitamin D; Vitamin D Deficiency | 1992 |
Iatrogenic hypercalcemia in hemodialysis patients.
Topics: Adult; Calcitriol; Calcium Carbonate; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Iatrogenic Disease; Male; Middle Aged; Phosphorus; Renal Dialysis; Risk Factors | 1991 |
[Status of phosphorus-calcium metabolism and secretion of calcium- regulating hormones in diabetic nephropathy].
Topics: Adult; Aged; Calcitonin; Calcium; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Hyperparathyroidism, Secondary; Middle Aged; Nephrotic Syndrome; Parathyroid Hormone; Phosphorus | 1991 |
Impaired potassium-induced insulin secretion in chronic renal failure.
Topics: Animals; Calcium; Creatinine; Hyperparathyroidism, Secondary; Insulin; Insulin Secretion; Islets of Langerhans; Kidney Failure, Chronic; Male; Parathyroid Hormone; Phosphorus; Potassium; Rats; Rats, Inbred Strains; Secretory Rate; Signal Transduction | 1991 |
Effects of dietary phosphorus restriction on secondary hyperparathyroidism in hemodialysis patients during intermittent oral high-dose 1,25(OH)2D3 treatment.
Topics: Administration, Oral; Adult; Alkaline Phosphatase; Calcitriol; Calcium; Humans; Hyperparathyroidism, Secondary; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis | 1991 |
Effect of intermittent oral 1,25(OH)2D3 therapy on bone Gla protein in dialysis patients.
Topics: Administration, Oral; Alkaline Phosphatase; Analysis of Variance; Bone and Bones; Calcitriol; Calcium; Humans; Hyperparathyroidism, Secondary; Immunoradiometric Assay; Osteocalcin; Parathyroid Hormone; Phosphorus; Radioimmunoassay; Renal Dialysis; Time Factors | 1991 |
[Hypophosphatemia and hyperphosphatemia].
Topics: Aluminum Hydroxide; Dialysis; Female; Glomerular Filtration Rate; Humans; Hyperparathyroidism, Secondary; Intestine, Small; Kidney; Male; Phosphorus; Phosphorus Metabolism Disorders | 1991 |
[Clinical study of concerning factors of decreased bone mineral content in hemodialysis patients].
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Alkaline Phosphatase; Aluminum; Aluminum Hydroxide; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Calcium; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Parathyroid Hormone; Phosphorus; Renal Dialysis; Sex Factors | 1991 |
Radioimmunoassay of carboxyl and amino terminal fragments of parathyroid hormone for the evaluation of secondary hyperparathyroidism in chronic renal failure.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Calcium; Creatinine; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Peptide Fragments; Phosphorus; Renal Dialysis; Teriparatide | 1990 |
Comparison of different parathyroid hormone radioimmunoassays in uremic patients with secondary hyperparathyroidism.
Topics: Bone Diseases, Metabolic; Calcium; Female; Humans; Hyperparathyroidism, Secondary; Kidney; Male; Parathyroid Hormone; Peptide Fragments; Phosphorus; Radioimmunoassay; Uremia | 1990 |
Parathyroid sonography in secondary hyperparathyroidism: correlation with clinical findings.
Topics: Adult; Alkaline Phosphatase; Calcium; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Glands; Parathyroid Hormone; Peptide Fragments; Phosphorus; Renal Dialysis; Ultrasonography | 1989 |
Short-term effects of parathyroidectomy on plasma biochemistry in chronic uremia.
Topics: Alkaline Phosphatase; Aluminum; Bone and Bones; Calcifediol; Calcium; Chronic Disease; Cohort Studies; Deferoxamine; gamma-Glutamyltransferase; Humans; Hyperparathyroidism, Secondary; Osteocalcin; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Renal Dialysis; Time Factors; Uremia | 1989 |
Persistant abnormal serum parathyroid hormone after renal transplantation: correlation between renal graft function.
Topics: Calcium; Creatinine; Female; Humans; Hyperparathyroidism, Secondary; Kidney; Kidney Transplantation; Male; Parathyroid Hormone; Phosphorus; Uremia | 1989 |
[Peculiar problems of phosphocalcium metabolism in chronic renal insufficiency].
Topics: Calcium; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Osteomalacia; Phosphates; Phosphorus | 1989 |
Tendinous laxity and Jaccoud's syndrome in patients with systemic lupus erythematosus. Possible role of secondary hyperparathyroidism.
Topics: Adolescent; Adult; Arthritis; Calcium; Child; Creatinine; Female; Foot Deformities, Congenital; Hand Deformities, Congenital; Humans; Hyperparathyroidism, Secondary; Joint Instability; Knee Joint; Lupus Erythematosus, Systemic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Tendons; Uric Acid | 1989 |
[Long-term treatment of secondary hyperparathyroidism in the chronic hemodialysis patient with 1,25-(OH)2D3].
Topics: Adolescent; Adult; Aged; Alkaline Phosphatase; Calcium; Cholecalciferol; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Long-Term Care; Male; Middle Aged; Osteomalacia; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Radiography; Receptors, Calcitriol; Receptors, Steroid; Renal Dialysis | 1985 |
[Mineral metabolism and secondary hyperparathyroidism in celiac disease].
Topics: Adolescent; Adult; Calcium; Celiac Disease; Child; Cyclic AMP; Female; Growth Disorders; Humans; Hyperparathyroidism, Secondary; Jejunum; Male; Middle Aged; Parathyroid Glands; Phosphorus | 1985 |
Reduced binding of [3H]1,25-dihydroxyvitamin D3 in the parathyroid glands of patients with renal failure.
Topics: Adolescent; Adult; Aged; Calcitriol; Child; Female; Humans; Hyperparathyroidism; Hyperparathyroidism, Secondary; In Vitro Techniques; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Receptors, Calcitriol; Receptors, Steroid | 1987 |
Purple pigeon grass (Setaria incrassata): a potential cause of nutritional secondary hyperpharathyroidism of grazing horses.
Topics: Animal Feed; Animals; Calcium; Horse Diseases; Horses; Hyperparathyroidism, Secondary; Phosphorus; Poaceae; Time Factors | 1988 |
Influence of keto acid (KA) treatment on renal osteodystrophy.
Topics: Amino Acids; Calcitriol; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Dietary Proteins; Ergocalciferols; Food, Fortified; Humans; Hyperparathyroidism, Secondary; Keto Acids; Kidney Failure, Chronic; Parathyroid Hormone; Phosphorus | 1987 |
[Use of hormonal parameters of phospho-calcium metabolism as a means of discriminating bone and joint disorders in patients with renal insufficiency].
Topics: Adolescent; Adult; Aged; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Diagnosis, Differential; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis | 1986 |
Total parathyroidectomy and forearm autotransplantation for chronic renal failure: a useful tool for the general surgeon in private practice.
Topics: Adult; Calcium; Forearm; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Middle Aged; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Private Practice; Retrospective Studies; Transplantation, Autologous | 1986 |
Lack of relation between secondary hyperparathyroidism and red blood cell osmotic fragility in chronic renal failure.
Topics: Adult; Aged; Alkaline Phosphatase; Calcitriol; Calcium; Female; Hand; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Osmotic Fragility; Parathyroid Hormone; Phosphorus; Radiography | 1985 |
Vitamin D metabolism and osteomalacia in cystic fibrosis.
Topics: Adult; Bone and Bones; Calcium; Cystic Fibrosis; Ergocalciferols; Humans; Hydroxycholecalciferols; Hyperparathyroidism, Secondary; Hypocalcemia; Liver; Liver Cirrhosis; Magnesium; Malabsorption Syndromes; Male; Osteomalacia; Parathyroid Hormone; Phosphorus; Serum Albumin; Vitamin D | 1985 |
Late infantile tetany and secondary hyperparathyroidism in infants fed humanized cow milk formula. Longitudinal follow-up.
Topics: 25-Hydroxyvitamin D 2; Animals; Breast Feeding; Calcitonin; Calcitriol; Calcium; Cattle; Ergocalciferols; Humans; Hyperparathyroidism, Secondary; Infant Food; Infant, Newborn; Longitudinal Studies; Magnesium; Milk; Parathyroid Hormone; Phosphorus; Tetany | 1985 |
Value of high resolution real-time ultrasonography in secondary hyperparathyroidism.
Topics: Adenoma; Adolescent; Adult; Aged; Alkaline Phosphatase; Calcium; Female; Humans; Hyperparathyroidism, Secondary; Hyperplasia; Male; Middle Aged; Parathyroid Glands; Parathyroid Hormone; Parathyroid Neoplasms; Phosphorus; Recurrence; Reoperation; Ultrasonography | 1985 |
[Parathormone as a uremic toxin. Physiopathological bases and general therapeutic guidelines].
Topics: Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Nephrotic Syndrome; Parathyroid Glands; Parathyroid Hormone; Phosphates; Phosphorus; Uremia; Vitamin D | 1985 |
[Parathyroidectomy in secondary hyperparathyroidism in chronic uremic patients under dialysis treatment. Development of the surgical strategy].
Topics: Alkaline Phosphatase; Calcium; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Methods; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Renal Dialysis | 1985 |
Osmotic fragility of erythrocytes, cell deformability and secondary hyperparathyroidism in uremic patients on maintenance hemodialysis.
Topics: Adolescent; Adult; Aged; Alkaline Phosphatase; Calcium; Erythrocyte Deformability; Erythrocytes; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Osmotic Fragility; Parathyroid Hormone; Phosphorus; Renal Dialysis; Uremia | 1985 |
Erythrocyte survival in chronic renal failure. Role of secondary hyperparathyroidism.
Topics: Animals; Calcium; Creatinine; Dogs; Erythrocyte Aging; Female; Hemolysis; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Osmotic Fragility; Parathyroid Glands; Parathyroid Hormone; Phosphorus | 1985 |
Serum parathyroid hormone in hypophosphatemic vitamin D-resistant rickets.
Topics: Calcium; Child; Child, Preschool; Female; Humans; Hyperparathyroidism, Secondary; Hypophosphatemia, Familial; Infant; Kidney Tubules; Male; Parathyroid Hormone; Phosphorus; Radioimmunoassay; Vitamin D | 1972 |
The role of phosphorus restriction in the prevention of secondary hyperparathyroidism in chronic renal disease.
Topics: Aluminum; Animals; Calcium; Carbonates; Cholecalciferol; Diet Therapy; Dogs; Glomerular Filtration Rate; Humans; Hydroxides; Hyperparathyroidism, Secondary; Kidney; Kidney Failure, Chronic; Kidney Tubules; Nephrons; Parathyroid Hormone; Phosphorus | 1973 |
Serum concentrations of parathyroid hormone in infants, children, and adolescents.
Topics: Adolescent; Adult; Aluminum Hydroxide; Animals; Anticonvulsants; Blood; Blood Urea Nitrogen; Calcium; Cattle; Child; Child, Preschool; Cross Reactions; Edetic Acid; Female; Guinea Pigs; Humans; Hypercalcemia; Hyperparathyroidism; Hyperparathyroidism, Secondary; Hypocalcemia; Hypophosphatemia, Familial; Infant; Infant, Newborn; Iodine Radioisotopes; Kidney Failure, Chronic; Kidney Transplantation; Male; Methods; Parathyroid Hormone; Phosphorus; Pregnancy; Radioimmunoassay; Transplantation, Homologous; Umbilical Cord | 1974 |
Secondary hyperparathyroidism in rats with experimentally induced pyelonephritis.
Topics: Animals; Body Weight; Calcium; Cell Nucleus; Creatinine; Glomerular Filtration Rate; Hyperparathyroidism, Secondary; Inclusion Bodies; Kidney; Male; Microscopy, Electron; Nephrectomy; Organ Size; Parathyroid Glands; Phosphorus; Pyelonephritis; Rats | 1974 |
[Letter: Parathyroidectomy (surgical or medicamentous?) in hyperparathyroidisms due to renal insufficiency].
Topics: Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Renal Dialysis; Vitamin D | 1974 |
Effect of nutritional hyperparathyroidism on experimental periodontitis in the dog.
Topics: Alveolar Process; Animals; Body Weight; Bone Diseases; Calcium; Chronic Disease; Deficiency Diseases; Dental Plaque; Diet; Dogs; Gingivitis; Hyperparathyroidism, Secondary; Parathyroid Glands; Periodontitis; Phosphorus; Tooth Mobility | 1973 |
Renal osteodystrophy in children: the effect of hemodialysis and renal homotransplantation.
Topics: Adolescent; Alkaline Phosphatase; Calcium; Child; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hyperparathyroidism; Hyperparathyroidism, Secondary; Infant; Kidney Diseases; Kidney Transplantation; Parathyroid Glands; Phosphorus; Radiography; Renal Dialysis; Transplantation, Homologous | 1972 |
Acute changes in serum calcium after renal transplantation.
Topics: Adolescent; Adult; Aluminum Hydroxide; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Glomerulonephritis; Humans; Hyperparathyroidism; Hyperparathyroidism, Secondary; Intestinal Absorption; Kidney Transplantation; Male; Phosphorus; Prednisone; Renal Dialysis; Transplantation, Homologous; Vitamin D | 1972 |
Diagnosis and management of parathyroid disorders.
Topics: Adult; Calcium; Child; Female; Humans; Hyperparathyroidism; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Diseases; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Pseudohypoparathyroidism; Pseudopseudohypoparathyroidism; Radiography | 1972 |
Bone disease and soft tissue calcification in chronic peritoneal dialysis.
Topics: Adult; Aortic Diseases; Bone Diseases; Bone Resorption; Calcinosis; Calcium; Evaluation Studies as Topic; Humans; Hyperparathyroidism, Secondary; Male; Pancreatic Diseases; Parathyroid Glands; Peritoneal Dialysis; Phosphorus; Radiography; Renal Dialysis | 1972 |
On the prevention of secondary hyperparathyroidism in experimental chronic renal disease using "proportional reduction" of dietary phosphorus intake.
Topics: Animals; Calcium; Creatinine; Diet; Disease Models, Animal; Dogs; Female; Glomerular Filtration Rate; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Tubules; Magnesium; Nephrons; Parathyroid Glands; Parathyroid Hormone; Phosphates; Phosphorus; Radioimmunoassay | 1972 |
Experience with hyperparathyroidism.
Topics: Adenoma; Autoanalysis; Calcium; Female; Humans; Hypercalcemia; Hyperparathyroidism; Hyperparathyroidism, Secondary; Kidney Calculi; Male; Middle Aged; Parathyroid Neoplasms; Phosphorus | 1973 |
Evidence for secondary hyperparathyroidism in idiopathic hypercalciuria.
Topics: Calcium; Creatinine; Female; Furosemide; Humans; Hyperparathyroidism, Secondary; Male; Parathyroid Hormone; Phosphorus; Radioimmunoassay; Spectrophotometry, Atomic; Trichlormethiazide | 1973 |
The effect of a diphosphonate on uremic hyperparathyroidism.
Topics: Animals; Bone and Bones; Bone Resorption; Calcium; Carbon Isotopes; Creatinine; Femur; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Lumbar Vertebrae; Organ Size; Organophosphonates; Parathyroid Glands; Phosphorus; Rats; Uremia | 1973 |
Rarity of renal osteodystrophy in Israel due to low phosphorus intake. A natural experiment.
Topics: Adolescent; Adult; Blood Urea Nitrogen; Calcium; Calcium, Dietary; Canada; Chronic Kidney Disease-Mineral and Bone Disorder; Creatinine; Diet; Dietary Proteins; Humans; Hyperparathyroidism, Secondary; Israel; Middle Aged; Osteomalacia; Phosphorus; Rickets; United Kingdom; United States | 1973 |
Decreased bone formation, mineralization, and enhanced resorption in calcium-deficient rats.
Topics: Animals; Bone Development; Bone Matrix; Bone Resorption; Calcium; Hyperparathyroidism, Secondary; Hypocalcemia; Male; Parathyroid Glands; Phosphorus; Rats; Tetracycline | 1973 |
The influence of a high calcium carbonate intake on bone disease in patients undergoing hemodialysis.
Topics: Administration, Oral; Alkaline Phosphatase; Aluminum Hydroxide; Biopsy; Bone and Bones; Calcification, Physiologic; Calcium; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Osteomalacia; Phosphorus; Radiography; Renal Dialysis | 1973 |
Hyperparathyroidism in patients on chronic hemodialysis.
Topics: Adult; Calcinosis; Calcium; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Middle Aged; Phosphorus; Renal Dialysis | 1973 |
Hypocalcemia following bilateral nephrectomy.
Topics: Alkaline Phosphatase; Aluminum Hydroxide; Calcium; Creatinine; Dihydroxycholecalciferols; Female; Gluconates; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Hypocalcemia; Middle Aged; Nephrectomy; Parathyroid Hormone; Phosphorus; Polycystic Kidney Diseases; Renal Dialysis; Serum Albumin | 1973 |
Hyperparathyroidism and experimental chronic renal failure.
Topics: Animals; Blood Urea Nitrogen; Calcium; Creatinine; Cytoplasm; Dogs; Endoplasmic Reticulum; Female; Glycogen; Golgi Apparatus; Hypercalcemia; Hyperparathyroidism; Hyperparathyroidism, Secondary; Kidney; Kidney Failure, Chronic; Male; Microscopy, Electron; Mitochondria; Nephrectomy; Parathyroid Glands; Phosphates; Phosphorus | 1973 |
Divalent ions in renal failure. Introduction.
Topics: Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Collagen; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Parathyroid Hormone; Phosphorus; Uremia; Vitamin D | 1973 |
Parathyroid function in patients with Paget's disease treated with salmon calcitonin.
Topics: Aged; Animals; Antigens; Calcitonin; Calcium; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Osteitis Deformans; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Salmonidae | 1973 |
Nutritional secondary hyperparathyroidism in Alaskan red fox kits.
Topics: Alaska; Animals; Blood Urea Nitrogen; Calcium; Calcium, Dietary; Conjunctivitis; Deficiency Diseases; Fibrous Dysplasia of Bone; Foxes; Hyperparathyroidism, Secondary; Kyphosis; Phosphorus | 1974 |
Nutritional secondary hyperparathyroidism in the parrakeet.
Topics: Animal Feed; Animals; Bird Diseases; Calcium, Dietary; Deficiency Diseases; Diet; Femur; Hyperparathyroidism, Secondary; Parathyroid Glands; Phosphorus; Psittaciformes; Radiography | 1974 |
Parathyroid function in uremic children with and without osteodystrophy.
Topics: Adolescent; Adult; Calcium; Child; Child, Preschool; Chronic Kidney Disease-Mineral and Bone Disorder; Creatinine; Humans; Hyperparathyroidism, Secondary; Infant; Infusions, Parenteral; Iodine Radioisotopes; Kidney Tubules; Magnesium; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Radioimmunoassay; Uremia | 1974 |
Metabolic bone disease in patients on maintenance hemodialysis.
Topics: Biopsy; Bone Diseases; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Osteocytes; Osteomalacia; Phosphorus; Renal Dialysis; Vitamin D; Vitamin D Deficiency | 1974 |
Prevention and reversal of progressive secondary hyperparathyroidism in patients maintained by hemodialysis.
Topics: Bone Resorption; Calcium; Homeostasis; Hyperparathyroidism, Secondary; Parathyroid Hormone; Phosphorus; Renal Dialysis | 1974 |
Skeletal complications of kidney disease.
Topics: Acidosis, Renal Tubular; Adolescent; Adult; Bone Diseases; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Creatinine; Fanconi Syndrome; Female; Humans; Hyperparathyroidism; Hyperparathyroidism, Secondary; Hypophosphatemia, Familial; Kidney Diseases; Kidney Failure, Chronic; Kidney Transplantation; Kidney Tubules; Male; Osteosclerosis; Phosphates; Phosphorus; Radiography; Radionuclide Imaging; Strontium Isotopes | 1971 |
Parathyroid-hormone concentrations in nutritional rickets.
Topics: Alkaline Phosphatase; Calcium; Child; Child, Preschool; Female; Humans; Hyperparathyroidism, Secondary; Infant; Kwashiorkor; Male; Parathyroid Hormone; Phosphorus; Radiography; Rickets; Vitamin D | 1972 |
Pathogenesis of osteomalacia in secondary hyperparathyroidism after gastrectomy.
Topics: Adult; Alkaline Phosphatase; Calcium; Calcium Isotopes; Dihydrotachysterol; Gastrectomy; Humans; Hyperparathyroidism, Secondary; Intestinal Absorption; Magnesium; Male; Osteomalacia; Parathyroid Hormone; Phosphates; Phosphorus; Time Factors | 1972 |
Primary renal tubular acidosis and secondary hyperparathyroidism.
Topics: Acid-Base Equilibrium; Acidosis, Renal Tubular; Adult; Calcium; Calcium Isotopes; Female; Femoral Fractures; Humans; Hyperparathyroidism, Secondary; Models, Biological; Nephrocalcinosis; Parathyroid Glands; Phosphorus | 1972 |
[Histopathology and pathogenesis of calcium deposits in the skin during hemodialysis].
Topics: Calcinosis; Calcium; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Phosphorus; Pruritus; Renal Dialysis; Skin; Spectrum Analysis | 1972 |
[Disorders of calcium-phosphorus homeostasis in 2 cases of fibrous dysplasia of bone].
Topics: Alkaline Phosphatase; Calcium; Child; Child, Preschool; Female; Fibrous Dysplasia of Bone; Humans; Hyperparathyroidism, Secondary; Male; Phosphates; Phosphorus | 1972 |
Renal handling of phosphorus in oliguric and nonoliguric mercury-induced acute renal failure in rats.
Topics: Absorption; Acute Kidney Injury; Animals; Anuria; Calcium; Carbon Isotopes; Creatinine; Female; Glomerular Filtration Rate; Hyperparathyroidism, Secondary; Inulin; Kidney Tubules; Mercury Poisoning; Phosphorus; Rats | 1971 |
Clinical study of nutritional secondary hyperparathyroidism in horses.
Topics: Alkaline Phosphatase; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Calcium; Calcium, Dietary; Diet Therapy; Facial Bones; Horse Diseases; Horses; Hypercalcemia; Hyperparathyroidism, Secondary; Mandible; Medicago sativa; Phosphorus | 1971 |
Disordered calcium and phosphorus metabolism during maintenance hemodialysis. Correlation of clinical, roentgenographic and biochemical changes.
Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Aminopeptidases; Arthritis; Blood Urea Nitrogen; Bone Diseases; Calcinosis; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Creatinine; Diet Therapy; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Muscle Cramp; Periarthritis; Phosphates; Phosphorus; Pruritus; Renal Dialysis | 1971 |
Endemic skeletal fluorosis.
Topics: Adolescent; Biopsy; Bone and Bones; Bone Diseases; Calcinosis; Calcium; Child; Feces; Female; Fluoridation; Fluoride Poisoning; Fluorides; Fluorosis, Dental; Hip; Humans; Hyperparathyroidism, Secondary; India; Knee; Magnesium; Male; Nitrogen; Osteosclerosis; Pelvic Bones; Phosphorus; Radiography; Spine; Water Supply | 1971 |
A study of calcium absorption using an automated fluorimetric assay procedure.
Topics: Bilirubin; Body Weight; Calcium; Colorimetry; Fasting; Fluorometry; Hemoglobins; Humans; Hyperparathyroidism, Secondary; Kidney Calculi; Kidney Failure, Chronic; Lipids; Magnesium; Methods; Phosphorus; Time Factors | 1971 |
[Bone changes after subtotal gastrectomy and various small intestine resections in dogs].
Topics: Alkaline Phosphatase; Animals; Body Weight; Bone Resorption; Calcium; Dogs; Feces; Gastrectomy; Hyperparathyroidism, Secondary; Hypocalcemia; Ileum; Intestine, Small; Jejunum; Lipids; Phosphorus; Postgastrectomy Syndromes; Postoperative Complications; Vitamin D | 1971 |
Hyperparathyroidism in idiopathic hypercalciuria: primary or secondary?
Topics: Calcium; Calcium Metabolism Disorders; Diuretics; Female; Humans; Hyperparathyroidism; Hyperparathyroidism, Secondary; Male; Parathyroid Hormone; Phosphorus | 1971 |
Pathology and ultrastructure of the human parathyroid glands in chronic renal failure.
Topics: Adenoma; Adult; Animals; Calcium; Cell Membrane; Cell Nucleus; Cytoplasm; Cytoplasmic Granules; Electrolytes; Endoplasmic Reticulum; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Mice; Microscopy, Electron; Mitochondria; Organ Size; Osteitis Fibrosa Cystica; Parathyroid Glands; Parathyroid Hormone; Parathyroid Neoplasms; Phosphorus; Rats | 1969 |